https://www.novartis.com/us-en/
2024-01-31T09:14:45-05:00
daily
1.0
https://www.novartis.com/us-en/about/country-leadership-team/vishal-patel
2022-03-25T03:51:40-04:00
daily
1.0
https://www.novartis.com/us-en/about/country-leadership-team/vicki-rawlinson
2022-07-20T09:57:59-04:00
daily
1.0
https://www.novartis.com/us-en/about/country-leadership-team/shefali-kothari
2022-07-20T09:55:46-04:00
daily
1.0
https://www.novartis.com/us-en/about/country-leadership-team/mary-treacy
2022-07-20T09:28:41-04:00
daily
1.0
https://www.novartis.com/us-en/about/country-leadership-team/linda-armstrong
2023-02-15T11:40:01-05:00
daily
1.0
https://www.novartis.com/us-en/about/country-leadership-team/emma-harrington
2022-03-25T07:03:54-04:00
daily
1.0
https://www.novartis.com/us-en/about/country-leadership-team/elizabeth-liz-mcgee
2022-07-20T09:17:40-04:00
daily
1.0
https://www.novartis.com/us-en/about/country-leadership-team/courtney-piron
2023-12-01T15:49:48-05:00
daily
1.0
https://www.novartis.com/us-en/about/country-leadership-team/chris-klee
2022-03-25T07:11:39-04:00
daily
1.0
https://www.novartis.com/us-en/about/country-leadership-team/alexandra-bach-weidmuller
2022-07-20T10:05:31-04:00
daily
1.0
https://www.novartis.com/us-en/about/country-leadership-team/emily-chee
2022-07-20T10:08:43-04:00
daily
1.0
https://www.novartis.com/us-en/about/country-leadership-team/john-mckenna
2022-07-20T10:13:07-04:00
daily
1.0
https://www.novartis.com/us-en/page-not-found
2022-03-30T01:06:54-04:00
daily
1.0
https://www.novartis.com/us-en/news/news-archive
2023-03-13T06:01:19-04:00
daily
1.0
https://www.novartis.com/us-en/careers
2023-12-01T10:34:28-05:00
daily
1.0
https://www.novartis.com/us-en/about/us-country-coordinating-committee
2023-12-01T15:56:05-05:00
daily
1.0
https://www.novartis.com/us-en/patients-and-caregivers/novartis-commitment-patients-and-caregivers
2023-10-20T20:27:32-04:00
daily
1.0
https://www.novartis.com/us-en/esg/ethical-behavior
2022-06-06T15:43:19-04:00
daily
1.0
https://www.novartis.com/us-en/esg/ethical-behavior/code-ethics
2021-12-15T03:40:43-05:00
daily
1.0
https://www.novartis.com/us-en/esg/ethical-behavior/speakup
2022-03-28T09:19:12-04:00
daily
1.0
https://www.novartis.com/us-en/about-us/contact-us/office-locations
2022-03-13T11:21:01-04:00
daily
1.0
https://www.novartis.com/us-en/terms-use
2022-03-22T05:01:08-04:00
daily
1.0
https://www.novartis.com/us-en/careers/awards-recognition
2022-05-13T07:57:11-04:00
daily
1.0
https://www.novartis.com/us-en/about/novartis-us/company-glance/research-and-development/therapeutic-areas
2022-03-28T08:32:36-04:00
daily
1.0
https://www.novartis.com/us-en/careers/working-novartis
2022-03-28T12:10:13-04:00
daily
1.0
https://www.novartis.com/us-en/about/company-history
2022-04-01T07:50:28-04:00
daily
1.0
https://www.novartis.com/us-en/careers/employee-benefits
2022-03-25T03:56:53-04:00
daily
1.0
https://www.novartis.com/us-en/patients-and-caregivers/patient-assistance/patient-assistance-programs
2023-08-11T11:04:07-04:00
daily
1.0
https://www.novartis.com/us-en/careers/working-novartis/company-mission
2022-03-24T03:29:56-04:00
daily
1.0
https://www.novartis.com/us-en/careers/career-development
2022-03-24T09:17:34-04:00
daily
1.0
https://www.novartis.com/us-en/esg/corporate-responsibility/people-and-communities
2022-03-24T03:41:32-04:00
daily
1.0
https://www.novartis.com/us-en/esg/ethical-behavior/business-principles
2022-03-28T10:07:00-04:00
daily
1.0
https://www.novartis.com/us-en/esg/corporate-responsibility/environmental-sustainability
2022-03-31T07:00:41-04:00
daily
1.0
https://www.novartis.com/us-en/esg/ethics-risk-and-compliance/compliance-program
2022-03-28T10:27:28-04:00
daily
1.0
https://www.novartis.com/us-en/esg/ethics-risk-and-compliance/state-laws
2023-01-30T14:28:33-05:00
daily
1.0
https://www.novartis.com/us-en/esg/ethical-behavior/phrma-code-interactions-healthcare-professionals
2022-03-23T05:31:54-04:00
daily
1.0
https://www.novartis.com/us-en/esg/ethics-risk-and-compliance/corporate-integrity-agreement
2022-03-28T11:55:15-04:00
daily
1.0
https://www.novartis.com/us-en/esg/ethics-risk-and-compliance/payments-hcps-hcos
2022-03-28T12:02:01-04:00
daily
1.0
https://www.novartis.com/us-en/patients-and-caregivers/patient-assistance/patient-assistance-foundation-enrollment
2024-03-05T12:56:46-05:00
daily
1.0
https://www.novartis.com/us-en/careers/diversity-and-inclusion
2022-03-22T09:13:24-04:00
daily
1.0
https://www.novartis.com/us-en/esg/ethics-risk-and-compliance/state-laws/ca-health-and-safety-code-ss119402
2023-01-30T14:30:50-05:00
daily
1.0
https://www.novartis.com/us-en/esg/ethics-risk-and-compliance/state-laws/annual-description-comprehensive-compliance-program
2023-01-30T14:29:53-05:00
daily
1.0
https://www.novartis.com/us-en/esg/ethics-risk-and-compliance/state-laws/california-npc-declaration-compliance
2023-01-30T14:27:53-05:00
daily
1.0
https://www.novartis.com/us-en/careers/meet-teams
2023-04-11T13:38:11-04:00
daily
1.0
https://www.novartis.com/us-en/news/us-media-contacts
2024-02-21T13:31:09-05:00
daily
1.0
https://www.novartis.com/us-en/contact-select
2022-07-20T16:20:22-04:00
daily
1.0
https://www.novartis.com/us-en/careers/nibr-careers-frequently-asked-questions
2022-03-13T11:21:01-04:00
daily
1.0
https://www.novartis.com/us-en/recall-zofran-and-entresto-packages
2022-04-01T09:25:43-04:00
daily
1.0
https://www.novartis.com/us-en/esg/ethics-risk-and-compliance/enhanced-verification-request
2022-03-28T12:17:10-04:00
daily
1.0
https://www.novartis.com/us-en/novartis-jp-morgan-2020
2022-03-13T11:21:01-04:00
daily
1.0
https://www.novartis.com/us-en/esg/corporate-responsibility/novartis-society-us-reports
2022-03-28T12:58:42-04:00
daily
1.0
https://www.novartis.com/us-en/coronavirus/novartis-us-covid-19-initiatives
2022-03-29T04:09:58-04:00
daily
1.0
https://www.novartis.com/us-en/about/diversity-and-inclusion/standing-racial-equity-and-justice-one-novartis
2022-08-31T19:47:32-04:00
daily
1.0
https://www.novartis.com/us-en/coronavirus/novartis-us-covid-19-initiatives/novartis-us-foundation-provides-support-40-community-organizations-covid-19-pandemic-response-efforts
2022-03-29T04:15:06-04:00
daily
1.0
https://www.novartis.com/us-en/careers/personal-growth
2023-11-13T07:46:34-05:00
daily
1.0
https://www.novartis.com/us-en/about/novartis-us/company-glance/research-and-development
2022-03-28T08:40:16-04:00
daily
1.0
https://www.novartis.com/us-en/about/novartis-us/company-glance/value-and-pricing
2022-03-28T12:51:24-04:00
daily
1.0
https://www.novartis.com/us-en/about/novartis-us/company-glance/responsible-business-practices
2022-03-25T01:44:34-04:00
daily
1.0
https://www.novartis.com/us-en/about/novartis-us/company-glance/shaping-our-healthcare-environment
2022-03-28T08:12:33-04:00
daily
1.0
https://www.novartis.com/us-en/about/novartis-us/numbers
2022-05-10T12:50:42-04:00
daily
1.0
https://www.novartis.com/us-en/about/novartis-us/diversity-and-inclusion
2022-03-28T09:04:55-04:00
daily
1.0
https://www.novartis.com/us-en/about/novartis-us-glance/pay-transparency-epic
2022-03-22T05:04:55-04:00
daily
1.0
https://www.novartis.com/us-en/about/novartis-us-glance/our-code-ethics
2022-03-22T05:05:31-04:00
daily
1.0
https://www.novartis.com/us-en/about/novartis-us/our-commitment-patients-caregivers/access-principles
2022-03-28T07:38:20-04:00
daily
1.0
https://www.novartis.com/us-en/about/novartis-us/our-commitment-patients-caregivers/diversity-clinical-trials
2022-03-28T07:33:06-04:00
daily
1.0
https://www.novartis.com/us-en/esg/corporate-responsibility/novartis-us-foundation
2022-03-28T13:05:34-04:00
daily
1.0
https://www.novartis.com/us-en/coronavirus/our-response-covid-19
2022-03-25T08:33:22-04:00
daily
1.0
https://www.novartis.com/us-en/about/novartis-us/our-commitment-patients-caregivers
2022-03-25T09:37:33-04:00
daily
1.0
https://www.novartis.com/us-en/about/novartis-us/company-glance
2022-05-10T11:59:20-04:00
daily
1.0
https://www.novartis.com/us-en/patients-and-caregivers/patient-assistance
2024-01-30T09:11:00-05:00
daily
1.0
https://www.novartis.com/us-en/about/novartis-us/our-commitment-patients-caregivers/novartis-commitment-patients-caregivers
2022-03-28T07:57:14-04:00
daily
1.0
https://www.novartis.com/us-en/about/external-funding
2023-04-11T11:58:14-04:00
daily
1.0
https://www.novartis.com/us-en/about/external-funding/educational-grants
2022-05-17T11:18:02-04:00
daily
1.0
https://www.novartis.com/us-en/about/external-funding/sponsorships-and-memberships
2024-01-19T15:40:14-05:00
daily
1.0
https://www.novartis.com/us-en/about/external-funding/faqs
2022-05-17T11:29:14-04:00
daily
1.0
https://www.novartis.com/us-en/about/external-funding/educational-grants/professional-medical-education-grants
2024-02-14T11:19:26-05:00
daily
1.0
https://www.novartis.com/us-en/about/external-funding/educational-grants/patient-education-grants
2022-05-17T11:27:15-04:00
daily
1.0
https://www.novartis.com/us-en/about/diversity-and-inclusion/supplier-diversity
2023-04-20T00:52:22-04:00
daily
1.0
https://www.novartis.com/us-en/about/diversity-and-inclusion/standing-together-equity-and-social-justice
2022-05-10T13:02:23-04:00
daily
1.0
https://www.novartis.com/us-en/about/diversity-and-inclusion/unleashing-power-our-people-spirit-inclusivity
2022-05-10T13:07:01-04:00
daily
1.0
https://www.novartis.com/us-en/about/diversity-and-inclusion/toward-better-society
2022-03-22T05:17:03-04:00
daily
1.0
https://www.novartis.com/us-en/careers/meet-teams/careers-research
2023-11-13T08:04:56-05:00
daily
1.0
https://www.novartis.com/us-en/careers/meet-teams/careers-digital
2023-11-13T08:03:33-05:00
daily
1.0
https://www.novartis.com/us-en/careers/meet-teams/careers-information-technology-it
2023-11-13T08:02:01-05:00
daily
1.0
https://www.novartis.com/us-en/careers/meet-teams/careers-procurement
2023-11-13T08:00:33-05:00
daily
1.0
https://www.novartis.com/us-en/careers/meet-teams/careers-health-safety-environment
2023-11-13T07:55:36-05:00
daily
1.0
https://www.novartis.com/us-en/careers/meet-teams/careers-medical-development
2023-11-13T07:54:48-05:00
daily
1.0
https://www.novartis.com/us-en/careers/meet-teams/careers-people-organization
2023-11-13T07:53:25-05:00
daily
1.0
https://www.novartis.com/us-en/careers/meet-teams/careers-communications-and-advocacy
2022-03-29T03:38:49-04:00
daily
1.0
https://www.novartis.com/us-en/careers/meet-teams/careers-consulting
2023-11-13T07:50:46-05:00
daily
1.0
https://www.novartis.com/us-en/careers/meet-teams/careers-technical-operations
2023-11-13T07:49:07-05:00
daily
1.0
https://www.novartis.com/us-en/careers/meet-teams/careers-strategy
2022-03-29T03:13:12-04:00
daily
1.0
https://www.novartis.com/us-en/careers/meet-teams/careers-commercial
2023-11-13T07:52:06-05:00
daily
1.0
https://www.novartis.com/us-en/patients-and-caregivers/step-program/program-overview
2022-05-17T19:03:36-04:00
daily
1.0
https://www.novartis.com/us-en/patients-and-caregivers/step-program/application-funding-help-address-health-disparities
2022-05-17T19:05:11-04:00
daily
1.0
https://www.novartis.com/us-en/patients-and-caregivers/step-program/cancer
2022-05-17T19:04:40-04:00
daily
1.0
https://www.novartis.com/us-en/patients-and-caregivers/step-program/sickle-cell-disease-scd
2022-05-17T19:03:02-04:00
daily
1.0
https://www.novartis.com/us-en/patients-and-caregivers/step-program/multiple-sclerosis-ms
2022-05-17T19:04:07-04:00
daily
1.0
https://www.novartis.com/us-en/news/step-program/age-related-macular-degeneration-amd
2022-03-28T10:07:02-04:00
daily
1.0
https://www.novartis.com/us-en/about/novartis-us/our-commitment-improving-population-health-heart-disease
2022-06-06T16:36:35-04:00
daily
1.0
https://www.novartis.com/us-en/careers/early-talent
2023-12-04T06:35:50-05:00
daily
1.0
https://www.novartis.com/us-en/patients-and-caregivers/step-program/health-disparities
2022-05-17T19:05:44-04:00
daily
1.0
https://www.novartis.com/us-en/about/contact-us
2023-12-01T11:24:48-05:00
daily
1.0
https://www.novartis.com/us-en/careers/how-we-work
2022-12-14T10:51:34-05:00
daily
1.0
https://www.novartis.com/us-en/about/strategy
2022-03-29T05:43:33-04:00
daily
1.0
https://www.novartis.com/us-en/esg/beacon-hope/beacon-hope-measurable-solutions-health-equity
2023-07-11T17:18:19-04:00
daily
1.0
https://www.novartis.com/us-en/gilenya-guides-community-privacy-policy
2022-07-22T15:01:14-04:00
daily
1.0
https://www.novartis.com/us-en/privacy
2023-01-09T10:34:18-05:00
daily
1.0
https://www.novartis.com/us-en/about/external-funding/educational-grants/professional-medical-education-grants/request-proposal-rfp-paroxysmal-nocturnal-hemoglobinuria-pnh
2023-01-20T12:59:44-05:00
daily
1.0
https://www.novartis.com/us-en/about/external-funding/educational-grants/professional-medical-education-grants/request-proposal-rfp-hyperlipidemia
2023-01-20T12:58:36-05:00
daily
1.0
https://www.novartis.com/us-en/news/radioligand-therapy-supply-information/patient-faqs
2023-06-02T12:52:01-04:00
daily
1.0
https://www.novartis.com/us-en/esg/beacon-hope/paving-way-brighter-more-equitable-future
2023-06-26T11:19:22-04:00
daily
1.0
https://www.novartis.com/us-en/patients-and-caregivers/diseases/reality-living-chronic-spontaneous-urticaria-csu
2023-09-13T10:30:43-04:00
daily
1.0
https://www.novartis.com/us-en/patients-and-caregivers/diseases/hidradenitis-suppurativa-hs
2024-03-01T21:00:25-05:00
daily
1.0
https://www.novartis.com/us-en/privacy/consumer-health
2024-03-15T07:22:27-04:00
daily
1.0
https://www.novartis.com/us-en/careers/career-search/job-details/390595br/field-medical-excellence-lead
2024-02-22T09:02:16-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/390781br/medical-da-lead
2024-02-01T00:30:11-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/390806br/coordinateur-strategy-operations-hf
2024-03-13T08:03:37-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/390880br/country-medical-affairs-head-im
2024-02-01T09:02:35-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/391012br/cell-processing-specialist-temporary-2-years-contract
2024-02-01T00:30:11-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/391070br/research-scientist-immuno-oncology-cell-and-gene-therapy
2024-03-04T17:03:23-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/391143br/ad-access-reimbursement-radioligand-therapy-remote-springfield-il
2024-03-06T21:02:08-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/391108br/accounting-lead-mfd
2024-03-13T02:03:23-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/391112br/fra-analyst-mfd
2024-03-01T03:02:48-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/391120br/hospital-sales-representative-ta-cardiovascular-dwm-gebiet-heilbr
2024-02-01T00:30:11-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/391183br/responsable-grands-comptes-neuro-bfc-aura-hf
2024-02-13T05:02:03-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/391201br/warehouse-executive
2024-03-13T02:03:23-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/391207br/local-gcppv-auditor
2024-02-01T00:30:11-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/391216br/senior-financial-compliance-manager
2024-03-15T06:03:53-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/391228br/supply-demand-manager
2024-02-23T05:02:11-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/391248br/technicien-services-techniques-utilites-hf
2024-02-01T00:30:11-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/391254br/medical-science-liaison-manager-mwd-baden-wurttemberg
2024-02-22T09:02:16-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/391256br/ad-access-reimbursement-radioligand-therapy-remote-detroit-mi
2024-03-07T17:02:10-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/391260br/ad-access-reimbursement-nps-radioligand-therapy-remote-los-angeles
2024-02-01T11:02:42-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/390168br/senior-scientist-iii-vivo-pharmacology-80-100
2024-02-01T00:30:11-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/382933br/senior-process-expert-mfd
2024-02-19T11:02:03-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/384003br/global-procurement-head-category-warehousing-distribution
2024-02-01T00:30:11-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/384220br/principal-scientist-vivo-pharmacologyb-cell-therapies-80-100
2024-03-08T07:02:28-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/385833br/associate-director-aiml-products
2024-03-14T02:03:17-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/386887br/associate-director-itot-lead
2024-03-15T16:05:48-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/386891br/associate-director-itot-lead
2024-03-15T16:05:48-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/387911br/chef-de-produit-senior-tumeurs-solides-hf
2024-02-01T00:30:11-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/389137br/senior-statistical-programmer
2024-03-13T02:03:23-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/389474br/senior-medical-information-manager-ii
2024-02-01T00:30:11-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/389956br/warehouse-logistics-expert-mwd
2024-03-12T12:03:38-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/390150br/senior-business-analyst-japanese-speaker
2024-02-26T23:02:28-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/390166br/qa-evaluation-and-integration-lead
2024-03-11T12:03:24-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/391257br/ad-access-reimbursement-radioligand-therapy-remote-lexington-ky
2024-03-07T17:02:10-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/391258br/ad-access-reimbursement-radioligand-therapy-remote-nashville-tn
2024-03-07T17:02:10-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/391268br/senior-process-expert-fmd
2024-02-01T00:30:11-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/391278br/responsable-grands-comptes-neuro-normandie-bretagne-hf
2024-02-01T00:30:11-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/391284br/disease-area-partner-hematology-cairo
2024-03-06T09:02:18-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/369935br/22-principal-clinical-data-scientist-trial-data-managerproject-data
2024-03-01T07:10:44-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/369937br/senior-clinical-data-scientist-trial-data-manager
2024-03-01T07:10:44-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/369943br/sr-principal-clinical-data-scientist-project-data-manager
2024-03-01T07:10:44-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/370976br/22-principal-statistical-programmer
2024-03-01T07:10:44-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/370990br/23-senior-statistical-programmer
2024-03-01T07:10:44-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/381885br/senior-tax-analyst-state-local-tax
2024-03-15T18:05:24-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/381886br/manager-state-local-tax
2024-03-15T18:05:24-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/383647br/head-protective-security-asia-pacific
2024-02-19T05:02:04-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/384123br/brand-lead-solid-tumors-madridbarcelona
2024-03-05T03:03:48-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/386479br/real-estate-lead-data-technology
2024-03-15T14:05:37-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/386838br/rlt-sasayamaassociate-scm-planner
2024-02-01T00:30:11-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/386980br/srlead-agile-coach
2024-02-01T00:30:11-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/387664br/rwe-team-lead
2024-03-06T11:02:08-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/387775br/technical-product-owner-data-analytics
2024-03-11T14:02:55-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/388236br/technical-product-manager-veeva-crm
2024-03-11T14:02:55-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/388403br/financial-reporting-and-accounting-fra-analyst-mfd
2024-03-01T03:02:48-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/389070br/pharmacovigilance-governance-manager-fmd
2024-02-01T00:30:11-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/389458br/lead-senior-lead-rwe-bio-statistics-specialist
2024-03-05T03:03:48-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/389462br/sr-cluster-procurement-manager-lmm-apma
2024-02-01T00:30:11-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/389542br/assoc-dir-dermatology-clinical-specialist-mn-ia-remote
2024-02-01T00:30:11-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/389793br/manufacturing-systems-expert
2024-02-01T00:30:11-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/389852br/sr-spec-ddit-dev-bp-gco
2024-03-08T05:02:30-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/389854br/territory-business-executive
2024-03-13T02:03:23-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/389941br/associate-expert-science-technology-mfd-80-100
2024-03-01T17:03:10-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/389951br/expert-science-technology-80-100
2024-02-01T00:30:11-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/389995br/responsable-comptabilite-generale-hf
2024-02-01T00:30:11-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/390419br/expert-science-technology-mfd
2024-03-01T17:03:10-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/390422br/health-and-safety-hse-officer
2024-02-01T00:30:11-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/390748br/storage-engineering-associate-director
2024-02-01T00:30:11-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/390750br/windows-engineering-expert
2024-02-01T00:30:11-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/390950br/disease-area-partner-immunology-cairo
2024-03-03T07:02:44-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/390975br/procurement-manager
2024-02-01T00:30:11-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/390977br/expert-technique-utilites-propres-hf
2024-02-01T00:30:11-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/391056br/senior-expert-science-technology
2024-02-01T00:30:11-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/391147br/ad-access-reimbursement-radioligand-therapy-remote-milwaukee-wi
2024-03-07T17:02:10-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/391082br/internship-pharmacometrics
2024-02-01T00:30:11-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/391090br/data-steward
2024-03-15T08:04:19-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/391094br/legal-trainee-development-and-innovative-medicines
2024-02-05T09:02:30-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/391095br/technical-data-architect-officer
2024-03-05T03:03:48-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/391100br/qiyuesheyuanzongwuashisutantozhangkaizhecaiyong
2024-02-01T00:30:11-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/391103br/qiyuesheyuankurinikarutoraiaru-ashisutanto-ctazhangkaizhecaiyong
2024-02-01T00:30:11-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/391104br/director-data-analytics-platforms-architect
2024-02-20T11:02:08-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/391125br/responsable-grands-comptes-onco-region-ouest
2024-02-01T00:30:11-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/391129br/sr-specialistsap-basis-aws
2024-02-07T07:02:58-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/391150br/associate-director-sap-basis-b4-hana-aws
2024-02-01T00:30:11-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/391154br/ad-access-reimbursement-radioligand-therapy-remote-albany-ny
2024-02-20T15:02:03-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/391155br/assoc-dir-sol-architect-automation
2024-02-01T00:30:11-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/391158br/ad-access-reimbursement-radioligand-therapy-remote-boston-ma
2024-02-01T00:30:11-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/391161br/ad-access-reimbursement-radioligand-therapy-remote-pittsburgh-pa
2024-03-08T19:02:38-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/391163br/assoc-dir-platform-analytics-architect
2024-02-01T00:30:11-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/391164br/ad-access-reimbursement-radioligand-therapy-remote-washington-dc
2024-03-08T19:02:38-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/391166br/ad-access-reimbursement-radioligand-therapy-remote-charlotte-nc
2024-03-08T19:02:38-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/391169br/ad-access-reimbursement-radioligand-therapy-remote-tampa-fl
2024-02-01T00:30:11-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/391173br/ad-access-reimbursement-radioligand-therapy-remote-miami-fl
2024-03-08T19:02:38-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/391175br/ad-access-reimbursement-radioligand-therapy-remote-memphis-tn
2024-03-08T19:02:38-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/391185br/executive-personnel-specialist
2024-03-03T13:02:47-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/391188br/disease-area-partner-heart-failure-sharkia
2024-03-14T08:04:10-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/391190br/disease-area-partner-heart-failure-beheira
2024-03-14T08:04:10-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/391191br/disease-area-partner-heart-failure-beni-suef
2024-03-14T08:04:10-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/391192br/responsable-grands-comptes-neuro-centre-val-de-loire-hf
2024-02-01T00:30:11-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/391193br/disease-area-partner-heart-failure-aswan
2024-03-14T08:04:10-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/391197br/life-cycle-manager
2024-02-16T05:02:08-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/382976br/regional-senior-manager-erc-operations
2024-03-05T05:03:41-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/385749br/lead-ta-medical-specialty
2024-03-07T05:02:20-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/386145br/assoc-dir-ddit-ops-sol-architecture
2024-02-19T05:02:04-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/387241br/senior-study-leader
2024-03-11T10:03:28-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/387530br/continuous-improvement-engineer-mfd
2024-02-12T05:01:56-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/387537br/production-support-engineer-mfd
2024-02-12T05:01:56-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/388177br/principal-scientist-cadd
2024-03-11T16:03:00-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/389739br/principal-biostatistician
2024-03-13T02:03:23-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/390181br/external-materials-planner-morris-plains-site-ljubljana
2024-02-01T00:30:11-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/390196br/executive-director-launch-excellence
2024-02-01T00:30:11-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/390424br/general-coordinating-expert-acd
2024-03-07T07:02:16-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/391073br/head-ra-mow-new-product-strategy
2024-03-06T19:02:29-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/390730br/cq-engineer-emsr
2024-02-01T00:30:11-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/390929br/qc-supervisor
2024-03-14T06:03:53-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/390967br/principal-statistical-programmer
2024-03-13T02:03:23-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/390991br/qc-analyst-i-temporary-2-years-contract
2024-02-01T00:30:11-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/390993br/qc-analyst-i-temporary-1-year-contract
2024-02-01T00:30:11-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/391014br/qc-lab-analyst-i-temp
2024-02-16T09:02:13-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/391017br/chef-de-projet-ingenierie-hf
2024-02-01T00:30:11-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/387466br/medical-lead-new-products
2024-03-13T08:03:37-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/390953br/study-start-manager
2024-02-21T05:02:14-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/390956br/associate-medical-advisor-neuroscience
2024-02-01T00:30:11-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/388907br/head-market-access
2024-02-07T07:02:58-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/390948br/ast-specialist-mfd
2024-03-06T11:02:08-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/384809br/global-head-clinical-quantitative-sciences
2024-02-02T15:02:33-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/386927br/shift-lead-ii
2024-02-01T00:30:11-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/388361br/sr-regulatory-affairs-specialist
2024-02-26T09:02:26-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/388543br/clinical-research-medical-advisor
2024-02-26T05:02:25-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/388801br/senior-regulatory-affairs-manager
2024-02-01T00:30:11-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/388985br/production-aid-temporary
2024-03-14T06:03:53-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/389126br/strategy-bd-manager
2024-02-23T05:02:11-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/389444br/technicien-de-production-controle-qualite-saint-genis-pouilly-hf
2024-03-11T12:03:24-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/389461br/director-regional-search-evaluation
2024-02-05T05:02:29-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/389673br/senior-people-organization-business-partner-site
2024-02-23T05:02:11-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/390210br/senior-infrastructure-engineering-aws-expert
2024-02-01T00:30:11-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/390248br/qa-documentation-coordinator-mfd
2024-03-07T05:02:20-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/390761br/gcp-team-lead-basel
2024-02-01T00:30:11-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/390824br/senior-technical-transfer-lead
2024-02-18T23:01:59-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/390875br/quality-compliance-coordinator
2024-03-01T01:03:56-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/390879br/erp-assurance-manager
2024-02-26T03:02:17-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/390888br/senior-regulatory-writer
2024-02-01T00:30:11-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/390893br/director-search-evaluation
2024-02-01T00:30:11-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/390906br/qiyuesheyuanzhangkaizhecaiyong
2024-02-01T00:30:11-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/390921br/qualified-person-qp
2024-02-01T00:30:11-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/390927br/responsable-grands-comptes-onco-idf-et-nord
2024-02-01T00:30:11-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/390941br/ed-access-reimbursement-nps-radioligand-therapy-remote-nj
2024-03-12T16:03:24-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/390937br/people-partner-site
2024-02-01T00:30:11-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/390938br/rd-access-reimbursement-nps-radioligand-therapy-west-remote-az
2024-03-12T16:03:24-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/390939br/rd-access-reimbursement-nps-radioligand-therapy-southeast-remote-ga
2024-03-12T16:03:24-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/390946br/marketing-account-manager-and-engagement
2024-02-29T19:02:55-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/390947br/executive-medical-director-us-medical-program-head-allergy
2024-02-02T09:02:44-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/379318br/elektrotechniker-mwd
2024-03-07T09:02:21-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/383895br/global-procurement-category-manager-infrastructure-and-security
2024-03-06T05:02:15-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/385760br/qc-specialist-mfd
2024-03-11T12:03:24-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/387667br/production-head
2024-03-06T09:02:18-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/387980br/sr-spec-ddit-ies-cloud-engineerin
2024-02-29T01:03:22-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/388569br/medical-director-nephrologygenetic-diseases-translational-medicine
2024-02-01T00:30:11-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/389529br/customer-service-team-lead-molecular-imaging-mwd
2024-02-19T07:02:07-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/390328br/sr-supply-demand-planner
2024-03-05T05:03:41-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/389961br/clinical-operations-program-head
2024-03-15T10:04:31-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/390540br/pharmaziepraktikant-wmd-im-bereich-manufacturing-ab-marzapril
2024-02-01T00:30:11-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/390865br/global-process-owner-requisition-order-remote-usa
2024-03-08T17:02:37-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/390859br/senior-expert-structural-bioinformatician
2024-03-11T14:02:55-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/390786br/regional-business-manager
2024-03-13T04:03:38-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/390788br/senior-specialist-integration-platform-bods-and-informatica
2024-02-01T00:30:11-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/390789br/senior-specialistsap-bwhana
2024-02-01T00:30:11-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/390818br/commissioning-qualification-specialist
2024-03-14T10:04:01-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/390846br/associate-director-solution-design-erp-supply-chain-management
2024-02-14T11:02:15-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/390866br/private-access-manager
2024-03-06T19:02:29-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/375415br/expert-clinical-research-associate-hungaryhome-based
2024-03-13T12:03:19-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/385607br/seniorclinical-development-medical-director-renal-80-100
2024-02-01T00:30:11-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/387793br/pnh-specialist-multiple-locations-may-be-considered
2024-03-07T03:02:09-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/388022br/associate-director-biotherapeutic-engineering
2024-03-13T18:03:13-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/388021br/associate-director-xrna-therapeutics
2024-03-13T18:03:13-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/388532br/senior-study-leader
2024-03-05T11:03:32-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/390368br/senior-medical-information-manager-ii
2024-02-01T00:30:11-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/390700br/managerassociate-msl
2024-03-04T07:03:25-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/390727br/senior-scientific-writer-ii
2024-03-05T09:04:08-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/390728br/expert-scientific-writer
2024-03-01T07:10:44-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/390738br/assoc-dir-ddit-dev-technical-solution-delivery-gco
2024-03-06T05:02:15-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/390747br/sales-value-associate-toluca
2024-03-11T14:02:55-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/390774br/senior-scientist-quality-control-analytics-sun-wed-7am-530pm
2024-02-01T00:30:11-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/390777br/senior-scientist-quality-control-analytics-wed-sat-7am-530pm
2024-02-01T00:30:11-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/390778br/senior-scientist-quality-control-analytics-wed-sat-230pm-1am
2024-02-01T00:30:11-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/378407br/bpa-analyst
2024-03-14T16:03:15-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/383066br/global-operational-excellence-director
2024-03-13T04:03:38-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/383768br/senior-global-program-clinical-head
2024-02-01T00:30:11-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/384527br/r2r-senior-specialist-gl-reporting
2024-02-01T00:30:11-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/388539br/key-account-manager-east-scotland-ne-england-newcastle-area
2024-03-15T08:04:19-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/389267br/engineer-multidiscipline-i-mfd-automation
2024-03-12T04:04:04-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/389413br/cq-engineer-ii-mfd
2024-03-12T04:04:04-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/389472br/rewards-manager
2024-03-07T05:02:20-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/390679br/snr-ra-compliance-associate
2024-03-07T23:02:23-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/390588br/medical-representative
2024-03-14T22:03:31-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/390604br/stagiaires-chef-de-projets-meetings-congres-et-evenements
2024-02-01T00:30:11-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/390605br/stagiaires-chef-de-projets-meetings-congres-et-evenements
2024-02-01T00:30:11-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/390611br/manager-system-operations
2024-03-05T07:03:36-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/390615br/operater-mzd
2024-03-06T07:02:13-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/390621br/equipment-specialist-iii
2024-03-06T05:02:15-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/390632br/senior-specialist-power-apps
2024-02-01T00:30:11-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/390639br/senior-principal-scientist-computational-medicinal-chemistry
2024-02-01T00:30:11-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/390641br/computational-medicinal-chemistsenior-expert-data-science
2024-02-01T00:30:11-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/390665br/associate-director-rare-renal-training-remote
2024-03-12T16:03:24-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/390669br/medical-science-liaison-msl-allergy-derm-ky-sw-oh-remote
2024-03-05T19:03:48-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/385901br/netzwerkmanager-mwd-neuroscience-gebiet-mitte
2024-02-01T00:30:11-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/387431br/technicien-de-production-cq-marseille-hf
2024-03-04T13:03:37-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/387640br/medical-safety-lead
2024-03-13T14:03:21-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/388358br/engineering-lead-trd-rlt
2024-03-13T06:03:36-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/388658br/clinical-development-medical-director-nuclear-medicine
2024-03-07T19:02:13-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/389521br/qa-operations-expert-fmd
2024-02-27T09:02:39-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/389836br/tehnik-vzdrzevanja-mzd
2024-03-05T05:03:41-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/390044br/starshiy-inzhener-tekhnolog-po-processu-upakovki
2024-02-01T00:30:11-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/390286br/legal-traineeship-novartis-corporate-functions
2024-02-05T09:02:30-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/390412br/associate-director-thought-leader-liaison-allergy-new-england
2024-02-26T11:02:28-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/390469br/oncology-specialist-rlt-prostate-ann-arbor-mi-remote
2024-03-12T10:03:16-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/390485br/scientist-quality-control-sun-wed-7am-530pm
2024-02-01T00:30:11-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/390504br/expert-science-technology-nitrosamine-scientist-ard
2024-02-01T00:30:11-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/390506br/area-manager-ha-noi
2024-02-23T07:02:23-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/390509br/associate-director-sap-pp-pm
2024-02-01T00:30:11-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/390517br/data-quality-analyst
2024-02-20T07:02:12-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/390520br/medical-excellence-strategic-advisor-manager
2024-02-01T00:30:11-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/390522br/stage-chef-de-produit-oncologie
2024-02-01T00:30:11-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/390542br/associate-scientist-hours-wed-sat-230pm-100am
2024-02-01T00:30:11-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/390556br/scientist-quality-control-wed-sat-230pm-100am
2024-02-01T00:30:11-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/390574br/senior-study-leader
2024-03-13T20:03:16-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/390578br/general-accounting-senior-specialist
2024-03-14T12:03:39-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/383173br/manager-new-product-dwm-focus-radioligandtherapy-rlt
2024-03-11T14:02:55-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/387900br/senior-scientist
2024-02-01T03:02:27-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/390198br/associate-dir-business-relationship-mgmt
2024-02-01T00:30:11-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/375015br/cardiovascular-institutional-sales-specialist-springfield-remote
2024-02-29T17:02:50-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/379770br/medical-scientific-liaison-msl-dwm-berlin
2024-03-04T15:03:32-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/383898br/sr-specialistaws-cloud-formationpythonterraform-eks
2024-03-06T07:02:13-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/383935br/senior-study-leader
2024-03-07T03:02:09-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/385750br/head-corporate-archives
2024-02-01T00:30:11-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/386288br/key-account-manager
2024-03-12T02:03:00-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/387308br/commissioning-qualification-engineer
2024-03-14T06:03:53-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/388232br/container-platform-kubernetes-sr-specialist
2024-03-05T15:03:33-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/388928br/director-enterprise-architect-apd
2024-03-14T10:04:01-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/389477br/directoritil-salesforce
2024-02-20T13:02:14-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/389799br/novartis-country-quality-head-central-eastern-europe-cluster-mfd
2024-03-12T08:03:12-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/390343br/senior-expert-science-technology
2024-02-01T00:30:11-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/390350br/country-medical-head-ap-leprosy
2024-03-11T02:02:44-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/390361br/operations-manager-arogya-parivar
2024-03-11T02:02:44-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/390364br/stage-excellence-medicale
2024-02-01T00:30:11-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/390373br/director-ldc-program-test-manager
2024-02-01T00:30:11-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/390377br/documentation-specialist-gmp-fmd-teilzeit-60-kundl-tirol
2024-02-01T00:30:11-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/390380br/associate-director-solution-delivery-sap-fico
2024-02-01T00:30:11-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/369405br/data-solution-architect-sr-manager
2024-03-13T18:03:13-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/380285br/da-solution-delivery-integration-lead
2024-03-05T09:04:08-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/381718br/sr-prin-clinical-data-scientist-prog-data-mgr
2024-03-05T11:03:32-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/382621br/clinical-development-medical-director-radioligand-imagingtherapy
2024-03-08T03:02:20-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/386084br/clinical-document-mgmt-inspection-capa-and-risk-oversight-manager
2024-02-01T00:30:11-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/386248br/solutions-delivery-lead-mdm
2024-02-01T00:30:11-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/386247br/mdm-products-lead
2024-02-01T00:30:11-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/386629br/medical-science-liaison-onc-prostate-radioligand-therapies-sd-or-oc-ca
2024-02-01T00:30:11-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/387160br/medical-director-nephrologygenetic-diseases-translational-medicine
2024-02-01T00:30:11-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/389056br/responsable-marketing-rlt-radioligand-therapy-hf
2024-02-01T00:30:11-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/390014br/government-relations-public-policy-manager
2024-02-11T23:01:51-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/390047br/reliability-engineer
2024-02-13T13:02:12-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/390135br/medical-representative-nsw-south-wollongong-sth-highlands
2024-03-14T02:03:17-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/390230br/sr-digital-operation-excellence
2024-02-01T00:30:11-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/390241br/sr-rlt-medical-launch-liaison
2024-02-01T00:30:11-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/390283br/business-execution-manager-mwd
2024-02-28T07:03:04-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/390310br/medical-science-liaison-onc-prostate-radioligand-therapies-chicago
2024-03-06T17:02:11-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/390300br/medical-science-liaison-onc-prostate-radioligand-therapies-los-angeles
2024-02-07T11:02:09-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/390301br/medical-science-liaison-onc-prostate-radioligand-therapies-dallas
2024-02-07T11:02:09-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/390306br/medical-science-liaison-onc-prostate-radioligand-therapies-oh-remote
2024-03-06T17:02:11-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/390315br/medical-science-liaison-onc-prostate-radioligand-therapies-mpls-remote
2024-03-06T17:02:11-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/384341br/technical-design-expert-snow-portal-css-java-script-angular-js
2024-02-01T00:30:11-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/387549br/laboratorijski-analitik-ekspert-mzd
2024-03-07T03:02:09-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/387623br/ingenieur-biotech-purification-hf-cdd
2024-02-01T00:30:11-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/388688br/site-quality-head
2024-02-20T07:02:12-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/389433br/cloud-infrastructure-architect
2024-03-01T11:03:03-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/389957br/mechatroniker-abfullung-inspektion-mwd
2024-02-01T00:30:11-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/389958br/mechaniker-abfullung-inspektion-mwd
2024-02-01T00:30:11-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/390043br/manufacturing-projects-engineer
2024-02-01T00:30:11-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/390116br/operations-manager-site
2024-02-01T00:30:11-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/381487br/curation-expert
2024-03-05T07:03:36-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/387868br/biochemicalchemical-engineer-early-talent-program
2024-03-04T05:03:24-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/388717br/qc-analyst-i
2024-03-06T09:02:18-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/389981br/netzwerkmanager-mwd-ta-cardio-region-berlin
2024-02-01T00:30:11-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/383853br/senior-clinical-project-manager
2024-03-04T07:03:25-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/383978br/lead-or-senior-lead-medical-solid
2024-03-06T05:02:15-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/384238br/clinical-document-management-technology-team-lead
2024-02-01T00:30:11-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/384282br/time-service-delivery-expert-german-speaking
2024-03-13T10:03:40-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/384496br/hire-retire-services-expert-hr-services-german-speaking
2024-03-11T06:03:11-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/385020br/country-communications-engagement-head
2024-02-20T03:02:03-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/387781br/first-line-manager-mwd-ta-neuroscience-regionth-sn-ni
2024-02-01T00:30:11-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/387968br/legal-trainee-legal-procurement-datadigital-it
2024-03-14T10:04:01-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/389256br/scientist-mst-senior-fmd
2024-02-28T05:02:47-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/389752br/community-key-account-manager-south-east-london-12-month-ftc
2024-02-01T00:30:11-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/389960br/netzwerkmanager-mwd-ta-prostate-cancer-region-rp-und-saarland
2024-02-01T00:30:11-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/386223br/senior-analystsap-fi-implementation
2024-02-21T11:02:15-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/388014br/ad-access-reimbursement-nps-crm-peoria-il-remote
2024-03-04T21:03:13-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/389432br/hcp-engagement-expert-mwd
2024-02-01T00:30:11-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/389811br/senior-global-head-clinical-development-equity
2024-02-01T00:30:11-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/389823br/digitaldevice-data-scientist
2024-02-01T00:30:11-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/389827br/regional-htavalue-specialist
2024-02-19T17:01:57-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/363916br/clinical-document-management-reference-model-manager
2024-02-12T07:01:53-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/363935br/clinical-document-management-process-standards-manager
2024-03-06T09:02:18-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/363938br/clinical-document-management-process-user-support-team-lead
2024-02-12T07:01:53-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/389023br/responsable-grands-comptes-ophta-centre-est-hf
2024-02-13T05:02:03-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/389764br/laboratorijski-analitik-mzd
2024-03-13T12:03:19-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/382599br/director-corporate-strategy
2024-03-11T10:03:28-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/386265br/director-commercial-it-architecture-advanced-therapies
2024-02-01T00:30:11-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/388058br/business-process-analyst-license-mgmt
2024-03-11T02:02:44-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/389083br/associate-director-devit-clinical-analytics-business-analyst
2024-02-15T01:02:35-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/389685br/global-mobility-leader-americas
2024-02-01T00:30:11-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/389683br/menedzher-po-rabote-s-klyuchevymi-klientami-tula-ateroskleroz
2024-02-01T00:30:11-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/389712br/sr-application-expertveeva-vaultcrm
2024-02-27T09:02:39-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/389726br/senior-material-planning-supervisor
2024-02-01T00:30:11-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/384331br/quality-operations-manager
2024-03-08T05:02:30-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/385873br/process-specialist
2024-03-11T10:03:28-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/385882br/novartis-kurtkoy-site-general-application
2024-03-08T05:02:30-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/389435br/senior-buyer-german-indirect-procurement
2024-02-05T07:02:34-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/389601br/senior-cluster-procurement-manager-german
2024-03-04T09:03:28-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/379575br/associate-director-gdd-technical-rd-mzd
2024-03-05T09:04:08-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/382684br/strategic-materials-lifecycle-manager
2024-03-15T10:04:31-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/382935br/finance-manager-im-japan
2024-03-06T07:02:13-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/385879br/people-partner
2024-02-01T00:30:11-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/386440br/associate-director-cloud-security-architect
2024-03-07T09:02:21-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/387767br/manufacturing-systems-expert-mfd
2024-02-01T00:30:11-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/388304br/sso-feasibility-manager
2024-03-04T11:06:33-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/389481br/medical-lead-cardiology
2024-03-05T07:03:36-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/389503br/assoc-director-automationrpa
2024-03-14T04:03:26-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/389515br/senior-clinical-data-scientist
2024-03-13T04:03:38-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/388851br/expert-validation-senior-hf
2024-02-01T00:30:11-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/388202br/onderhoudstechnieker
2024-02-01T00:30:11-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/377160br/field-excellence-incentives-manager-dwm
2024-02-01T00:30:11-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/377503br/business-insights-manager-wmd
2024-02-28T11:03:03-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/382307br/associate-director-data-architect-po-people-org
2024-03-06T11:02:08-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/386081br/clinical-document-management-process-user-support-team-lead
2024-02-07T15:01:56-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/388235br/clinical-document-management-reference-model-manager
2024-02-07T15:01:56-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/388578br/medical-science-liaison-msl-solid-tumor-oncology-st-louis-mo-remote
2024-03-05T19:03:48-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/388652br/medical-science-liaison-msl-solid-tumor-oncology-houston-tx
2024-02-01T00:30:11-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/386345br/senior-expert-biologics-analytical-operations-mfd
2024-03-05T09:04:08-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/388827br/process-engineer-mfd
2024-02-09T09:02:08-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/389179br/senior-expert-science-technology
2024-02-01T00:30:11-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/387226br/executive-director-trans-med-neuroscience-neurodegeneration
2024-02-01T00:30:11-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/388520br/critical-reagent-manager
2024-03-12T14:03:16-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/389145br/regionalnyy-menedzher-kardiologiya-moskva
2024-03-01T05:02:53-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/388317br/medical-science-liaison-msl-renal-nephrology-heartland-remote
2024-03-08T21:02:25-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/382952br/global-category-head-it-outsourcing-services
2024-03-06T05:02:15-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/388619br/medical-science-liaison-manager-mwd-cardio-regionostdeutschland
2024-02-01T00:30:11-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/383462br/chef-de-projet-data-hf
2024-03-08T11:02:27-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/387829br/expert-electricite-hf
2024-02-01T00:30:11-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/388718br/senior-process-expert-fmd
2024-02-01T00:30:11-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/388901br/healthcare-solutions-lead
2024-03-05T05:03:41-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/388923br/crm-japan-program-clinical-head
2024-02-01T00:30:11-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/388168br/project-engineer-mfd
2024-02-01T00:30:11-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/372600br/director-ethics-risk-compliance-integrated-marketing-advisor
2024-03-08T15:02:15-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/384884br/lead-medical-device-risk-management-control-strategy-engineer-fmd
2024-03-05T09:04:08-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/387779br/technical-transfer-lead-medical-device-fmd
2024-02-20T15:02:03-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/388542br/ast-expert-mwd
2024-03-13T08:03:37-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/388530br/senior-specialist-itom-event-management-cloudsnow-discovery
2024-02-20T01:02:30-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/388540br/assc-director-servicenow
2024-03-15T12:05:05-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/388553br/sr-specialistsnow-operations-soxaudit
2024-02-26T01:02:33-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/388561br/brand-manager-solid-tumors
2024-02-01T00:30:11-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/388416br/senior-specialist-knowledge-management
2024-03-05T03:03:48-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/383499br/senior-consultant-pmo
2024-03-06T05:02:15-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/388223br/postdoc-bioprocess-modelling-new-technologies-mfd
2024-02-01T00:30:11-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/388272br/technicien-de-production-biotech-hf
2024-02-01T00:30:11-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/388315br/bioprocess-engineer-iiiiii-downstream-fillfinish-2-2-3-day-shift
2024-02-23T17:02:05-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/388079br/health-care-analytics-manager-mwd
2024-02-09T09:02:08-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/388195br/vendor-category-expert
2024-02-01T00:30:11-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/387496br/inzhener-po-obsluzhivaniyu-proizvodstvennogo-oborudovaniya-i-planirovaniyu
2024-02-01T00:30:11-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/386267br/commercial-it-domain-architect
2024-02-01T00:30:11-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/385896br/labortechnikerin-mst-mwd-kundl-tirol
2024-02-01T00:30:11-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/387812br/maintenance-coordinator-mwd
2024-02-01T00:30:11-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/365067br/public-affairs-manager-mwd
2024-03-12T10:03:16-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/377387br/senior-public-affairs-manager-dwm
2024-02-01T00:30:11-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/386008br/cardiovascular-institutional-sales-specialist-denver-westco-remote
2024-03-08T15:02:15-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/387674br/senior-specialistsap-bpc
2024-03-01T07:10:44-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/387609br/sr-specialist-network-engineering
2024-02-01T00:30:11-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/378718br/network-manager-dwm-ost-deutschland
2024-03-15T06:03:53-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/386319br/senior-brand-manager
2024-02-01T00:30:11-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/386320br/senior-brand-manager
2024-02-01T00:30:11-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/386403br/senior-brand-manager
2024-02-01T00:30:11-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/386406br/market-access-manager
2024-03-04T07:03:25-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/386815br/medical-manager-oncology
2024-02-01T00:30:11-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/386818br/medical-sciences-liaison
2024-02-20T23:03:28-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/387418br/marketing-lead-cardiovascular
2024-02-25T09:02:04-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/387465br/manager-retail-e-commerce-platformdianshangjingli
2024-02-01T00:30:11-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/381510br/japan-program-head
2024-03-06T01:02:39-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/385454br/chemielabortechniker-qc-analyst-ii-mwd-tirol-osterreich
2024-03-15T08:04:19-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/385606br/lead-software-developer-r-remote
2024-02-01T00:30:11-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/374288br/cell-culture-lead-mfd
2024-02-01T00:30:11-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/383937br/cardiologist-physician-scientist-translational-medicine
2024-03-07T15:02:14-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/387109br/laborantin-mikrobiologie-mwd-tirol-osterreich
2024-02-01T00:30:11-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/384967br/clinical-program-leader
2024-02-01T00:30:11-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/386009br/clinical-program-leader
2024-02-01T00:30:11-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/386692br/rlt-sasayamafinance-manager-business-planning-and-analysis
2024-03-08T09:02:32-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/386694br/rlt-sasayamahse-health-safety-environment-head
2024-03-08T09:02:32-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/386698br/rlt-sasayamaautomation-manager
2024-03-04T23:03:28-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/386700br/rlt-sasayamatechnical-systems-lead
2024-03-04T23:03:28-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/387232br/e2e-supply-network-planning-manager-mfd
2024-03-06T09:02:18-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/386830br/produktionsmitarbeiter-mwd-kundl-tirol
2024-03-06T09:02:18-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/384631br/msl-manager
2024-02-21T23:02:07-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/386757br/lehrling-fur-den-lehrberuf-mechatronik-fertigungstechnik-mwd
2024-02-01T00:30:11-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/386657br/labeling-manager-japan
2024-02-01T00:30:11-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/379140br/cybersecurity-solutions-architect-global-drug-development-team
2024-02-01T00:30:11-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/384820br/lehrling-fur-den-lehrberuf-pharmatechnologie-mwd
2024-02-01T00:30:11-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/384822br/lehrling-fur-den-lehrberuf-mechatronik-automatisierungstechnik-mwd
2024-02-01T00:30:11-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/384823br/lehrling-fur-den-lehrberuf-labortechnik-chemie-mwd
2024-02-01T00:30:11-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/384824br/lehrling-fur-den-lehrberuf-elektrotechnik-mwd
2024-02-01T00:30:11-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/384825br/lehrling-fur-den-lehrberuf-chemieverfahrenstechnik-mwd
2024-02-01T00:30:11-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/386303br/senior-expert-data-digital
2024-03-15T04:04:00-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/384888br/process-expert-wed-sat-2nd-shift
2024-02-29T17:02:50-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/385923br/medical-director-rheumatology-autoimmune-translational-medicine
2024-02-01T00:30:11-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/383770br/clinical-development-director-cardio-renal-metabolic
2024-02-02T15:02:33-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/383771br/clinical-development-medical-director
2024-02-01T00:30:11-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/383772br/sr-clinical-development-medical-director
2024-02-01T00:30:11-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/383782br/senior-financial-reporting-and-accounting-specialist-tehcnical
2024-02-14T05:02:10-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/385748br/apprenti-pharmacien-hf-saint-genis-pouilly
2024-02-01T00:30:11-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/385753br/apprenti-pharmacien-hf-saint-cloud
2024-02-01T00:30:11-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/385754br/apprenti-pharmacien-hf-marseille
2024-02-01T00:30:11-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/385757br/apprenti-pharmacien-european-raw-materials-hf-bethune
2024-02-01T00:30:11-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/385791br/cardiovascular-territory-account-specialist-fremont-remote
2024-03-14T18:03:36-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/385396br/especialista-en-radiofarmacia
2024-03-05T09:04:08-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/383989br/japan-program-manager
2024-03-06T07:02:13-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/384547br/medical-director-translational-medicine-neuroscience
2024-03-05T05:03:41-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/383790br/technical-accounting-senior-specialist
2024-02-01T00:30:11-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/383306br/srsales-manager
2024-02-01T00:30:11-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/379141br/cybersecurity-solutions-architect-mergers-acquisitions
2024-03-06T07:02:13-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/363942br/clinical-document-management-technology-release-manager
2024-02-01T00:30:11-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/382732br/security-solution-architect
2024-03-07T13:02:24-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/377209br/global-program-clinical-head-rheumatology
2024-02-01T00:30:11-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/356163br/maschinenbediener-mwd-im-bereich-pharmazeutische-produktion
2024-02-01T00:30:11-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/345502br/technical-operator-mwd
2024-03-07T03:02:09-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/391304br/qa-compliance-operations-lead-rlt-cn
2024-02-01T03:02:27-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/391313br/associate-director-ml-engineeringaws-sagemaker-azure-mlops
2024-02-01T05:02:39-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/391315br/responsable-grands-comptes-hemato-maladies-rares-sud-est-bfc-aura-hf
2024-02-13T05:02:03-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/374705br/specialiste-contrat-hf
2024-03-06T15:02:07-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/390023br/study-and-site-operations-study-start-manager
2024-02-23T05:02:11-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/391324br/product-steward-mfd
2024-03-07T11:02:17-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/388915br/functional-trainer
2024-02-16T03:02:03-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/390409br/global-esg-reporting-analyst
2024-02-01T09:02:35-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/391345br/snr-specialistappian-low-code-bpm-automation
2024-02-27T03:02:20-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/391347br/hr-business-partner-12-monate-mwd
2024-02-21T13:02:19-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/391349br/chef-de-produit-dermatologie
2024-03-08T13:02:25-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/389222br/senior-global-program-regulatory-manager-cardio-renal-metabolism
2024-02-27T17:02:36-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/391355br/director-integrated-evidence-planning-2-positions
2024-03-11T08:02:58-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/390204br/service-applications-manager-sap-operations
2024-03-11T12:03:24-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/385625br/quality-assurance-operations-manager
2024-02-08T11:02:07-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/391363br/senior-product-specialist-heart-failure-melaka
2024-03-07T21:02:08-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/390189br/rheumatology-institutional-sales-specialist-mi-and-oh-remote
2024-03-03T11:02:40-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/391378br/customer-engagement-partner-solid-tumor-ta
2024-03-04T05:03:24-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/391379br/customer-engagement-partner-immunology
2024-03-04T05:03:24-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/391380br/senior-principal-clinical-data-scientist-project-data-manager
2024-03-01T07:10:44-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/391389br/assocdirector-visualization
2024-02-02T07:02:43-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/391405br/responsable-grands-comptes-hemato-cell-gene-est-hf
2024-02-05T07:02:34-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/391407br/novartis-executive-advisors-lead
2024-02-02T09:02:44-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/391416br/assoc-director-erp-sap-btp-s4hana
2024-02-02T09:02:44-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/391059br/assoc-dir-ddit-ops-data-science
2024-03-05T13:03:26-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/391130br/it-commercial-excellence-sr-manager
2024-03-15T12:05:05-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/391413br/director-portfolio-analytics
2024-02-02T11:02:40-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/391424br/senior-specialistsap-abap-btps4hana
2024-02-02T11:02:40-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/390889br/tactical-planner
2024-02-27T05:02:25-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/367533br/senior-scientist-small-scale-sirna-analytics-processing-80-100
2024-03-12T06:03:33-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/383527br/sourcing-manager-it-digital
2024-03-06T05:02:15-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/386988br/global-category-manager-it-procurement-outsourcing
2024-03-12T08:03:12-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/391452br/territory-business-executive
2024-03-13T02:03:23-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/391453br/product-specialist
2024-03-13T04:03:38-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/391455br/gaojiyiyaodaibiao-zishenchanpinzhuanyuan
2024-03-15T04:04:00-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/391462br/head-kam-new-commercial-opportunities
2024-03-11T02:02:44-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/391468br/senior-regulatory-affairs-associate
2024-03-07T23:02:23-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/391480br/specialist-content-compliance-monitoring
2024-03-14T06:03:53-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/391478br/hse-lead-rlt-cn
2024-03-07T07:02:16-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/388201br/medical-science-liaison-breast-cancer
2024-03-04T01:03:10-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/386844br/global-gfcc-sme-senior-manager-pin-pca
2024-03-14T12:03:39-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/391305br/direct-tax-process-lead
2024-03-14T06:03:53-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/388643br/field-project-manager-radioligand-therapy
2024-02-06T11:02:03-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/391157br/senior-medical-director
2024-02-20T09:02:17-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/391514br/delegue-hospitalier-neuro-nouvelle-aquitaine-hf
2024-02-09T09:02:08-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/389782br/technicien-de-production-cq-saint-cloud-hf
2024-03-05T05:03:41-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/391498br/senior-key-account-manager-neuroscience
2024-03-12T12:03:38-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/388103br/director-salesforce-data-cloud-technical-product-lead
2024-03-14T14:03:45-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/390577br/pricing-manager
2024-03-14T02:03:17-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/391542br/dir-integrated-insights-gep-net
2024-03-11T14:02:55-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/391543br/dir-commercial-analytics-rltprostate
2024-03-11T14:02:55-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/391544br/dir-integrated-insights-rlt-platform
2024-03-11T14:02:55-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/391547br/gaojiyiyaodaibiao-zishenchanpinzhuanyuan
2024-03-06T01:02:39-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/391551br/medical-advisor
2024-03-15T06:03:53-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/391564br/assoc-dir-funct-security-architect
2024-03-14T08:04:10-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/391590br/assoc-dir-ddit-ies-cloud-engineering
2024-02-21T03:01:59-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/391585br/customer-service-assistant-cdd-hf
2024-02-06T09:02:02-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/388151br/quality-assurance-head-nordics
2024-02-06T11:02:03-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/391626br/translational-research-lab-based-scientist
2024-02-06T13:02:00-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/391121br/itot-automation-engineer
2024-02-06T13:02:00-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/391122br/itot-site-lead
2024-02-06T13:02:00-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/391635br/specialist-automation-information-technology-operational-technology
2024-03-15T16:05:48-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/390214br/record-report-sr-specialist-centroamerica
2024-03-14T14:03:45-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/391647br/access-reimbursement-manager-renal-remote-los-angeles-ca
2024-03-06T17:02:11-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/386176br/medical-science-liaison
2024-03-13T00:03:33-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/391653br/adsr-principal-scientist-cadd
2024-03-11T18:02:56-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/391681br/production-technician
2024-02-08T07:01:59-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/383374br/data-science-manager
2024-03-05T07:03:36-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/390383br/gcp-bioanalysis-senior-scientist-iii
2024-02-07T07:02:58-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/390531br/senior-scientist-pks-vivo-preclinical-pkadme
2024-02-07T07:02:58-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/391625br/quality-control-technician
2024-03-13T04:03:38-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/391627br/quality-control-supervisor
2024-02-21T13:02:19-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/391678br/sr-manager-integrated-insights
2024-02-07T07:02:58-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/391709br/product-cost-planning-manager
2024-03-04T23:03:28-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/386432br/prozessmitarbeiter
2024-02-07T11:02:09-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/389115br/seniorglobal-regulatory-manager
2024-02-22T13:02:17-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/375810br/associate-director-ddit-im-data-products
2024-03-12T08:03:12-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/390654br/planning-logistics-specialist-2nd-shift
2024-03-12T20:03:16-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/391641br/specialist-automation-information-technology-operational-technology
2024-03-14T14:03:45-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/391730br/investor-relations-strategic-analyst-communications-director
2024-03-11T12:03:24-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/391740br/senior-or-expert-clinical-scientist-translational-medicine-nbr
2024-02-08T01:02:28-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/391757br/data-science-intern
2024-03-12T08:03:12-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/357636br/werkstudent-der-pharmazeutischen-produktion-mwd
2024-03-06T09:02:18-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/391612br/quality-assurance-specialist
2024-02-23T11:02:12-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/391633br/microbiological-supervisor
2024-02-16T13:02:11-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/391716br/senior-specialist-data-science
2024-02-08T11:02:07-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/391809br/associate-director-commercial-erp-solution-design
2024-02-26T13:02:27-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/388162br/quality-compliance-lead
2024-03-06T13:02:10-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/388941br/sr-business-analyst-salesforce-data-cloud
2024-03-14T14:03:45-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/389998br/ai-architect-developer-x2
2024-03-12T10:03:16-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/391616br/isc-security-solutions-architect-us
2024-02-27T13:02:34-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/391821br/supervisor-manufacturing-nights
2024-02-08T17:01:55-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/391822br/quality-assurance-engineering-specialist
2024-03-14T20:03:27-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/391830br/vendor-program-lead
2024-02-08T21:01:56-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/391832br/operations-executive-commercial-excellence
2024-03-10T22:02:32-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/391833br/principal-biostatistician
2024-03-12T06:03:33-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/390562br/principal-scientist-drug-discovery-glomerulonephritis-80-100
2024-02-09T01:02:33-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/391836br/qa-supplier-management-specialist-ii-mfd
2024-03-12T04:04:04-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/391838br/senior-principal-biostatistician
2024-03-12T06:03:33-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/387956br/head-sales-and-marketing-breast-cancer
2024-03-13T04:03:38-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/390770br/senior-specialistsnowflake-admin-iaac
2024-02-09T03:01:53-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/386321br/laboratorijski-analitik-mzd
2024-03-14T06:03:53-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/391683br/operational-scheduler-wmd
2024-03-15T06:03:53-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/391763br/consultant-pmo
2024-03-15T02:03:39-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/391844br/head-integrated-health-solutions-value-access-key-accounts
2024-03-12T06:03:33-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/390622br/director-it-security-policy-framework-data-digital-it
2024-02-09T07:02:10-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/391859br/pharmaziepraktikant-wmd-mst-ab-01042024-oder-fruher
2024-02-09T07:02:10-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/391430br/senior-legal-counsel-datadigital-and-it-fmd
2024-02-09T09:02:08-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/391864br/people-organization-hr-internship-fmd
2024-02-09T09:02:08-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/391886br/supervizor-lc-ms
2024-02-13T13:02:12-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/391525br/process-validation-expert
2024-03-14T06:03:53-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/391693br/product-steward
2024-03-14T06:03:53-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/391878br/executive-director-process-development-cell-therapy
2024-02-09T11:02:02-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/391900br/sr-specialist-visualization-automation
2024-02-09T15:01:58-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/387088br/assoc-dir-platform-svcs-developer
2024-02-10T11:01:51-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/391918br/research-scientist-veterinary-medicine
2024-02-10T15:01:49-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/387765br/group-product-manager
2024-03-13T04:03:38-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/390555br/technicien-support-maintenance-journee-hf
2024-02-12T01:02:08-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/389665br/data-engineering-manager
2024-02-12T05:01:56-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/390933br/operational-scheduler
2024-03-14T06:03:53-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/390754br/validation-expert
2024-03-15T10:04:31-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/391958br/warehouse-and-distribution-manager
2024-03-07T03:02:09-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/391959br/director-ddit-analytics-products
2024-03-08T01:02:36-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/385935br/director-launch-co-pilot
2024-03-05T09:04:08-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/391818br/quality-assurance-validation-specialist
2024-03-14T20:03:27-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/391891br/assoc-dir-solutions-delivery-lead-mdm
2024-03-05T03:03:48-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/391996br/manager-quality-assurance-operations
2024-02-12T15:02:02-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392006br/rlt-drug-product-project-leader-dppl-mfd
2024-03-14T18:03:36-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392007br/rlt-formulation-project-leader-mfd
2024-03-14T18:03:36-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392011br/rlt-analytical-project-leader-mfd
2024-03-14T18:03:36-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392016br/rlt-analytical-expert-mfd
2024-03-14T18:03:36-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/381813br/junior-radiation-safety-expert
2024-03-13T06:03:36-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/391881br/regional-va-bp-lead
2024-03-11T06:03:11-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392042br/associate-directorsap-mdg
2024-02-13T05:02:03-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/391978br/san-block-storage-engineer
2024-02-13T07:02:12-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392075br/onderhoudstechnieker-pharma
2024-03-06T11:02:08-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/391581br/chemielabortechniker-qc-analyst-ii-mwd-kundl-tirol
2024-02-13T11:02:04-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392110br/director-quantitative-solutions-engineering
2024-02-13T13:02:12-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392112br/director-analytical-project-lead
2024-02-13T15:02:04-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392113br/senior-cluster-procurement-manager-belgium-italy
2024-02-13T15:02:04-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/391046br/radioligand-therapy-specialist-mid-atlantic-mdnjde
2024-02-13T15:02:04-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/391037br/radioligand-therapy-specialist-rocky-mountains-utwyco-nv-az-id
2024-02-13T17:02:07-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/391038br/radioligand-therapy-specialist-texasnm
2024-02-13T17:02:07-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/391040br/radioligand-therapy-specialist-mid-west-miok-io-nd-sd-ne-ks
2024-02-13T17:02:07-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/391043br/radioligand-therapy-specialist-gulf-coast-al-ms-la-ar
2024-02-13T17:02:07-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/391044br/radioligand-therapy-specialist-south-florida
2024-02-13T17:02:07-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/391045br/radioligand-therapy-specialist-georgianorth-florida
2024-02-13T17:02:07-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/374865br/director-data-science-ai-research-chemistry
2024-03-11T12:03:24-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/391033br/radioligand-therapy-specialist-northern-california
2024-02-13T17:02:07-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392125br/principal-lab-it-engineer
2024-03-06T17:02:11-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392140br/data-steward
2024-02-14T01:02:19-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392143br/senior-knowledge-management-strategist
2024-03-14T12:03:39-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/385870br/dir-ddit-isc-ent-architect-net-sec
2024-03-14T04:03:26-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/389390br/principal-rwe-research-analyst
2024-03-13T02:03:23-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/391869br/medical-manager-breast-cancer
2024-02-29T09:03:00-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/391948br/assistante-de-direction-hf
2024-02-14T07:02:08-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392159br/analyst-social-media-listening
2024-02-14T07:02:08-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392162br/manager-gprm-japan
2024-02-22T03:02:16-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/391793br/ldc-buying-channels-adopt-manager
2024-03-15T10:04:31-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392180br/assoc-director-science-technology-cell-therapy-process-analytics
2024-02-14T11:02:15-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392181br/site-quality-head
2024-02-14T11:02:15-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392187br/senior-patient-access-lead
2024-02-14T13:02:05-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/391901br/associate-director-congress-management-and-association-relations
2024-03-08T03:02:20-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/391835br/medical-head-governance-excellence
2024-02-29T23:02:40-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392210br/medical-representative
2024-02-15T01:02:35-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392211br/medical-representative
2024-02-15T01:02:35-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/385973br/sr-spec-ddit-isc-ies
2024-03-12T02:03:00-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/390891br/customer-engagement-manager-dermatology
2024-03-15T08:04:19-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392217br/mmdm-textdesign-expert
2024-03-05T03:03:48-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392220br/first-line-sales-manager-immunology-south
2024-02-15T05:02:11-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392227br/senior-medical-information-manager-i
2024-02-15T05:02:11-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/383072br/director-data-science
2024-03-05T07:03:36-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392061br/global-people-and-organization-hr-business-partner-fmd
2024-02-15T07:02:10-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392234br/analyst-competitive-intelligence-manufacturing
2024-02-15T07:02:10-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392236br/analyst-competitive-intelligence
2024-02-15T07:02:10-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392237br/senior-analyst-competitive-intelligence
2024-02-15T07:02:10-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392238br/automation-engineer-senior-specialist
2024-03-01T07:10:44-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392241br/automation-engineering-associate-director
2024-02-28T11:03:03-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392243br/production-planning-senior-specialist
2024-02-27T07:02:32-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392250br/global-program-regulatory-manager-lcm
2024-02-15T09:02:16-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/391255br/director-quantitative-safety-statistician
2024-03-12T14:03:16-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/391879br/regional-va-business-partner-immunology
2024-02-15T09:02:16-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/391880br/regional-va-business-partner-oncology
2024-02-15T09:02:16-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/391883br/territory-market-access-manager-krasnodar
2024-02-15T09:02:16-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392245br/financial-master-data-specialist
2024-02-16T05:02:08-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392255br/cardiovascular-territory-account-specialist-fresno-south-remote
2024-03-14T18:03:36-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392265br/head-medical-affairs
2024-03-06T01:02:39-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/391426br/vendor-category-expert
2024-02-15T11:02:19-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392283br/associate-director-integrated-insights-market-research
2024-02-15T15:02:09-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/385944br/expert-science-technology-process-analytics
2024-02-15T17:02:10-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392306br/manager-ra-cmc-manager-japan
2024-02-20T03:02:03-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392224br/laboratorijski-analitik-mzd
2024-03-07T13:02:24-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392309br/buyer-mandarin-speaker
2024-03-07T05:02:20-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392311br/buyer-japanese-speaker
2024-03-06T05:02:15-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/390590br/medical-lead-oncology-hematology
2024-03-07T03:02:09-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/391783br/heor-manager-nordic-countries
2024-03-13T06:03:36-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/391808br/customer-engagement-manager-north-east-netherlands
2024-03-04T11:06:33-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392164br/associate-director-solution-delivery-mfd
2024-02-16T05:02:08-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392321br/cooperative-study-program-bwl-healthcare-management-dhbw
2024-02-28T09:02:39-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392322br/cooperative-study-program-bwl-human-resources-management-dhbw
2024-02-28T09:02:39-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392323br/cooperative-study-program-bwl-digital-business-managementdhbw
2024-02-28T07:03:04-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/391001br/computerized-systems-and-qualification-engineer
2024-02-16T07:02:07-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392337br/gestionnaire-adv-transport-cdd-saint-genis-pouilly-01
2024-03-11T06:03:11-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392376br/territory-business-executive
2024-03-14T04:03:26-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392377br/territory-business-executive
2024-03-13T02:03:23-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/391061br/health-safety-environment-expert-process-safety
2024-02-19T11:02:03-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/386897br/xianyuzhurenxianyuzhuguan
2024-03-03T23:02:45-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392381br/pipeline-manager
2024-02-18T01:02:16-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392382br/senior-regulatory-writer
2024-03-06T21:02:08-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392384br/immunology-japan-program-clinical-head
2024-02-18T05:01:55-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392386br/specialist-environmental-health-and-safety
2024-03-08T13:02:25-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392393br/knowledge-management-reporting-lead
2024-02-19T03:01:57-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/391584br/medical-science-liaison-manager-mwd-hessen-rlp-saarland
2024-02-21T05:02:14-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392398br/territory-business-executive
2024-03-13T02:03:23-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392401br/territory-business-executive
2024-03-13T02:03:23-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392248br/innovation-manager
2024-02-19T07:02:07-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392399br/senior-manager-ethics-risk-compliance-and-assurance
2024-03-07T03:02:09-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392420br/information-security-awareness-senior-specialist
2024-03-01T07:10:44-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392424br/apprenti-technicien-de-production-hf-saint-genis-pouilly
2024-02-19T09:02:13-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392426br/apprenti-technicien-de-production-hf-bethune
2024-02-19T09:02:13-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392429br/apprenti-technicien-de-production-hf-saint-cloud
2024-02-19T09:02:13-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392431br/apprenti-technicien-de-production-hf-troyes
2024-02-19T09:02:13-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392432br/apprenti-technicien-de-production-hf-marseille
2024-02-19T09:02:13-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392324br/production-planning-associate-director
2024-02-27T07:02:32-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392443br/specialist-solution-design-qlik-sense-aws-data-warehouse
2024-02-19T13:02:02-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392455br/sr-leadstrategic-planning
2024-02-20T01:02:30-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392456br/healthcare-solution-lead
2024-03-13T04:03:38-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392457br/senior-lead-early-medical
2024-02-20T01:02:30-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/374978br/it-business-analyst-regulatory-affairs
2024-03-15T04:04:00-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392467br/associate-director
2024-02-20T03:02:03-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392468br/associate-director
2024-02-20T03:02:03-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392469br/associate-director
2024-02-20T03:02:03-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392471br/director-platforms-analytics-aws
2024-02-20T03:02:03-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392472br/associate-director
2024-02-20T03:02:03-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392466br/payroll-services-head-emea
2024-03-06T07:02:13-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392484br/ta-head-oncology
2024-02-20T05:02:09-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392497br/head-dpdai-china
2024-02-20T07:02:12-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392501br/sr-manager-analytical-formulation-development
2024-02-20T07:02:12-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392504br/customer-engagement-lead
2024-03-06T07:02:13-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392516br/medical-safety-processes-projects-lead
2024-03-12T04:04:04-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392340br/maintenance-technician-instrumentation
2024-02-20T09:02:17-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392408br/gxp-metrics-manager
2024-03-06T07:02:13-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392421br/kierownik-ds-kluczowych-klientow-neurologia
2024-03-06T09:02:18-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392517br/digital-health-innovation-manager
2024-03-04T09:03:28-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392536br/snr-spec-platform-analytics-ai-machine-learning-aws-mlops
2024-02-20T13:02:14-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392550br/associate-director-institutional-multiple
2024-02-20T17:02:11-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392552br/associate-director-institutional-chargebacks
2024-02-20T17:02:11-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392551br/associate-director-managed-care-multiple
2024-02-20T17:02:11-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392558br/director-ethics-risk-compliance-advisor-corporate-functions
2024-03-07T15:02:14-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392029br/medical-representative-cardiovascular-mornington-peninsula
2024-03-10T18:02:18-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392010br/addirector-bio-cancer-therapeutics-dual-posting
2024-03-06T13:02:10-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/385632br/country-patient-safety-head
2024-03-07T23:02:23-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392569br/oncology-sales-specialist-melanoma-atlanta-remote
2024-03-15T16:05:48-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392574br/sr-spec-ddit-dev-technical-design-regulatory-affairs
2024-03-07T05:02:20-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/391482br/senior-tax-operations-specialist
2024-02-21T05:02:14-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392526br/pop-governance-manager-hf
2024-02-21T05:02:14-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392582br/clinical-research-associate
2024-02-21T05:02:14-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392585br/praktikant-mwd-der-internen-und-externen-kommunikation
2024-02-21T05:02:14-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392586br/junior-process-expert
2024-03-07T05:02:20-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392219br/public-affairs-patient-access-senior-manager
2024-02-21T07:02:08-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392415br/qa-operations-expert-mfd
2024-02-21T07:02:08-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392463br/tm-academy-fellow-preclinical-safety
2024-03-01T05:02:53-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392464br/tm-academy-fellow-data-science
2024-03-01T07:10:44-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392577br/discovery-postdoctoral-fellow-immunology
2024-02-21T07:02:08-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392600br/senior-heor-lead
2024-03-08T01:02:36-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392605br/disease-area-partner-ascvd-greater-cairo
2024-03-14T08:04:10-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392618br/clinical-bio-specimen-senior-scientist
2024-02-21T11:02:15-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392621br/snr-specialist-snow-platform-services
2024-02-21T13:02:19-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392623br/research-scientist-ii-cell-pharmacology-cvm
2024-02-21T13:02:19-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392637br/record-report-sr-specialist
2024-03-07T23:02:23-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392638br/site-head-health-safety-environment
2024-02-21T13:02:19-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392639br/time-management-expert-temporary
2024-03-07T23:02:23-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392640br/time-service-specialist-temporary
2024-03-07T23:02:23-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392643br/assoc-director-science-technology-cell-therapy-process-development
2024-02-21T15:02:11-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392646br/gcp-laboratory-compliance-lead
2024-02-21T17:02:08-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392649br/digital-workspace-manager-brazil
2024-03-04T13:03:37-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392655br/utility-engineer-i
2024-02-21T23:02:07-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392657br/assoc-director-ddit-apd-shared-services
2024-02-26T23:02:28-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/385080br/r2r-senior-specialist-gl-reporting
2024-02-22T03:02:16-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/391834br/hire-retire-services-expert
2024-03-11T06:03:11-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392661br/associate-supply-chain-manager
2024-02-22T03:02:16-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392662br/sr-spec-ddit-gf-soldel-treasury
2024-02-22T03:02:16-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392617br/postdoc-functional-genomics
2024-02-22T05:02:13-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392671br/associate-director-lan-sol-architect-czech-republic-spain-india
2024-03-04T09:03:28-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392674br/manufacturing-systems-expert-mwd-teilzeit-50
2024-03-06T07:02:13-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392683br/process-expert
2024-02-22T05:02:13-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392048br/discovery-postdoc-data-science
2024-02-22T07:05:28-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392518br/specialist-life-cycle-implementation
2024-02-22T07:05:28-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392519br/specialist-life-cycle-implementation
2024-02-22T07:05:28-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392686br/gaojiyiyaodaibiao-zishenchanpinzhuanyuan
2024-02-22T07:05:28-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392697br/sr-spec-ddit-ies-cloud-engineering
2024-02-29T01:03:22-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/389526br/technical-steward
2024-02-22T11:02:19-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/390414br/medical-directorsenior-medical-director-radiopharmaceuticals-rlt
2024-02-22T11:02:19-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392260br/therapeutic-area-biomarker-leadbiomarker-strategy-immunology
2024-02-22T11:02:19-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392549br/head-operations-country-development-qa
2024-03-13T08:03:37-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392676br/payroll-services-senior-expert-italian
2024-03-04T11:06:33-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392703br/access-and-reimbursement-manager-immunology-indianapolis-remote
2024-02-26T11:02:28-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/388926br/administrative-professional-mfd
2024-02-22T13:02:17-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392553br/payroll-analyst-temporary-12-months
2024-03-07T13:02:24-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392706br/senior-transparency-associate
2024-03-08T05:02:30-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392710br/associate-director-ddit-dev-gco
2024-03-08T03:02:20-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392713br/director-innovation-lab-ai-innovation-lead
2024-02-22T15:02:10-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392717br/senior-privacy-counsel-us
2024-02-22T19:02:13-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/385341br/planning-logistics-specialist-1st-shift
2024-02-22T21:02:17-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392038br/medical-lead-cmlchronic-myelogenous-leukemia
2024-03-11T22:02:54-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392724br/xianyuzhurenxianyuzhuguan
2024-03-08T07:02:28-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392727br/technicien-de-production-centrale-de-pesee-hf
2024-02-23T05:02:11-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392752br/senior-fra-gl-specialist-south
2024-02-23T07:02:23-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/385036br/senior-cad-designer-mfd-medical-device
2024-03-05T07:03:36-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392524br/operational-excellence-expert-mfd
2024-02-23T11:02:12-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392763br/cvm-therapeutic-area-biomarker-lead
2024-02-23T11:02:12-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392770br/chef-de-produit-cardio-hf
2024-03-06T09:02:18-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/389544br/ad-disease-and-clinical-specialist-raleigh-remote
2024-02-23T13:02:05-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392748br/associate-director-clinical-trial-acceleration
2024-02-23T13:02:05-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392784br/reimbursement-specialist-1
2024-02-23T19:02:04-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392785br/director-nps-program-strategy-management-immunology
2024-02-24T11:02:02-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392790br/senior-vendor-program-manager
2024-02-24T11:02:02-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392793br/ad-experience-personalization-optimization
2024-03-05T21:02:01-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392797br/regionalnyy-kommercheskiy-menedzher-kazan
2024-02-25T09:02:04-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392798br/regionalnyy-kommercheskiy-menedzher-tyumen
2024-02-25T09:02:04-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392799br/regionalnyy-kommercheskiy-menedzher-vladivostok
2024-02-25T09:02:04-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392800br/regionalnyy-kommercheskiy-menedzher-yaroslavl
2024-02-25T09:02:04-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392801br/regionalnyy-kommercheskiy-menedzher-tver
2024-02-25T09:02:04-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392802br/regionalnyy-kommercheskiy-menedzher-novosibirsk
2024-02-25T09:02:04-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392803br/regionalnyy-kommercheskiy-menedzher-nizhniy-novgorod
2024-02-25T09:02:04-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392303br/cell-processing-specialist-i-sun-thur-pm
2024-02-25T13:01:58-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392815br/gcp-bioanalysis-principal-scientist
2024-03-11T18:02:56-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392814br/gcp-lab-associate
2024-03-10T20:02:31-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392824br/associate-country-qa-compliance
2024-02-26T01:02:33-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392825br/associate-country-qa-operations-core-products
2024-02-26T01:02:33-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/387803br/sales-representative-hematology-central
2024-02-26T05:02:25-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392838br/global-digital-fra-automation-lead
2024-02-26T05:02:25-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392842br/key-account-executive-lipids-johor
2024-02-26T05:02:25-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392849br/hire-retire-services-expert-japanese
2024-02-26T05:02:25-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392705br/senior-scientist-vitro-radiobiology-80-100
2024-02-26T07:02:29-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392869br/associate-supply-chain-performance-manager
2024-02-26T09:02:26-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392874br/ad-market-access-contracting-analytics-multiple-positions-remote
2024-03-08T15:02:15-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392875br/postgraduatepostdoc-manufacturing-unit-galenic
2024-02-28T05:02:47-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392597br/quality-manager-qualified-person-gmp
2024-02-26T11:02:28-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392839br/discovery-postdoctoral-fellow-glomerulonephritis
2024-02-26T11:02:28-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392877br/msc-student-proc-dev-new-technologies
2024-02-26T13:02:27-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392895br/bioinformatician-data-scientist-computational-biologist
2024-02-26T13:02:27-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392901br/strategic-manager
2024-02-26T13:02:27-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392912br/team-lead-reimbursement-specialist-team
2024-02-26T17:02:18-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392898br/valueaccess-commercial-dev-head
2024-02-26T19:02:28-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392914br/medical-science-liaison-prostate-radioligand-therapies-me-nh-vt-ny
2024-03-06T17:02:11-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392915br/planning-and-logistics-lead
2024-02-26T19:02:28-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392916br/medical-science-liaison-msl-solid-tumor-oncology-miami-fl
2024-03-06T17:02:11-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392924br/gaojiyiyaodaibiao-zishenchanpinzhuanyuan
2024-02-26T23:02:28-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392452br/representante-de-ventas
2024-02-26T23:02:28-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392899br/medical-director-translational-medicine-neuroscience
2024-02-27T01:03:03-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392928br/data-steward
2024-03-06T01:02:39-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392941br/management-report-senior-specialist
2024-02-27T05:02:25-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392957br/medical-science-liaison-hemato-voronezh
2024-02-27T05:02:25-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/391985br/director-im-arch-int-marketing-customer-engagement
2024-02-27T07:02:32-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392731br/medical-director-dermatology-translational-medicine
2024-02-27T07:02:32-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392841br/hire-retire-services-expert-indonesian-speaker
2024-02-27T07:02:32-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/383698br/director-region-europe-project-manager
2024-02-27T09:02:39-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392699br/regional-director-radioligand-therapy-western-us
2024-02-27T09:02:39-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392981br/praktikum-im-bereich-automation-engineering
2024-03-13T08:03:37-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392988br/associate-director-us-market-access-strategy-remote
2024-02-27T11:02:36-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392736br/process-expert
2024-02-27T11:02:36-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392997br/territorialnyy-kommercheskiy-menedzher-kazan
2024-02-27T13:02:34-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392998br/territorialnyy-kommercheskiy-menedzher-novosibirsk
2024-02-27T13:02:34-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392911br/director-us-market-access-strategy-remote-1of-2
2024-03-12T12:03:38-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393006br/bioprocess-engineer-i-upstream-nights
2024-02-27T15:02:24-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393009br/business-data-migration-expert-commercial-2-positions
2024-03-04T15:03:32-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393010br/business-data-migration-expert-manufacturing
2024-03-15T14:05:37-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393036br/sr-product-manager
2024-02-27T23:02:33-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393037br/sso-contracting-specialist
2024-02-27T23:02:33-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393039br/gaojiyiyaodaibiao-zishenchanpinzhuguan
2024-02-28T03:02:47-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393052br/sales-manager-oncology
2024-02-28T03:02:47-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393067br/sr-specialist-hcmworkday-config-implementation
2024-02-28T05:02:47-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393069br/clinical-project-manager
2024-02-28T05:02:47-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393073br/territory-business-executive
2024-03-13T02:03:23-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393079br/director-public-affairs
2024-02-28T07:03:04-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393081br/market-access-manager
2024-02-28T07:03:04-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392771br/maintenance-technician-i-mechanical
2024-02-28T09:02:39-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392978br/engineer-process-hvac
2024-03-05T09:04:08-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393099br/associate-manager-mdm
2024-02-28T09:02:39-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393103br/associate-manager-erp-bpm
2024-02-28T09:02:39-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/387156br/stage-chef-de-produit-dermatologie-psoriasis-hf
2024-02-28T11:03:03-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392985br/study-start-team-lead
2024-02-28T11:03:03-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393000br/omnichannel-engagement-manager-mwd
2024-03-07T09:02:21-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393139br/specialist-data-science-ai-ml
2024-02-28T17:02:34-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392954br/director-content-delivery
2024-03-05T09:04:08-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393164br/gaojiyiyaodaibiao-zishenchanpinzhuanyuan
2024-02-29T03:02:40-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392532br/business-coordinator
2024-02-29T05:02:54-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393047br/regionalnyy-kommercheskiy-menedzher-stavropol
2024-02-29T05:02:54-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393192br/head-inmarket-brands-biz-innovation
2024-02-29T05:02:54-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393193br/marketing-manager
2024-02-29T05:02:54-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393195br/senior-knowledge-management-strategist
2024-02-29T05:02:54-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/391474br/senior-bpa-manager-rlt-cn
2024-02-29T07:03:16-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393208br/knowledge-management-expert
2024-02-29T07:03:16-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393202br/menedzher-po-klyuchevym-klientam-kardiologiya-gtula
2024-02-29T07:03:16-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393217br/manager-erp-bpm
2024-02-29T09:03:00-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/387273br/head-search-and-evaluation-platform-enabling-technologies
2024-02-29T09:03:00-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392739br/clinical-research-associate-hungary-home-based
2024-03-15T06:03:53-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393094br/country-quality-manager-qprp
2024-02-29T11:02:51-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/390896br/patient-support-programs-manager
2024-02-29T13:02:37-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/388687br/clinical-project-manager
2024-02-29T17:02:50-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392714br/ad-access-reimbursement-cardiovascular-dakotas-remote
2024-02-29T19:02:55-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393015br/retirement-plans-specialist
2024-03-01T13:03:00-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392040br/operational-health-lead
2024-03-01T01:03:56-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392052br/so-ndp-governance-principal-analyst
2024-03-01T01:03:56-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/386190br/territory-business-executive
2024-03-13T02:03:23-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392966br/quality-control-manager-deputy-qualified-person
2024-03-01T05:02:53-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393276br/postdoc-discovery-sciences
2024-03-04T03:03:16-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393219br/production-technician
2024-03-01T07:10:44-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393312br/laborant-scheikunde
2024-03-01T09:02:59-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393314br/laborant
2024-03-01T09:02:59-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/385222br/process-team-lead-mfd
2024-03-01T09:02:59-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/391991br/senior-specialist-it-operations-manufacturing-site
2024-03-01T11:03:03-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393247br/business-data-migration-expert-procurement
2024-03-04T15:03:32-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/390898br/associate-director-product-growth-manager-x3-switzerland-or-us
2024-03-01T13:03:00-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392198br/associate-director-product-growth-manager-x3-us-or-switzerland
2024-03-01T13:03:00-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392792br/associate-director-data-strategy-solutions
2024-03-01T15:03:17-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393339br/allergy-area-business-leader-new-york-remote
2024-03-01T15:03:17-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393340br/allergy-area-business-leader-philadelphia-remote
2024-03-01T15:03:17-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393341br/allergy-area-business-leader-charlotte-nc-remote
2024-03-01T15:03:17-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393343br/allergy-area-business-leader-baltimore-remote
2024-03-01T15:03:17-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393344br/allergy-area-business-leader-atlanta-ga-remote
2024-03-01T15:03:17-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393345br/allergy-area-business-leader-san-francisco-ca-remote
2024-03-01T15:03:17-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393347br/allergy-area-business-leader-cincinnati-oh-remote
2024-03-01T15:03:17-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393350br/allergy-area-business-leader-detroit-mi-remote
2024-03-06T15:02:07-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393351br/allergy-area-business-leader-memphis-tn-remote
2024-03-01T15:03:17-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393352br/allergy-area-business-leader-chicago-il-remote
2024-03-01T15:03:17-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393353br/allergy-area-business-leader-denver-co-remote
2024-03-01T15:03:17-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393354br/allergy-area-business-leader-dallas-tx-remote
2024-03-01T15:03:17-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393356br/associate-expert-science-technology-downstream-processing
2024-03-04T05:03:24-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393358br/principal-scientist-vitro-adme
2024-03-04T11:06:33-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392273br/vivo-senior-scientist-i-80-100
2024-03-02T01:09:10-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393376br/disease-area-partner-immunology-giza
2024-03-03T07:02:44-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393377br/administrative-assistant
2024-03-03T07:02:44-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393256br/country-head-people-organisation
2024-03-03T17:02:39-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393380br/lead-medical-science
2024-03-03T21:02:42-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393387br/senior-fin-analyst-imus-bpa
2024-03-04T01:03:10-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/382887br/qc-analyst-i-visuelle-inspektion-2-schichten-schaftenau
2024-03-04T03:03:16-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393274br/senior-good-clinical-practices-pharmacovigilance-auditor
2024-03-04T03:03:16-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393389br/associate-director-drug-substance-early-phase
2024-03-04T03:03:16-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393398br/medical-lead
2024-03-04T03:03:16-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393395br/gaojiyiyaodaibiao-zishenchanpinzhuanyuan
2024-03-04T03:03:16-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393397br/senior-brand-manager
2024-03-04T03:03:16-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393399br/manager-im-us-bpa
2024-03-04T03:03:16-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393091br/gl-platform-quality-head-sm-lmm
2024-03-12T12:03:38-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393215br/people-partner-mfd
2024-03-04T05:03:24-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393235br/responsable-grands-comptes-urticaire-grand-est-bfc-hf
2024-03-08T03:02:20-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393357br/medical-engagement-lead
2024-03-04T05:03:24-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393392br/sr-principal-clin-data-stds-specialist
2024-03-06T01:02:39-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393405br/business-analysis-manager
2024-03-04T05:03:24-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393413br/responsable-grands-comptes-urticaire-idf-sud-hf
2024-03-08T03:02:20-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393418br/specialist
2024-03-04T05:03:24-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393419br/regional-business-manager
2024-03-13T04:03:38-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393420br/specialist
2024-03-04T07:03:25-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393429br/responsable-grands-comptes-urticaire-bretagne-centre-hf
2024-03-08T03:02:20-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393432br/territory-business-executive
2024-03-13T02:03:23-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/389741br/hr-systems-and-integration-lead
2024-03-05T07:03:36-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393402br/przedstawiciel-medyczny-linia-cardio-bialystok
2024-03-11T10:03:28-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393421br/clinical-research-medical-advisor-haemato-oncology
2024-03-04T09:03:28-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393440br/complaint-hub-associate
2024-03-04T09:03:28-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393441br/people-organization-hr-business-partner-vienna-80-100-mfd
2024-03-04T09:03:28-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/382667br/infrastructure-enterprise-architect-mergers-acquisitions
2024-03-04T09:03:28-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/388343br/pca-center-excellence-lead
2024-03-05T03:03:48-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/391976br/business-process-analyst-it-supply-chain-logistics-mfd
2024-03-04T09:03:28-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392905br/tm-academy-clinical-sciences-innovation-fellow
2024-03-04T09:03:28-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393213br/clinical-project-manager
2024-03-04T09:03:28-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393216br/associate-director-it-advanced-therapy-business-analyst
2024-03-04T09:03:28-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393316br/clinical-research-medical-advisor-oncology
2024-03-04T09:03:28-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393409br/senior-fra-specialist-inventory
2024-03-04T11:06:33-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393453br/sr-bus-analyst-ddit-usi-cpm
2024-03-04T11:06:33-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393455br/associate-director-architecture
2024-03-04T11:06:33-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/386244br/qa-engineer
2024-03-04T11:06:33-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/387600br/sales-representative-mwd-rheuma-heidelbergfreiburg
2024-03-04T11:06:33-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393204br/saperp-deployment-director
2024-03-14T14:03:45-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393459br/responsable-de-radiofarmacia
2024-03-04T13:03:37-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393462br/managersr-manager-partnering-and-access-innovation-global-health
2024-03-04T13:03:37-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393463br/buyer-rd-mandarin-speaker
2024-03-04T13:03:37-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393464br/discovery-postdoctoral-fellow-chronic-inflammation
2024-03-04T13:03:37-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/383530br/sourcing-manager-it-digital
2024-03-04T13:03:37-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/391966br/senior-process-expert-aseptic-processing
2024-03-04T13:03:37-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392675br/product-specialist-neurosciences-puglia
2024-03-04T13:03:37-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393003br/business-data-migration-lead-americas
2024-03-04T15:03:32-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393240br/associate-director-pk-sciences
2024-03-04T15:03:32-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392117br/director-congress-strategy-and-orchestration
2024-03-04T15:03:32-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393466br/patient-access-lead
2024-03-04T15:03:32-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393467br/customer-experience-content-partner
2024-03-04T15:03:32-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393468br/therapy-area-lead
2024-03-04T15:03:32-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393470br/new-products-strategic-pricing-partner
2024-03-04T15:03:32-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393474br/business-data-migration-expert-material-management-procurement
2024-03-04T15:03:32-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393476br/disease-area-partner-ascvd-alexandria
2024-03-04T15:03:32-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393477br/senior-disease-area-partner-ascvd-cairo
2024-03-04T15:03:32-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/385722br/director-business-development-licensing
2024-03-04T17:03:23-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393482br/delegue-hospitalier-dermatologie
2024-03-14T08:04:10-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393483br/radioligand-therapy-area-business-leader-southwest-remote
2024-03-04T17:03:23-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393484br/oncology-sales-specialist-hematology-columbus-remote
2024-03-04T17:03:23-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/387071br/sales-value-manager-monterrey
2024-03-04T19:03:19-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/390852br/customer-service-fmd
2024-03-06T09:02:18-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393485br/benefits-expert
2024-03-04T19:03:19-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393486br/commercial-analyst
2024-03-06T11:02:08-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/386836br/rlt-sasayamaassociate-qa-operation-compliance
2024-03-04T23:03:28-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393491br/gaojiyiyaodaibiao-zishenchanpinzhuguan
2024-03-04T23:03:28-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393493br/rlt-sasayamaassociate-rlt-lab-technician
2024-03-04T23:03:28-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392170br/specialiste-process-culture-cellulaire-hf
2024-03-05T01:03:55-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393495br/access-new-commercial-partnerships-manager
2024-03-05T01:03:55-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392223br/field-sales-leader-hematology
2024-03-11T06:03:11-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393505br/gaojidaqujingli
2024-03-05T05:03:41-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393509br/scheduling-manager-mfd
2024-03-15T10:04:31-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393514br/qc-site-manager-pharmacien-adjoint-marseille-hf
2024-03-05T05:03:41-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393522br/qa-officer
2024-03-13T08:03:37-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393532br/senior-legal-counsel-operations-china
2024-03-05T07:03:36-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393545br/site-quality-lead-saint-genis-pouilly-01-hf
2024-03-05T07:03:36-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392581br/senior-specialistsap-abap-btps4hana
2024-03-05T07:03:36-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393378br/internship-particle-characterization-masters-student
2024-03-05T07:03:36-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393423br/manager-inspection-audit-readiness
2024-03-05T07:03:36-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393544br/maintenance-coordinator-process
2024-03-05T09:04:08-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393547br/engineer-process
2024-03-05T09:04:08-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393552br/global-environmental-social-governance-controls-compliance-lead
2024-03-05T09:04:08-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393561br/it-assistant-digital-workspace-et-projet-it
2024-03-05T09:04:08-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393566br/expert-medico-economie-heor-health-economics-outcomes-research
2024-03-08T13:02:25-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393567br/pharmaziepraktikant-mwd-regulatory-affairs-ab-november-2024
2024-03-05T09:04:08-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/375075br/ddit-im-ux-design-lead
2024-03-05T09:04:08-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393542br/global-category-head-fleet
2024-03-05T11:03:32-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393548br/clinical-development-medical-director-renal
2024-03-05T11:03:32-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393570br/medical-goverance-lead-scientific-affairs
2024-03-05T11:03:32-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393573br/business-data-migration-expert-commercial
2024-03-05T11:03:32-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393575br/business-data-migration-expert-manufacturing
2024-03-05T11:03:32-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393578br/business-data-migration-expert-procurement
2024-03-05T11:03:32-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393591br/delegue-hospitalier-paris-idf-et-normandie
2024-03-05T11:03:32-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393336br/administrative-professionalproject-coordinator
2024-03-05T13:03:26-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393564br/medical-director-clinical-pharmacology
2024-03-05T13:03:26-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393584br/qa-operations-specialist-mfd
2024-03-05T13:03:26-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393587br/itot-site-lead
2024-03-05T13:03:26-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393588br/itot-support-engineer
2024-03-05T13:03:26-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393601br/neuroscience-territory-account-specialist-atlanta-remote
2024-03-05T13:03:26-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392835br/l-t-central-services-specialist
2024-03-05T15:03:33-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393605br/rewards-process-specialist
2024-03-05T15:03:33-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393603br/learning-services-specialist
2024-03-15T04:04:00-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393606br/global-reg-sub-publishing-specialist
2024-03-05T15:03:33-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393331br/qc-analyst-ii-temporary-2-years-contract
2024-03-05T17:03:48-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/387866br/head-record-report-us-operations-nocc-mexico
2024-03-05T17:03:48-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393613br/equipment-specialist-befristet-2-jahre
2024-03-05T17:03:48-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393614br/summer-student-marketing
2024-03-05T17:03:48-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393615br/cardiovascular-territory-account-specialist-salem-or-remote
2024-03-05T17:03:48-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393616br/summer-student-value-access
2024-03-05T17:03:48-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393619br/director-data-strategy-acquisition-and-contracting
2024-03-05T17:03:48-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393621br/gcp-bioanalysis-lab-operations-expert
2024-03-11T18:02:56-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393620br/summer-student-marketing
2024-03-05T19:03:48-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393622br/summer-student-psp-operations
2024-03-05T19:03:48-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393623br/summer-student-oncology
2024-03-05T19:03:48-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393625br/summer-student-value-access-npp
2024-03-05T19:03:48-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392913br/customer-engagement-lead
2024-03-05T21:02:01-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393626br/summer-student-online-experience
2024-03-05T21:02:01-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393627br/summer-student-capability-building
2024-03-05T21:02:01-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393628br/summer-student-ce-channel-performance
2024-03-05T21:02:01-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393629br/summer-student-business-planning-analysis
2024-03-05T21:02:01-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393630br/summer-student-legal-services
2024-03-05T21:02:01-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393631br/summer-student-supply-chain
2024-03-05T21:02:01-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393632br/summer-student-marketing
2024-03-05T21:02:01-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393633br/summer-student-data-strategy
2024-03-05T21:02:01-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393634br/summer-student-data-strategy
2024-03-05T21:02:01-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393635br/xianyuzhurenxianyuzhuguan
2024-03-05T23:02:07-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393645br/sso-clinical-project-manager
2024-03-06T03:01:59-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393648br/lead-consultant-management-consulting-early-research-drug-developme
2024-03-06T03:01:59-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/386046br/manager-digital-analytics
2024-03-06T05:02:15-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/391944br/global-product-manager
2024-03-08T05:02:30-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393624br/senior-international-trade-expert-mfd
2024-03-06T05:02:15-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393654br/produktionsmitarbeiterin-keine-nachtschicht-mo-so-schaftenau
2024-03-07T05:02:20-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393655br/people-engagement-expert
2024-03-06T05:02:15-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393658br/clinical-operations-program-head
2024-03-06T05:02:15-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/383218br/tehnik-v-biofarmacevtiki-mzd
2024-03-06T07:02:13-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392482br/associate-director-isc-endpoint-data-protection
2024-03-06T07:02:13-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392511br/senior-process-expert-cgt
2024-03-06T07:02:13-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392707br/sr-spec-ddit-dev-ba-trd
2024-03-06T07:02:13-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393565br/production-technician-1-year-temporary-contract
2024-03-06T07:02:13-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393664br/netzwerkmanager-mwd-ta-prostate-cancer-region-sudbayern
2024-03-06T07:02:13-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393465br/authority-affairs-manager
2024-03-06T09:02:18-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393677br/associate-director-data-management
2024-03-06T09:02:18-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393679br/associate-director-aiml-products
2024-03-06T09:02:18-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/390708br/produktionsmitarbeiterin-3-schichten-schaftenau-tirol
2024-03-06T09:02:18-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393318br/senior-fra-specialist-gl
2024-03-06T11:02:08-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393681br/head-ip-immunology
2024-03-06T11:02:08-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393685br/junior-mass-spectrometry-expert-mfd-analytical-characterization
2024-03-07T07:02:16-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393652br/associate-clinical-trial-supply-manager
2024-03-06T13:02:10-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393689br/tehnolog-proizvodnih-procesov-pakiranja-i-mzd
2024-03-06T13:02:10-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393694br/oncology-sales-specialist-womens-breast-cancer-harriburg-remote
2024-03-06T13:02:10-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393686br/research-scientist-necropsyhistology-preclinical-safety
2024-03-06T15:02:07-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393699br/rheumatology-territory-account-specialist-central-nj-remote
2024-03-06T15:02:07-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393700br/associate-director-hcp-education-delivery
2024-03-15T16:05:48-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/389800br/sso-study-start-team-lead
2024-03-06T17:02:11-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393706br/formulation-scientist-focus-rlt-mfd
2024-03-06T17:02:11-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393338br/crm-incentives-expert
2024-03-06T19:02:29-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393723br/associate-director-thought-leader-liaison-dermatology-southeast
2024-03-15T00:03:58-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393727br/medical-science-liaison-neuroscience-coastal-southeast-remote
2024-03-08T21:02:25-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393725br/regulatory-affairs-specialist
2024-03-06T23:02:11-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393729br/regulatory-affairs-associate-director
2024-03-06T23:02:11-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393731br/medical-representative
2024-03-06T23:02:11-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392256br/acheteur-industriel-hf
2024-03-07T01:02:37-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393730br/oncology-product-manager
2024-03-07T01:02:37-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393734br/senior-medical-safety-lead
2024-03-07T01:02:37-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393738br/project-coordinator
2024-03-07T03:02:09-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/385362br/program-change-manager-operations-workstream
2024-03-07T05:02:20-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/389591br/global-program-safety-lead-cardio-renal-metabolic
2024-03-07T05:02:20-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392230br/laboratorijski-analitik-mzd
2024-03-07T05:02:20-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392595br/senior-process-technologist
2024-03-07T05:02:20-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393585br/qa-operations-expert
2024-03-07T05:02:20-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393748br/legal-trainee-novartis-operations
2024-03-07T05:02:20-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393753br/senior-safety-signal-expert
2024-03-07T05:02:20-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393758br/qc-analyst-ii
2024-03-07T05:02:20-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393762br/qc-specialist-ii
2024-03-07T05:02:20-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393543br/buyer-german
2024-03-07T09:02:21-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393546br/senior-country-procurement-manager-germany
2024-03-07T09:02:21-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393776br/senior-coordinator
2024-03-07T09:02:21-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393784br/senior-mass-spectrometry-expert-analytical-characterisation-mfd
2024-03-07T09:02:21-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393787br/qa-assistant-troyes-hf
2024-03-07T11:02:17-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393788br/qa-assistant-bethune-hf
2024-03-07T11:02:17-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393791br/discovery-postdoctoral-fellow-covalent-drug-discovery
2024-03-07T11:02:17-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393794br/director-systems-accounts-cardiovascular-mountain-west-remote
2024-03-07T11:02:17-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/391404br/chef-de-produit-senior-ophta-hf
2024-03-07T11:02:17-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393798br/site-engineering-lead-toulouse-hf
2024-03-14T10:04:01-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393801br/clinical-biospecimen-expert-scientist
2024-03-07T13:02:24-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393807br/associate-director-ma-it-isc
2024-03-07T13:02:24-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393568br/process-expert
2024-03-07T13:02:24-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393604br/business-data-migration-expert-finance-2-positions
2024-03-12T14:03:16-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393815br/general-accounting-senior-specialist
2024-03-07T17:02:10-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393816br/general-accounting-manager
2024-03-07T17:02:10-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393817br/oncology-field-lead
2024-03-07T17:02:10-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393823br/associate-director-global-program-management
2024-03-07T19:02:13-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393819br/global-program-head-neuroscience-phd-or-md
2024-03-08T17:02:37-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393820br/summer-student-people-organization
2024-03-07T19:02:13-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393822br/summer-student-communications-engagement
2024-03-07T19:02:13-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393826br/senior-legal-counsel
2024-03-07T19:02:13-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393403br/sales-representative-market-brands-oncology-and-hematology
2024-03-07T21:02:08-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393743br/marketing-manager
2024-03-07T21:02:08-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393818br/neuro-portfolio-lead
2024-03-07T23:02:23-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393830br/xianyuzhurenxianyuzhuguan
2024-03-07T23:02:23-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393831br/gaojiyiyaodaibiao-zishenchanpinzhuguan
2024-03-07T23:02:23-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393832br/portfolio-account-specialist-wellington-waikato-region
2024-03-07T23:02:23-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393833br/portfolio-account-specialist-christchurch-region
2024-03-07T23:02:23-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393834br/senior-product-manager-auckland-based
2024-03-07T23:02:23-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393835br/marketing-coe-lead
2024-03-07T23:02:23-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392987br/automation-engineer-mfd
2024-03-08T01:02:36-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393837br/specialist
2024-03-08T01:02:36-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393840br/specialist
2024-03-08T01:02:36-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393841br/japan-clinical-trial-lead
2024-03-08T01:02:36-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393842br/specialist
2024-03-08T03:02:20-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393844br/dir-ddit-apd-ai-platforms
2024-03-15T04:04:00-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393854br/lead-consultant-management-consulting-change-management
2024-03-08T03:02:20-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393381br/associate-or-manager-associate-engagement
2024-03-12T02:03:00-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393855br/specialist-za-analitiko-mzd
2024-03-08T05:02:30-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393857br/head-global-finance-master-datagfmd
2024-03-08T05:02:30-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393859br/lead-consultant-management-consulting-campaign-management
2024-03-08T05:02:30-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/383281br/health-safety-environment-specialist
2024-03-08T07:02:28-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393057br/asset-life-cycle-lead
2024-03-08T07:02:28-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393220br/material-implementation-expert
2024-03-08T07:02:28-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393868br/senior-manager
2024-03-08T07:02:28-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393869br/sr-mgr-ddit-svcmgt-cn-data-platf
2024-03-08T07:02:28-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393875br/sr-mgr-ddit-soldel-china-data
2024-03-08T07:02:28-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393886br/laborant-scheikunde
2024-03-08T09:02:32-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393890br/senior-manager-commercial-analytics
2024-03-08T09:02:32-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/386842br/associate-qa-compliance
2024-03-08T09:02:32-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/391746br/associate-director-data-acquisition-contracting
2024-03-12T10:03:16-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393290br/elektrotechniker-mfd-kundl-tirol
2024-03-08T09:02:32-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393303br/technical-compliance-engineer-mfd
2024-03-14T04:03:26-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393456br/human-resources-specialist-german
2024-03-08T09:02:32-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393676br/change-manager-enterprise-data-management
2024-03-08T09:02:32-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393768br/patient-safety-specialist-fixed-term-contract
2024-03-08T09:02:32-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393882br/discovery-postdoctoral-fellow-diseases-aging-and-regenerative-medic
2024-03-08T11:02:27-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393897br/assoc-director-science-technology-molecular-analytical-development
2024-03-08T11:02:27-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/387389br/assoc-director-scrum-master
2024-03-08T11:02:27-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392857br/product-specialist-hematology-calabria-e-sicilia-orientale
2024-03-08T11:02:27-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393708br/applied-computational-biologist-renal-i
2024-03-08T11:02:27-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393342br/associate-director-ms-pbpk
2024-03-08T13:02:25-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393821br/global-program-head-oncology-md-or-phd
2024-03-08T15:02:15-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393361br/executive-director-us-patient-advocacy
2024-03-11T18:02:56-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393363br/executive-director-us-corporate-communications
2024-03-11T18:02:56-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393360br/head-public-affairs-lacan
2024-03-15T18:05:24-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393824br/global-program-clinical-head-neuroscience-md-phd-or-pharmd
2024-03-08T21:02:25-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393919br/group-head-regulatory-writing-and-submissions
2024-03-09T05:02:22-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393920br/tco-physician
2024-03-09T05:02:22-05:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393922br/ad-thought-leader-liaison-dermatology-rocky-mountain-region
2024-03-12T00:03:28-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393926br/gaojiyiyaodaibiao-zishenchanpinzhuguan
2024-03-10T22:02:32-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393927br/gaojiyiyaodaibiao-zishenchanpinzhuanyuan
2024-03-10T22:02:32-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392385br/gcp-bioanalysis-principal-scientist-ii
2024-03-11T00:03:04-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393928br/xianyuzhurenxianyuzhuguan
2024-03-11T00:03:04-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393931br/gaojiyiyaodaibiao-zishenchanpinzhuanyuan
2024-03-11T02:02:44-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393940br/medical-science-liaison-hematology-cluj
2024-03-11T04:02:49-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393941br/gaojiyiyaodaibiao-zishenchanpinzhuguan
2024-03-11T04:02:49-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392975br/business-data-migration-expert-finance
2024-03-11T06:03:11-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393934br/information-governance-manager
2024-03-11T06:03:11-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393944br/gaojiyiyaodaibiao-zishenchanpinzhuanyuan
2024-03-11T06:03:11-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393946br/gaojiyiyaodaibiao-zishenchanpinzhuanyuan
2024-03-11T06:03:11-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393948br/nadzornik-skladiscno-logisticnih-procesov
2024-03-11T06:03:11-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393951br/technicien-de-maintenance-utilites-hf-cdd
2024-03-11T06:03:11-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393952br/gaojiyiyaodaibiao-zishenchanpinzhuguan
2024-03-11T06:03:11-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393954br/medical-scientific-liaison-pre-launch-hematology
2024-03-11T06:03:11-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393955br/mgr-ddit-svcmgt-china
2024-03-11T06:03:11-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393880br/moderator-procesov-registracij-mzd
2024-03-11T08:02:58-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393961br/commercial-manager
2024-03-11T08:02:58-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393962br/procurement-analyst-ddit-procurement
2024-03-11T08:02:58-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393969br/specialist-data-scientist
2024-03-11T08:02:58-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393973br/equipment-specialist-i
2024-03-11T08:02:58-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393976br/senior-consultant
2024-03-11T10:03:28-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393979br/customer-engagement-manager
2024-03-11T10:03:28-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393987br/equipment-specialist-i
2024-03-11T10:03:28-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393594br/qa-compliance-expert-reg-cmc-facilitator
2024-03-11T10:03:28-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393671br/senior-business-planning-analyzes-manager-large-molecules
2024-03-11T10:03:28-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393687br/head-protective-security-switzerland
2024-03-11T10:03:28-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393782br/kierownik-ds-kluczowych-klientow-solid-tumors
2024-03-11T10:03:28-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393870br/specialist-kontrole-kakovosti-za-laboratorijsko-opremo-mzd
2024-03-11T10:03:28-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393990br/director-radioligand-therapy-access-lead-remote
2024-03-11T10:03:28-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393980br/access-reimbursement-manager-renal-remote-charlotte-nc
2024-03-11T10:03:28-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393992br/qc-site-manager-pharmacien-adjoint-saint-genis-pouilly-hf
2024-03-11T12:03:24-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393995br/postgraduate-external-analytics
2024-03-11T12:03:24-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393997br/technicien-de-production-controle-qualite-cdd-01-hf
2024-03-11T12:03:24-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393999br/clinical-research-associate-cra
2024-03-15T14:05:37-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/385231br/therapeutic-data-strategy-director
2024-03-11T12:03:24-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393994br/associate-director-radioligand-therapy-access-lead-1-5-roles
2024-03-12T22:03:03-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394004br/clinical-research-medical-advisor
2024-03-11T14:02:55-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394009br/global-program-safety-lead
2024-03-11T14:02:55-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394012br/associate-director-channel-pricing-strategy-remote
2024-03-11T14:02:55-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393721br/head-finance-communications
2024-03-11T16:03:00-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393998br/director-channel-and-pricing-strategy-remote
2024-03-11T16:03:00-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394014br/order-cash-treasury-cash-management-team-lead
2024-03-11T16:03:00-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394015br/clinical-development-medical-director
2024-03-11T16:03:00-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394016br/associate-director-marketing-strategy
2024-03-12T14:03:16-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393716br/director-corporate-affairs-storytelling
2024-03-11T16:03:00-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393717br/manager-strategic-projects-chief-staff-office
2024-03-11T16:03:00-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393720br/head-finance-communications
2024-03-11T16:03:00-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394021br/head-refs-us-real-estate-and-facility-services-executive-director
2024-03-14T12:03:39-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393986br/vp-channel-strategy-and-account-management-remote
2024-03-15T16:05:48-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393988br/ed-channel-strategy-advanced-platforms-remote
2024-03-11T20:02:58-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394026br/oncology-area-business-leader-melanoma-west
2024-03-11T20:02:58-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394033br/gaojiyiyaodaibiaozishenchanpinzhuguan
2024-03-12T00:03:28-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394034br/gaojiyiyaodaibiao-zishenchanpinzhuguan
2024-03-12T00:03:28-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394036br/gaojiyiyaodaibiao-zishenchanpinzhuguan
2024-03-12T00:03:28-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394038br/gaojiyiyaodaibiao-zishenchanpinzhuanyuan
2024-03-12T00:03:28-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394039br/quyushichangjingliarea-marketing-manager
2024-03-12T00:03:28-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394040br/gaojiyiyaodaibiao-zishenchanpinzhuanyuan
2024-03-12T00:03:28-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394041br/gaojiyiyaodaibiao-zishenchanpinzhuanyuan
2024-03-12T00:03:28-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394042br/quyushichangjingliarea-marketing-manager
2024-03-12T00:03:28-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394043br/gaojidequjingli
2024-03-12T00:03:28-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394045br/gaojiyiyaodaibiao-zishenchanpinzhuanyuan
2024-03-12T00:03:28-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394048br/gaojiyiyaodaibiao-zishenchanpinzhuanyuan
2024-03-12T00:03:28-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394049br/gaojiyiyaodaibiao-zishenchanpinzhuanyuan
2024-03-12T00:03:28-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394050br/sr-spec-ddit-dev-soldel-ppm
2024-03-12T02:03:00-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394053br/principal-rwe-scientific-data-analyst
2024-03-12T02:03:00-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394056br/rwe-scientific-data-analyst-ii
2024-03-12T02:03:00-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394059br/elearning-technical-developer
2024-03-12T04:04:04-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394061br/information-specialist-literature-intelligence
2024-03-12T04:04:04-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/384524br/manager
2024-03-12T06:03:33-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/391875br/process-support-unit-lead-mfd
2024-03-12T06:03:33-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393852br/external-engagement-manager
2024-03-12T06:03:33-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394073br/utilities-technieker-gebouwen
2024-03-12T06:03:33-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394062br/xianyuzhurenxianyuzhuguan
2024-03-12T06:03:33-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394067br/senior-analyst
2024-03-12T06:03:33-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/384519br/manager
2024-03-12T08:03:12-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393189br/chef-de-produit-rhumato-hf
2024-03-12T08:03:12-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394082br/therapeutic-area-partner-illaris-gulf-cluster
2024-03-12T08:03:12-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394084br/medical-advisor-hematology
2024-03-12T08:03:12-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394088br/qc-analyst-ii
2024-03-12T08:03:12-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393984br/external-analytical-operations-expert-fmd
2024-03-12T10:03:16-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394094br/qc-analyst-ii
2024-03-12T10:03:16-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394101br/gaojiyiyaodaibiao-zishenchanpinzhuanyuan
2024-03-12T10:03:16-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393908br/technicien-laboratoire-prelevement-microbiologie-hf-cdd
2024-03-12T12:03:38-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394103br/delegue-hospitalier-onco-val-de-loire
2024-03-12T12:03:38-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394104br/gaojiyiyaodaibiao-zishenchanpinzhuanyuan
2024-03-12T12:03:38-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394107br/oncology-sales-specialist-nm-hematology-indianapolis-remote
2024-03-12T12:03:38-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394105br/gaojiyiyaodaibiao-zishenchanpinzhuanyuan
2024-03-12T12:03:38-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394110br/chef-de-produit-hf
2024-03-12T12:03:38-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394111br/chef-de-produit-hf-cdd
2024-03-12T12:03:38-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/389583br/sales-representative-dwm-ta-onkologie-hannover-wolfsburg-braunsc
2024-03-12T12:03:38-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/389584br/sales-representative-dmw-ta-onkologie-bremen-hamburg-oldenburg
2024-03-12T12:03:38-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393035br/qc-analyst
2024-03-12T12:03:38-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393675br/responsable-grands-comptes-dermato-idf-nord-hf
2024-03-12T12:03:38-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394120br/talent-acquisition-lead-international-latin-america-and-canada-region
2024-03-12T14:03:16-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394122br/oncology-specialist-rlt-prostate-dayton-remote
2024-03-12T16:03:24-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394123br/manager-patient-access
2024-03-12T16:03:24-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394126br/territory-account-specialist-cardiovascular-seattle-north-remote
2024-03-12T18:03:09-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394129br/clinical-project-manager-site-study-operationssso
2024-03-12T18:03:09-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394130br/clinical-project-manager-site-study-operationssso
2024-03-12T18:03:09-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394132br/associate-director-marketing-strategist-rheumatology
2024-03-13T12:03:19-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394133br/discovery-postdoctoral-fellow-neuroscience-multi-modal-genomics
2024-03-12T18:03:09-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/378694br/sap-basisaws-cloud-manager
2024-03-12T18:03:09-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/391288br/head-health-data-insights-design
2024-03-12T18:03:09-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393639br/gerente-de-cuentas-clave
2024-03-12T20:03:16-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394139br/expert-science-technology-drug-product
2024-03-12T20:03:16-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394140br/trial-master-file-integration-oversight-manager
2024-03-13T10:03:40-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394141br/head-pco-center-excellence
2024-03-12T20:03:16-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/387704br/lead-solution-design-region-accelerator
2024-03-12T22:03:03-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394153br/gaojiyiyaodaibiao-zishenchanpinzhuanyuan
2024-03-14T00:04:05-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394154br/executive-director-martech-product-owner-salesforce
2024-03-13T00:03:33-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394155br/gaojiyiyaodaibiao-zishenchanpinzhuanyuan
2024-03-13T00:03:33-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/388804br/shengchancaozuogong
2024-03-13T02:03:23-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393744br/data-insights-business-planning
2024-03-13T04:03:38-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394160br/therapeutic-area-partner-qatar
2024-03-13T04:03:38-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394172br/rewards-process-specialist
2024-03-13T06:03:36-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394166br/associate-product-manager
2024-03-13T06:03:36-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394168br/assoc-dir-ddit-isc-ent-arch-digit-sec
2024-03-13T06:03:36-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393058br/engineer-automation
2024-03-13T08:03:37-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394184br/student-intern
2024-03-13T08:03:37-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394185br/supply-operations-manager
2024-03-13T08:03:37-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394189br/clinical-drug-development-postgraduate-training-program-mscphdmd
2024-03-13T08:03:37-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394193br/development-quality-assurance-manager-gcpgpvp
2024-03-13T08:03:37-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394187br/quality-specialist-managing-external-contractors-mfd
2024-03-13T10:03:40-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394196br/process-team-lead
2024-03-13T10:03:40-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394204br/analista-de-bi-efetividade-da-forca-de-vendas-sr-imi-sp
2024-03-13T10:03:40-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394205br/assoc-dir-ddit-dev-ba-usdus
2024-03-13T10:03:40-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393205br/re-lead-standards-process-governance
2024-03-13T10:03:40-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393879br/senior-qa-operations-specialist-mwd
2024-03-13T10:03:40-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393892br/solution-service-design-managers
2024-03-13T10:03:40-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393959br/quality-assurance-specialist-laboratory-support-mfd
2024-03-13T10:03:40-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394128br/pharmareferentin-onkologie-brustkrebs-westen
2024-03-13T10:03:40-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394217br/python-developer
2024-03-13T12:03:19-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/390766br/head-health-data-insights-design
2024-03-13T12:03:19-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394226br/engineering-maintenance-cmms-lead
2024-03-14T14:03:45-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394227br/sr-spec-ddit-isc-secops-cyber-tools
2024-03-13T14:03:21-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/391114br/ast-specialist-ii-mfd
2024-03-13T14:03:21-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392368br/ldc-adopt-mgr-demand-and-supply-americas
2024-03-13T16:03:04-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394241br/gaojiyiyaodaibiaozishenchanpinzhuguan
2024-03-14T04:03:26-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394245br/gaojiyiyaodaibiao-zishenchanpinzhuanyuan
2024-03-14T00:04:05-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394246br/director-product-strategy-lead-sma-intrathecal
2024-03-14T00:04:05-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392712br/senior-scientist-antigen-therapeutic-protein-production-80-100
2024-03-14T00:04:05-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393013br/research-scientist-immunogenicity-mechanistic-immunology-80-100
2024-03-14T00:04:05-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394247br/oncology-disease-area-lead-nm-hematology-columbus-remote
2024-03-14T02:03:17-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394249br/gaojiyiyaodaibiao-zishenchanpinzhuanyuan
2024-03-14T04:03:26-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394254br/lead-capability-learning-solutions
2024-03-14T04:03:26-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/391682br/assoc-dir-ddit-dev-gco-tech-design
2024-03-14T06:03:53-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394261br/lingshouteyaochanpinzhuanyuan
2024-03-14T06:03:53-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394262br/gaojiyiyaodaibiao-zishenchanpinzhuanyuan
2024-03-14T06:03:53-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394264br/gaojiyiyaodaibiao-zishenchanpinzhuanyuan
2024-03-14T06:03:53-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394267br/gaojiyiyaodaibiao-zishenchanpinzhuanyuan
2024-03-14T06:03:53-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393443br/customer-engagement-manager-hematology
2024-03-15T06:03:53-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394280br/office-administrator
2024-03-14T08:04:10-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394285br/cxzhanerito-cx-strategy-lead
2024-03-14T08:04:10-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394289br/lead-cx-content-creation
2024-03-14T08:04:10-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/383961br/analista-de-eventos-sr-im-sao-paulo
2024-03-14T10:04:01-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/386212br/it-product-lead-europe-patient-services-salesforce
2024-03-14T10:04:01-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393674br/delegue-hospitalier-idf-hf
2024-03-14T10:04:01-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393805br/head-legal-secretary-pension-fund-board-trustees-80
2024-03-14T10:04:01-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393911br/qa-operations-specialist-mfd
2024-03-14T10:04:01-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394159br/clinical-operations-specialist
2024-03-14T10:04:01-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394207br/hcm-engagement-manager
2024-03-14T10:04:01-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394302br/medical-representative
2024-03-14T12:03:39-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394306br/scm-analyst-mfd
2024-03-14T12:03:39-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394309br/senior-scientist-oncology-pathology-biomarkers
2024-03-14T12:03:39-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393877br/value-access-manager-senior-value-access-manager
2024-03-14T12:03:39-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394303br/ot-support-specialist-saint-genis-pouilly-01-hf
2024-03-14T12:03:39-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394006br/snr-key-account-manager-south-region-rare-diseases
2024-03-14T14:03:45-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394007br/snr-key-account-manager-north-region-rare-diseases
2024-03-14T14:03:45-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394311br/quality-projects-lead-cgmp
2024-03-14T14:03:45-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394313br/access-manager-marketing-population-health
2024-03-14T14:03:45-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394218br/bpa-fpa-core-consultant-global-functions-sao-paulo
2024-03-14T16:03:15-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394323br/disease-area-partner-immunology-giza
2024-03-14T16:03:15-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394030br/market-access-manager
2024-03-14T18:03:36-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394046br/associate-pricing-manager
2024-03-14T18:03:36-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394047br/associate-director-pricing
2024-03-14T18:03:36-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394325br/associate-director-market-access
2024-03-14T18:03:36-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/392367br/ldc-adopt-lead-supply-chain-americas
2024-03-14T18:03:36-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393223br/senior-regulatory-writer
2024-03-14T20:03:27-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394328br/associate-director-regulatory-writing
2024-03-14T20:03:27-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394331br/gaojiyiyaodaibiaozishenchanpinzhuguan
2024-03-14T22:03:31-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394332br/global-ops-manager
2024-03-14T22:03:31-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393229br/associate-director-biomarker-project-lead
2024-03-15T00:03:58-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393346br/principal-scientist-medicinal-chemist-80-100
2024-03-15T00:03:58-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394334br/gaojiyiyaodaibiao-zishenchanpinzhuanyuan
2024-03-15T00:03:58-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394335br/gaojiyiyaodaibiao-zishenchanpinzhuanyuan
2024-03-15T00:03:58-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394336br/gaojiyiyaodaibiao-zishenchanpinzhuanyuan
2024-03-15T00:03:58-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394337br/gaojiyiyaodaibiaozishenchanpinzhuguan
2024-03-15T00:03:58-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394338br/associate-external-operations-manager
2024-03-15T00:03:58-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394339br/oncology-disease-area-lead-nm-hematology-seattle-remote
2024-03-15T00:03:58-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394028br/associate-market-access-manager
2024-03-15T02:03:39-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394341br/gaojidequjingli
2024-03-15T02:03:39-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394342br/gaojiyiyaodaibiao-zishenchanpinzhuanyuan
2024-03-15T02:03:39-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394343br/gaojiyiyaodaibiao-zishenchanpinzhuanyuan
2024-03-15T02:03:39-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394344br/xianyuzhurenxianyuzhuguan
2024-03-15T02:03:39-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394345br/gaojiyiyaodaibiao-zishenchanpinzhuanyuan
2024-03-15T02:03:39-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394346br/gaojiyiyaodaibiao-zishenchanpinzhuanyuan
2024-03-15T02:03:39-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394340br/gaojidequjingli
2024-03-15T02:03:39-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393929br/customer-engagement-associate-12mth-contract
2024-03-15T04:04:00-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394032br/analytics-insights-manager
2024-03-15T04:04:00-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394347br/manager-advanced-analytics
2024-03-15T04:04:00-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394350br/manager-front-end-dev-python-java-angular-js-flask-quickly
2024-03-15T04:04:00-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394364br/field-product-specialist-cardiovascular
2024-03-15T06:03:53-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394363br/field-product-specialist-cardiovascular
2024-03-15T06:03:53-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394362br/field-product-specialist-cardiovascular
2024-03-15T06:03:53-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394357br/medical-representative
2024-03-15T06:03:53-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394360br/logistics-specialist
2024-03-15T06:03:53-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394365br/senior-analyst
2024-03-15T06:03:53-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394369br/snr-spec-ddit-apd-da-integration
2024-03-15T06:03:53-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393458br/human-resources-specialist-spanish
2024-03-15T08:04:19-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393760br/communication-manager-and-patient-relations
2024-03-15T08:04:19-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393895br/chemielabortechniker-qc-analyst-ii-mwd-schaftenau-osterreich
2024-03-15T08:04:19-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394393br/technology-product-associate-director
2024-03-15T08:04:19-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394315br/head-patient-centre-outcomes-center-excellence
2024-03-15T08:04:19-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394333br/senior-clinical-finance-manager
2024-03-15T08:04:19-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394372br/head-safety-case-processing
2024-03-15T08:04:19-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394392br/specialist-ddit-isc-qnova
2024-03-15T08:04:19-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394394br/asistant-manager-innovation-and-data-sc
2024-03-15T10:04:31-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394396br/manager-erc-policies
2024-03-15T10:04:31-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394397br/executive-ncq
2024-03-15T10:04:31-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394400br/allergy-territory-account-specialist-fort-collins-co-remote
2024-03-15T10:04:31-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394401br/allergy-territory-account-specialist-annapolis-md-remote
2024-03-15T10:04:31-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394403br/laborant-omgevingscontrole
2024-03-15T10:04:31-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394406br/allergy-territory-account-specialist-colorado-springsco-remote
2024-03-15T10:04:31-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394407br/allergy-territory-account-specialist-charleston-wv-remote
2024-03-15T10:04:31-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394409br/allergy-territory-account-specialist-denver-co-remote
2024-03-15T10:04:31-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394411br/director-solution-delivery-one-psp-sf
2024-03-15T10:04:31-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394412br/allergy-territory-account-specialist-lexington-remote
2024-03-15T10:04:31-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394413br/allergy-territory-account-specialist-tucson-az-remote
2024-03-15T10:04:31-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394414br/allergy-territory-account-specialist-louisville-south-remote
2024-03-15T10:04:31-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394415br/allergy-territory-account-specialist-phoenix-north-az-remote
2024-03-15T10:04:31-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393206br/associate-director-solution-delivery-quality-control
2024-03-15T10:04:31-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/393949br/strategic-account-manager-cardio-mfd
2024-03-15T10:04:31-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394144br/crm-incentives-expert
2024-03-15T10:04:31-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394417br/allergy-territory-account-specialist-phoenix-south-az-remote
2024-03-15T12:05:05-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394418br/allergy-territory-account-specialist-salt-lake-city-ut-remote
2024-03-15T12:05:05-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394420br/allergy-territory-account-specialist-spokane-wa-remote
2024-03-15T12:05:05-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394423br/allergy-territory-account-specialist-orange-county-ca-remote
2024-03-15T12:05:05-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394425br/allergy-territory-account-specialist-san-diego-ca-remote
2024-03-15T12:05:05-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394428br/allergy-territory-account-specialist-las-vegas-nv-remote
2024-03-15T12:05:05-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394429br/qc-analyst-omgevingscontrole
2024-03-15T12:05:05-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394431br/allergy-territory-account-specialist-seattle-east-wa-remote
2024-03-15T12:05:05-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394432br/allergy-territory-account-specialist-seattle-west-wa-remote
2024-03-15T12:05:05-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394433br/head-ddit-isc-business-continuity-mgmt
2024-03-15T12:05:05-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394434br/allergy-territory-account-specialist-portland-or-remote
2024-03-15T12:05:05-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394435br/allergy-territory-account-specialist-sacramento-ca-remote
2024-03-15T12:05:05-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394436br/allergy-territory-account-specialist-fresno-ca-remote
2024-03-15T12:05:05-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394437br/allergy-territory-account-specialist-san-francisco-ca-remote
2024-03-15T12:05:05-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394438br/allergy-territory-account-specialist-bakersfield-ca-remote
2024-03-15T12:05:05-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394440br/allergy-territory-account-specialist-los-angeles-west-ca-remote
2024-03-15T12:05:05-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394441br/allergy-territory-account-specialist-los-angeles-east-ca-remote
2024-03-15T12:05:05-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394442br/allergy-territory-account-specialist-san-jose-ca-remote
2024-03-15T12:05:05-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394443br/allergy-territory-account-specialist-pasadena-ca-remote
2024-03-15T12:05:05-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394444br/allergy-territory-account-specialist-atlanta-north-remote
2024-03-15T12:05:05-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394446br/allergy-territory-account-specialist-bowling-green-remote
2024-03-15T12:05:05-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394447br/allergy-territory-account-specialist-atlanta-south-remote
2024-03-15T12:05:05-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394448br/allergy-territory-account-specialist-chattanooga-tn-remote
2024-03-15T12:05:05-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394449br/allergy-territory-account-specialist-cincinnati-remote
2024-03-15T12:05:05-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394450br/allergy-territory-account-specialist-macon-ga-remote
2024-03-15T12:05:05-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394453br/allergy-territory-account-specialist-indianapolis-south-remote
2024-03-15T12:05:05-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394454br/allergy-territory-account-specialist-jacksonville-fl-remote
2024-03-15T12:05:05-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394455br/allergy-territory-account-specialist-daytona-beach-fl-remote
2024-03-15T12:05:05-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394231br/coordinateur-prestataire-operations-locales-hf
2024-03-15T12:05:05-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394297br/embrace-advisor-milano
2024-03-15T12:05:05-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394456br/allergy-territory-account-specialist-peoria-remote
2024-03-15T12:05:05-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394457br/allergy-territory-account-specialist-tampa-fl-remote
2024-03-15T12:05:05-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394416br/allergy-territory-account-specialist-louisville-north-remote
2024-03-15T14:05:37-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394002br/access-value-manager-onco-hematologia-brasil
2024-03-15T14:05:37-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394458br/allergy-territory-account-specialist-st-louis-remote
2024-03-15T14:05:37-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394459br/allergy-territory-account-specialist-palm-beach-fl-remote
2024-03-15T14:05:37-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394460br/allergy-territory-account-specialist-oklahoma-city-remote
2024-03-15T14:05:37-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394461br/allergy-territory-account-specialist-sarasota-fl-remote
2024-03-15T14:05:37-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394462br/allergy-territory-account-specialist-miami-fl-remote
2024-03-15T14:05:37-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394463br/allergy-territory-account-specialist-fort-worth-remote
2024-03-15T14:05:37-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394464br/allergy-territory-account-specialist-dallas-east-remote
2024-03-15T14:05:37-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394465br/allergy-territory-account-specialist-nashville-east-remote
2024-03-15T14:05:37-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394466br/allergy-territory-account-specialist-dallas-west-remote
2024-03-15T14:05:37-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394467br/allergy-territory-account-specialist-nashville-west-remote
2024-03-15T14:05:37-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394468br/allergy-territory-account-specialist-houston-east-remote
2024-03-15T14:05:37-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394469br/allergy-territory-account-specialist-houston-west-remote
2024-03-15T14:05:37-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394470br/allergy-territory-account-specialist-murfreesboro-tn-remote
2024-03-15T14:05:37-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394471br/allergy-territory-account-specialist-austin-north-remote
2024-03-15T14:05:37-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394472br/allergy-territory-account-specialist-birmingham-al-remote
2024-03-15T14:05:37-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394473br/allergy-territory-account-specialist-austin-south-remote
2024-03-15T14:05:37-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394474br/allergy-territory-account-specialist-pensacola-fl-remote
2024-03-15T14:05:37-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394475br/allergy-territory-account-specialist-san-antonio-remote
2024-03-15T14:05:37-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394478br/allergy-territory-account-specialist-corpus-christi-remote
2024-03-15T14:05:37-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394481br/allergy-territory-account-specialist-albuquerque-remote
2024-03-15T14:05:37-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394482br/allergy-territory-account-specialist-columbus-ms-remote
2024-03-15T14:05:37-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394483br/allergy-territory-account-specialist-jackson-ms-remote
2024-03-15T14:05:37-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394484br/allergy-territory-account-specialist-new-orleans-remote
2024-03-15T14:05:37-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394485br/allergy-territory-account-specialist-little-rock-ar-remote
2024-03-15T14:05:37-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394487br/allergy-territory-account-specialist-shreveport-la-remote
2024-03-15T14:05:37-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394488br/allergy-territory-account-specialist-knoxville-tn-remote
2024-03-15T14:05:37-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394489br/allergy-territory-account-specialist-detroit-mi-remote
2024-03-15T14:05:37-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394490br/allergy-territory-account-specialist-harrisburg-pa-remote
2024-03-15T14:05:37-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394492br/allergy-territory-account-specialist-flint-mi-remote
2024-03-15T14:05:37-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394493br/allergy-territory-account-specialist-baltimore-md-remote
2024-03-15T14:05:37-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394494br/allergy-territory-account-specialist-grand-rapids-mi-remote
2024-03-15T14:05:37-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394495br/allergy-territory-account-specialist-washington-dc-remote
2024-03-15T14:05:37-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394496br/allergy-territory-account-specialist-bethesda-md-remote
2024-03-15T14:05:37-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394497br/allergy-territory-account-specialist-fairfax-va-remote
2024-03-15T14:05:37-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394498br/allergy-territory-account-specialist-portland-me-remote
2024-03-15T14:05:37-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394500br/allergy-territory-account-specialist-pittsburgh-pa-remote
2024-03-15T14:05:37-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394501br/allergy-territory-account-specialist-newark-de-remote
2024-03-15T14:05:37-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394502br/allergy-territory-account-specialist-boston-north-remote
2024-03-15T14:05:37-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394503br/allergy-territory-account-specialist-boston-south-remote
2024-03-15T14:05:37-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394504br/allergy-territory-account-specialist-fredericksburg-va-remote
2024-03-15T14:05:37-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394505br/allergy-territory-account-specialist-norfolk-va-remote
2024-03-15T14:05:37-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394506br/allergy-territory-account-specialist-hartford-ct-remote
2024-03-15T14:05:37-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394507br/allergy-territory-account-specialist-richmond-va-remote
2024-03-15T14:05:37-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394508br/allergy-territory-account-specialist-new-haven-ct-remote
2024-03-15T14:05:37-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394549br/principal-scientist-cadd
2024-03-15T16:05:48-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394206br/research-development-quality-risk-management-manager
2024-03-15T16:05:48-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394511br/global-med-dir-autoimmune-disease
2024-03-15T16:05:48-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394510br/allergy-territory-account-specialist-raleigh-nc-remote
2024-03-15T16:05:48-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394512br/allergy-territory-account-specialist-white-plains-ny-remote
2024-03-15T16:05:48-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394513br/allergy-territory-account-specialist-albany-ny-remote
2024-03-15T16:05:48-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394514br/allergy-territory-account-specialist-syracuse-ny-remote
2024-03-15T16:05:48-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394515br/allergy-territory-account-specialist-buffalo-ny-remote
2024-03-15T16:05:48-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394516br/allergy-territory-account-specialist-springfield-ma-remote
2024-03-15T16:05:48-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394517br/allergy-territory-account-specialist-ann-arbor-mi-remote
2024-03-15T16:05:48-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394518br/allergy-territory-account-specialist-morristown-nj-remote
2024-03-15T16:05:48-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394519br/allergy-territory-account-specialist-allentown-pa-remote
2024-03-15T16:05:48-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394520br/allergy-territory-account-specialist-toledo-oh-remote
2024-03-15T16:05:48-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394521br/allergy-territory-account-specialist-edison-nj-remote
2024-03-15T16:05:48-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394522br/allergy-territory-account-specialist-durham-nc-remote
2024-03-15T16:05:48-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394523br/allergy-territory-account-specialist-philadelphia-pa-remote
2024-03-15T16:05:48-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394524br/allergy-territory-account-specialist-winston-salem-nc-remote
2024-03-15T16:05:48-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394525br/allergy-territory-account-specialist-toms-river-nj-remote
2024-03-15T16:05:48-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394526br/allergy-territory-account-specialist-columbus-oh-remote
2024-03-15T16:05:48-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394527br/allergy-territory-account-specialist-charlotte-nc-remote
2024-03-15T16:05:48-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394528br/allergy-territory-account-specialist-columbia-sc-remote
2024-03-15T16:05:48-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394529br/allergy-territory-account-specialist-midtown-manhattan-ny-remote
2024-03-15T16:05:48-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394530br/allergy-territory-account-specialist-indianapolis-north-remote
2024-03-15T16:05:48-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394531br/allergy-territory-account-specialist-charleston-sc-remote
2024-03-15T16:05:48-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394532br/allergy-territory-account-specialist-brooklyn-ny-remote
2024-03-15T16:05:48-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394533br/allergy-territory-account-specialist-queens-ny-remote
2024-03-15T16:05:48-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394534br/allergy-territory-account-specialist-johnson-city-tn-remote
2024-03-15T16:05:48-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394535br/allergy-territory-account-specialist-bay-shore-ny-remote
2024-03-15T16:05:48-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394536br/allergy-territory-account-specialist-jersey-city-nj-remote
2024-03-15T16:05:48-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394537br/allergy-territory-account-specialist-greenville-sc-remote
2024-03-15T16:05:48-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394538br/allergy-territory-account-specialist-cleveland-oh-remote
2024-03-15T16:05:48-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394539br/allergy-territory-account-specialist-akron-oh-remote
2024-03-15T16:05:48-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394540br/allergy-territory-account-specialist-chicago-n-remote
2024-03-15T16:05:48-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394541br/allergy-territory-account-specialist-chicago-s-remote
2024-03-15T16:05:48-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394542br/allergy-territory-account-specialist-green-bay-wi-remote
2024-03-15T16:05:48-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394543br/allergy-territory-account-specialist-milwaukee-wi-remote
2024-03-15T16:05:48-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394544br/allergy-territory-account-specialist-naperville-il-remote
2024-03-15T16:05:48-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394545br/allergy-territory-account-specialist-minneapolis-mn-remote
2024-03-15T16:05:48-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394546br/allergy-territory-account-specialist-des-moines-ia-remote
2024-03-15T16:05:48-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394547br/allergy-territory-account-specialist-kansas-city-mo-remote
2024-03-15T16:05:48-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394548br/allergy-territory-account-specialist-lincoln-ne-remote
2024-03-15T16:05:48-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394550br/allergy-territory-account-specialist-sioux-falls-sd-remote
2024-03-15T16:05:48-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394551br/allergy-territory-account-specialist-wichita-ks-remote
2024-03-15T16:05:48-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394553br/medical-science-liaison-allergy-derm-tennessee-remote
2024-03-15T16:05:48-04:00
daily
0.5
https://www.novartis.com/us-en/careers/career-search/job-details/394329br/associate-director-innovation-capability-clinical-trial-diversity
2024-03-15T18:05:24-04:00
daily
0.5
https://www.novartis.com/us-en/news
2023-12-01T19:21:21-05:00
daily
0.5
https://www.novartis.com/us-en/about
2024-01-08T04:26:41-05:00
daily
0.5
https://www.novartis.com/us-en/home
2024-01-31T09:14:45-05:00
daily
0.5
https://www.novartis.com/us-en/esg
2023-11-28T10:43:31-05:00
daily
0.5
https://www.novartis.com/us-en/patients-and-caregivers
2024-02-26T18:11:34-05:00
daily
0.5
https://www.novartis.com/us-en/healthcare-professionals
2024-02-26T18:30:45-05:00
daily
0.5
https://www.novartis.com/us-en/coronavirus
2023-11-13T07:42:59-05:00
daily
0.5
https://www.novartis.com/us-en/about/diversity-and-inclusion
2023-12-01T10:42:00-05:00
daily
0.5
https://www.novartis.com/us-en/about/novartis-us
2023-12-01T10:41:09-05:00
daily
0.5
https://www.novartis.com/us-en/patients-and-caregivers/step-program
2023-12-01T10:44:21-05:00
daily
0.5
https://www.novartis.com/us-en/esg/ethics-risk-and-compliance
2023-12-01T10:45:09-05:00
daily
0.5
https://www.novartis.com/us-en/esg/corporate-responsibility
2023-12-01T10:45:52-05:00
daily
0.5
https://www.novartis.com/us-en/esg/beacon-hope
2023-12-01T09:06:08-05:00
daily
0.5
https://www.novartis.com/us-en/clinicaltrials/cardio-renal-metabolism/renal/NCT04181762-us-en
2023-12-01T15:08:13-05:00
daily
0.5
https://www.novartis.com/us-en/clinicaltrials/respiratory-allergy/foodallergy/NCT04984876-us-es
2022-08-23T08:17:48-04:00
daily
0.5
https://www.novartis.com/us-en/clinicaltrials/immunology/osteoarthritis/NCT04886258-NCT04814368-NCT05462990
2024-01-17T23:25:31-05:00
daily
0.5
https://www.novartis.com/us-en/clinicaltrials/neuroscience/RMS/NCT05147220-NCT05156281
2023-11-22T21:13:31-05:00
daily
0.5
https://www.novartis.com/us-en/clinicaltrials/immunology/SLE/NCT05639114-NCT05624749
2024-02-28T09:24:57-05:00
daily
0.5
https://www.novartis.com/us-en/clinicaltrials/immunology/osteoarthritis/NCT04886258-NCT04814368-NCT05462990-es
2024-01-18T08:32:33-05:00
daily
0.5
https://www.novartis.com/us-en/clinicaltrials/immunology/RCT/NCT05722522-NCT05758415
2023-11-22T21:07:15-05:00
daily
0.5
https://www.novartis.com/us-en/clinicaltrials/immunology/LN/NCT05126277
2024-02-16T00:00:44-05:00
daily
0.5
https://www.novartis.com/us-en/patients-and-caregivers/diseases
2024-03-05T10:30:05-05:00
daily
0.5
https://www.novartis.com/us-en/clinicaltrials/hematology/ITPWAIHA/NCT05653349-NCT05653219-NCT05648968
2023-11-30T00:34:17-05:00
daily
0.5
https://www.novartis.com/us-en/patients-and-caregivers/novartis-patient-support-oncology
2024-01-08T10:21:43-05:00
daily
0.5
https://www.novartis.com/us-en/healthcare-professionals/novartis-patient-support-oncology
2023-12-01T14:53:22-05:00
daily
0.5
https://www.novartis.com/us-en/patients-and-caregivers/patient-resources
2024-02-26T17:34:14-05:00
daily
0.5
https://www.novartis.com/us-en/healthcare-professionals/hcp-resources
2024-02-26T17:34:50-05:00
daily
0.5
https://www.novartis.com/us-en/clinicaltrials/immunology/CINDU/NCT05976243
2024-03-15T08:18:42-04:00
daily
0.5
https://www.novartis.com/us-en/clinicaltrials/hematology/ITPWAIHA/NCT05653349-NCT05653219-NCT05648968-us-es
2024-02-08T20:46:10-05:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-pharmaceuticals-corporation-corrective-action-certain-blister-packages-sandimmune-and-neoral-100-mg-soft-gelatin-capsules-us-due-failure-meet-child-resistant-packaging-requirements
2022-04-04T03:14:46-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-announces-nejm-publication-three-pivotal-trials-showing-durable-and-potent-efficacy-inclisiran-investigational-first-class-sirna-cholesterol-lowering-therapy
2022-04-04T03:09:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-new-analysis-further-shows-durable-and-potent-ldl-c-reduction-inclisiran-investigational-first-class-sirna-cholesterol-lowering-treatment
2022-04-04T02:24:00-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-new-analysis-further-showed-durable-and-potent-ldl-c-reduction
2022-03-13T11:20:33-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-and-novartis-us-foundation-establish-usd-5-million-us-covid-19-community-response-fund
2022-07-25T11:29:50-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-us-foundation-supports-telehealth-programs-provide-access-care-new-jerseys-most-vulnerable-communities
2022-03-29T04:00:31-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-announces-fda-approval-met-inhibitor-tabrectatm-metastatic-non-small-cell-lung-cancer-metex14
2022-03-29T08:12:54-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-kisqali-shows-overall-survival-benefit-hrher2-advanced-breast-cancer-consistent-findings-patients-more-aggressive-disease
2022-03-29T03:57:19-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-announces-new-late-breaking-ofatumumab-data-ean-underscoring-commitment-advancing-treatment-relapsing-forms-multiple-sclerosis-rms
2022-03-29T08:15:09-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-announces-long-term-relapse-free-survival-benefit-high-risk-stage-iii-melanoma-patients-treated-tafinlar-mekinist-following-surgery
2022-03-29T08:18:43-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/us-fda-approves-updated-novartis-beovu-label-include-additional-safety-information
2022-03-29T08:20:08-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-manufactures-and-donates-27000-units-hand-sanitizer-new-york-state
2022-03-29T08:24:38-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-cosentyx-receives-fda-approval-new-indication-treat-active-non-radiographic-axial-spondyloarthritis
2022-03-29T08:28:20-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-ilaris-canakinumab-receives-fda-approval-new-indication-treat-adult-onset-stills-disease-aosd
2022-03-29T08:31:29-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-announces-fda-filing-acceptance-entresto-sacubitrilvalsartan-patients-heart-failure-preserved-ejection-fraction-hfpef
2022-03-29T08:34:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-announces-nejm-publication-phase-iii-asclepios-trials-demonstrating-superior-efficacy-ofatumumab-patients-relapsing-multiple-sclerosis
2022-03-29T08:00:46-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-announces-fda-filing-acceptance-xolair-omalizumab-prefilled-syringe-self-administration-across-all-indications
2022-03-29T09:10:25-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/fda-approves-novartis-kesimpta-ofatumumab-first-and-only-self-administered-targeted-b-cell-therapy-patients-relapsing-multiple-sclerosis
2022-03-29T08:38:12-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-launches-pso-know-podcast-series-hosted-music-icon-cyndi-lauper
2022-03-29T08:39:48-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-parallax-data-provides-further-evidence-potential-benefit-entresto-patients-hfpef
2022-03-29T08:41:12-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-new-analysis-shows-high-consistency-lowering-ldl-c-individual-response-investigational-inclisiran
2022-03-29T08:42:29-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-presents-data-actrims-ectrims-effects-treatment-mayzent-siponimod-studied-disability-progression-and-cognitive-processing-speed-patients-progressing-relapsing-multiple-sclerosis
2022-03-29T08:43:42-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-presents-data-actrims-ectrims-kesimpta-ofatumumab-newly-diagnosed-treatment-naive-adults-relapsing-multiple-sclerosis
2022-03-29T08:45:27-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-us-foundation-commits-25m-improve-health-equity-reducing-health-disparities-us
2022-03-29T08:48:51-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-step-programtm-awards-nearly-375000-patient-advocacy-organizations-their-innovative-solutions-biomarker-testing-now-accepting-proposals-caregiving-cancer-and-certain-blood-disorders
2022-03-29T08:51:10-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-announces-five-year-data-reinforce-safety-and-efficacy-profile-aimovig-erenumab-aooe-adult-patients-episodic-migraine
2022-03-29T09:07:56-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-cosentyx-shows-early-synovitis-reduction-patients-psoriatic-arthritis-first-its-kind-study
2022-03-29T08:59:08-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/new-novartis-analyses-investigational-inclisiran-demonstrate-consistently-effective-and-sustained-ldl-c-reduction-month-17-regardless-age-and-gender
2022-03-29T09:02:47-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/new-data-ash-reinforce-breadth-novartis-hematology-portfolio-across-multiple-blood-cancers-and-serious-hematologic-diseases
2022-03-29T09:05:40-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-announces-fda-approval-xolair-omalizumab-adults-nasal-polyps
2022-03-29T09:10:21-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-and-amgen-partner-karamo-brown-support-and-empower-people-living-migraine
2022-03-29T10:13:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-investigational-stamp-inhibitor-asciminib-abl001-shows-superior-mmr-rate-bosulif-chronic-myeloid-leukemia-trial
2022-03-29T10:09:39-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-kisqali-demonstrates-nearly-five-years-median-overall-survival-metastatic-breast-cancer
2022-03-29T10:15:12-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-announces-positive-fda-advisory-committee-recommendation-use-entresto-treat-patients-hfpef
2022-03-29T10:37:59-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-ligelizumab-qge031-receives-fda-breakthrough-therapy-designation-patients-chronic-idiopathic-urticaria-ciu
2022-03-29T10:34:55-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-entresto-granted-expanded-indication-chronic-heart-failure-fda
2022-07-25T11:38:27-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-awards-450000-eight-nonprofit-organizations-through-step-programtm
2022-03-29T10:48:05-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-receives-fda-approval-xolair-omalizumab-self-injection-prefilled-syringe-across-all-indications-appropriate-patients
2022-03-29T10:50:51-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-presents-data-aan-novel-combination-biomarker-may-predict-disability-worsening-secondary-progressive-multiple-sclerosis
2022-03-29T10:54:29-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/kesimpta-ofatumumab-data-aan-showed-reduction-disability-progression-independent-relapse-activity-newly-diagnosed-patients-rms
2022-03-29T11:00:13-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-cosentyx-data-aad-vmx-shows-improvement-skin-symptoms-and-quality-life-was-maintained-one-year-children-moderate-severe-plaque-psoriasis
2022-03-29T11:00:39-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-phase-iii-beovu-data-show-potential-fluid-resolution-more-diabetic-macular-edema-patients-fewer-injections-versus-aflibercept
2022-03-29T11:06:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-commits-addressing-racial-disparities-breast-cancer-screening-treatment-and-care
2022-03-29T11:05:57-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-reports-one-year-results-phase-iii-merlin-study-evaluating-beovu-every-four-week-dosing-and-provides-update-beovu-clinical-program
2022-03-29T10:09:33-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-cosentyx-receives-fda-approval-treatment-children-and-adolescents-moderate-severe-plaque-psoriasis
2022-03-29T10:09:26-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-kymriah-pivotal-trial-demonstrates-strong-response-rates-and-remarkable-safety-profile-relapsed-or-refractory-follicular-lymphoma
2022-03-29T10:08:40-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-kisqali-reports-longest-median-overall-survival-postmenopausal-hrher2-metastatic-breast-cancer-patients
2022-03-29T10:08:44-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-investigational-checkpoint-inhibitor-tislelizumab-met-primary-endpoint-overall-survival-pivotal-phase-iii-trial-esophageal-cancer-after-systemic-therapy
2022-03-29T10:08:02-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-announces-tabrecta-first-published-overall-survival-and-updated-overall-response-data-patients-metex14-metastatic-nsclc
2022-03-29T10:07:50-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-pledges-10-year-commitment-morehouse-school-medicine-26-historically-black-colleges-universities-medical-schools-and-other-leading-organizations-co-create-effective-measurable-solutions-health-equity
2022-03-29T10:19:17-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-announces-positive-results-from-phase-iii-trials-beovu-diabetic-macular-edema-including-dosing-intervals-16-weeks
2022-03-29T10:16:22-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-launches-meet-pros-raise-awareness-and-support-education-pik3ca-related-overgrowth-spectrum-pros
2022-03-29T10:31:46-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-announces-findings-from-real-world-study-alpelisib-demonstrating-clinical-benefit-people-pik3ca-related-overgrowth-spectrum-pros
2022-03-29T10:34:36-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-presents-new-kisqali-data-showing-longest-median-overall-survival-ever-reported-hrher2-advanced-breast-cancer
2022-03-29T10:38:03-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-announces-fda-and-ema-filing-acceptances-beovu-patients-diabetic-macular-edema
2022-03-29T10:58:55-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/kesimpta-ofatumumab-data-ectrims-highlights-preservation-igg-levels-and-safety-experience-over-extended-exposure-35-years-people-living-relapsing-multiple-sclerosis
2022-03-29T11:02:35-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/fda-approves-novartis-scemblix-asciminib-novel-mechanism-action-treatment-chronic-myeloid-leukemia
2022-03-29T11:09:22-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-iptacopan-meets-primary-endpoints-phase-ii-study-rare-kidney-disease-c3-glomerulopathy-c3g
2022-03-29T11:13:36-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-presents-positive-phase-iii-results-cosentyx-children-active-enthesitis-related-arthritis-era-and-juvenile-psoriatic-arthritis-jpsa-acr-2021
2022-03-29T11:20:19-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/new-kisqali-data-shows-consistent-overall-survival-benefit-across-genomic-and-clinical-subtypes-interest-hrher2-metastatic-breast-cancer
2022-03-29T11:27:32-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-data-highlight-efficacy-piqray-hrher2-metastatic-breast-cancer-pik3ca-driver-mutation-immediately-post-cdk46i
2022-03-29T11:32:03-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-kymriah-demonstrates-strong-responses-high-risk-patients-relapsed-or-refractory-follicular-lymphoma-extended-study-follow
2022-03-29T11:37:29-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-announces-t-chargetm-next-generation-car-t-platform-first-human-data-ash-2021
2022-03-29T11:33:25-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/fda-approves-novartis-leqvio-inclisiran-first-class-sirna-lower-cholesterol-and-keep-it-low-two-doses-year
2022-07-21T12:09:56-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-cosentyx-receives-fda-approval-treatment-children-and-adolescents-enthesitis-related-arthritis-and-psoriatic-arthritis
2022-03-29T11:25:10-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-177lu-psma-617-significantly-improves-overall-survival-and-radiographic-progression-free-survival-men-metastatic-castration-resistant-prostate-cancer-phase-iii-vision-study
2022-03-29T11:20:55-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/fda-approves-novartis-kymriah-car-t-cell-therapy-adult-patients-relapsed-or-refractory-follicular-lymphoma
2022-07-07T10:23:46-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/fda-approves-novartis-vijoice-alpelisib-first-and-only-treatment-select-patients-pik3ca-related-overgrowth-spectrum-pros
2022-07-07T10:23:48-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-pluvictotm-approved-fda-first-targeted-radioligand-therapy-treatment-progressive-psma-positive-metastatic-castration-resistant-prostate-cancer
2022-07-07T10:23:48-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-177lu-psma-617-significantly-improves-overall-survival-and-radiographic-progression-free-survival-men-metastatic-castration-resistant-prostate-cancer-phase-iii-vision-study-0
2022-07-07T10:23:57-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-new-analysis-further-showed-durable-and-potent-ldl-c-reduction-inclisiran-investigational-first-class-sirna-cholesterol-lowering-treatment
2022-07-07T10:24:24-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-announces-met-inhibitor-capmatinib-inc280-first-potential-treatment-metex14-mutated-advanced-non-small-cell-lung-cancer-granted-priority-fda-review
2022-07-07T10:24:27-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/public-private-collaboration-commits-accelerate-access-health-services-africa-reaching-17-million-people
2022-07-07T10:24:27-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-announces-fda-filing-acceptance-xolair-omalizumab-treatment-nasal-polyps
2022-07-07T10:24:27-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-kymriah-demonstrates-consistent-efficacy-and-safety-outcomes-us-patients-when-used-real-world-setting
2022-07-07T10:24:30-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/new-novartis-medicine-adakveo-crizanlizumab-tmca-approved-fda-reduce-frequency-pain-crises-individuals-living-sickle-cell-disease
2022-07-07T10:24:30-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-launches-pso-work-music-icon-cyndi-lauper-bring-life-impact-psoriasis-can-have-workplace
2022-07-07T10:24:30-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-step-programtm-now-accepting-submissions-proposals-address-unmet-patient-needs-cancer-biomarker-testing
2022-07-07T10:24:33-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-receives-fda-approval-beovu-offering-wet-amd-patients-vision-gains-and-greater-fluid-reductions-vs-aflibercept
2022-07-07T10:24:33-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-positive-52-week-prevent-data-confirm-cosentyx-efficacy-addressing-entire-axspa-spectrum
2022-07-07T10:24:33-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/avexis-presents-new-data-epns-continuing-show-significant-therapeutic-benefit-zolgensma-prolonging-event-free-survival-now-5-years-age-patients-spinal-muscular-atrophy-sma-type-1
2022-07-07T10:24:36-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/entresto-improved-measures-heart-structure-and-function-hfref-patients-new-novartis-study-additional-data-complement-findings
2022-07-07T10:24:36-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-teams-celebrity-interior-designer-nate-berkus-launch-my-home-sight-program-empowering-people-wet-amd-live-more-independently-home
2022-07-07T10:24:36-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/fda-accepts-file-and-accelerates-review-novartis-sickle-cell-disease-medicine-crizanlizumab-seg101
2022-07-07T10:24:38-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-offers-free-genetic-mutation-testing-program-advanced-melanoma-patients-results-can-help-doctors-and-patients-making-cancer-treatment-decisions
2022-07-07T10:24:38-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/long-term-survival-benefit-shown-metastatic-melanoma-patients-treated-novartis-tafinlar-mekinist
2022-07-07T10:24:38-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-shows-growing-strength-lung-cancer-innovation-new-capmatinib-investigational-data-and-novel-canakinumab-clinical-trials
2022-07-07T10:24:40-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/avexis-announces-innovative-zolgensma-gene-therapy-access-programs-us-payers-and-families
2022-07-07T10:24:40-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/avexis-receives-fda-approval-zolgensma-first-and-only-gene-therapy-pediatric-patients-spinal-muscular-atrophy-sma
2022-07-07T10:24:40-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-data-asco-and-eha-demonstrate-novel-approaches-reimagining-medicine-cancer-and-serious-blood-disorders
2022-07-07T10:24:43-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/five-nonprofit-organizations-receive-250000-through-novartis-step-programtm-support-sickle-cell-patient-initiatives
2022-07-07T10:24:43-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-issues-voluntary-nationwide-recall-promacta-125-mg-oral-suspension-due-potential-peanut-contamination
2022-07-07T10:24:43-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/new-avexis-data-aan-showed-long-term-durability-zolgensma-patients-spinal-muscular-atrophy-sma-type-1
2022-07-07T10:24:46-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/avexis-presented-robust-data-aan-demonstrating-efficacy-zolgensma-broad-spectrum-spinal-muscular-atrophy-sma-patients
2022-07-07T10:24:46-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-announces-fda-filing-acceptance-and-priority-review-brolucizumab-rth258-patients-wet-amd
2022-07-07T10:24:46-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/avexis-expands-world-leading-gene-therapy-manufacturing-capacity-purchase-advanced-biologics-therapy-manufacturing-campus-longmont-colorado
2022-07-07T10:24:48-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-receives-fda-approval-mayzent-siponimod-first-oral-drug-treat-secondary-progressive-ms-active-disease
2022-07-07T10:24:48-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-late-breaking-data-further-support-initiation-entresto-hospital-and-first-choice-systolic-heart-failure-therapy-stabilized-patients
2022-07-07T10:24:48-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-data-show-psoriasis-patients-treated-cosentyx-reported-improvements-quality-life-measures-early-week-4
2022-07-07T10:24:51-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-investigational-therapy-crizanlizumab-seg101-receives-fda-breakthrough-therapy-designation-prevention-vaso-occlusive-crises-sickle-cell-disease
2022-07-07T10:24:51-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-data-demonstrates-consistent-efficacy-and-tolerability-kisqali-combination-therapy-hrher2-advanced-breast-cancer-patients-difficult-treat-visceral-disease
2022-07-07T10:24:51-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-investigational-byl719-alpelisib-plus-fulvestrant-consistently-improved-pfs-patients-pik3ca-mutated-hrher2-advanced-breast-cancer-new-solar-1-analyses
2022-07-07T10:24:54-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/real-world-data-show-novartis-drug-promacta-improves-outcomes-itp-patients-compared-other-second-line-therapies
2022-07-07T10:24:54-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-announces-longer-term-analyses-from-pivotal-kymriah-trials-showed-durable-responses-are-maintained-patients-advanced-blood-cancers
2022-07-07T10:24:54-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-announces-new-crizanlizumab-seg101-data-analysis-sickle-cell-disease-and-investment-sentry-clinical-program
2022-07-07T10:24:57-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/fda-approves-novartis-drug-promacta-first-line-saa-and-grants-breakthrough-therapy-designation-additional-new-indication
2022-07-07T10:24:57-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-fund-five-innovative-ideas-support-patients-and-sickle-cell-community
2022-07-07T10:24:57-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/new-novartis-study-supports-entresto-foundational-hfref-therapy-and-hospital-initiation-appropriate-stabilized-heart-failure-patients
2022-07-07T10:25:00-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-data-ash-and-sabcs-show-strength-pipeline-and-portfolio-hematology-and-oncology
2022-07-07T10:25:00-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-wins-esteemed-prix-galien-foundation-best-biotechnology-product-award-car-t-cell-therapy-kymriah
2022-07-07T10:25:00-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/two-year-data-novartis-brolucizumab-reaffirm-superiority-versus-aflibercept-reducing-retinal-fluid-patients-namd
2022-07-07T10:25:03-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-presents-new-cosentyx-data-demonstrating-long-term-response-and-safety-ankylosing-spondylitis
2022-07-07T10:25:03-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-analysis-shows-crizanlizumab-seg101-increased-number-patients-free-sickle-cell-pain-crises-vs-placebo-during-sustain-study
2022-07-07T10:25:03-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-announces-fda-filing-acceptance-siponimod-baf312-first-and-only-oral-drug-shown-delay-disability-progression-typical-spms-patients
2022-07-07T10:25:07-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-teams-recording-artist-and-actress-jordin-sparks-and-scdaa-launch-generation-s-inspiring-new-sickle-cell-storytelling-project
2022-07-07T10:25:07-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-announces-nejm-publication-landmark-paradigms-study-demonstrating-significant-benefit-gilenya-children-and-adolescents-relapsing-multiple-sclerosis
2022-07-07T10:25:07-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-kisqali-now-first-and-only-cdk46-inhibitor-indicated-us-first-line-therapy-specifically-premenopausal-women-and-initial-therapy-fulvestrant-postmenopausal-women
2022-07-07T10:25:09-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-launches-galaxies-hope-app-digital-experience-neuroendocrine-tumor-net-cancer-community
2022-07-07T10:25:09-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/sandoz-inc-and-its-affiliate-novartis-pharmaceuticals-corporation-voluntarily-recall-select-blister-packages-products-us-due-packaging-requirements-child-resistance
2022-07-07T10:25:09-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-and-amgen-highlight-findings-from-large-global-patient-survey-revealing-worldwide-approximately-60-employed-people-migraine-missed-average-week-work-month
2022-07-07T10:25:12-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-announces-funding-patient-advocacy-initiatives-support-and-empower-metastatic-breast-cancer-community
2022-07-25T11:29:18-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-receives-fda-approval-inclusion-new-evidence-cosentyx-inhibits-progression-joint-structural-damage-psoriatic-arthritis
2022-07-07T10:25:12-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-juliet-trial-kymriah-demonstrates-more-one-year-durability-responses-adults-relapsed-or-refractory-dlbcl
2022-07-07T10:25:14-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-survey-uncovers-real-world-impact-immune-thrombocytopenia-or-itp-rare-blood-disease-patients-quality-life
2022-07-07T10:25:14-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/third-novartis-phase-iii-trial-shows-kisqali-combination-therapy-significantly-improves-pfs-hrher2-advanced-breast-cancer
2022-07-07T10:25:14-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/fda-expedites-review-novartis-drug-promacta-first-line-severe-aplastic-anemia-saa
2022-07-07T10:25:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/patient-reported-outcomes-tool-revealed-significant-improvement-symptom-frequency-and-quality-life-domains-entresto
2022-07-07T10:25:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-and-amgen-announce-fda-approval-aimovigtm-erenumab-aooe-novel-treatment-developed-specifically-migraine-prevention
2022-07-07T10:25:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-data-asco-and-eha-reinforce-companys-commitment-reimagining-cancer
2022-07-07T10:25:19-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/alcon-teams-venus-williams-tennis-champion-and-dry-eye-sufferer-launch-systane-complete-eye-drops
2022-07-07T10:25:19-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-announces-fda-approval-gilenya-first-disease-modifying-therapy-pediatric-relapsing-multiple-sclerosis
2022-07-07T10:25:19-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/kymriah-tisagenlecleucel-first-class-car-t-therapy-from-novartis-receives-second-fda-approval-treat-appropriate-rr-patients-large-b-cell-lymphoma
2022-07-07T10:25:22-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/alcon-introduces-air-optix-colors-contact-lenses-gemstone-collection-creating-new-ways-enhance-and-play-eye-color
2022-07-20T16:07:02-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/new-novartis-phase-iii-data-brolucizumab-demonstrate-reliability-12-week-treatment-interval
2022-07-07T10:25:22-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-launches-focalview-app-providing-opportunity-patients-participate-ophthalmology-clinical-trials-from-home
2022-07-07T10:25:25-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/phase-iii-data-lancet-show-novartis-siponimod-significantly-improved-outcomes-patients-secondary-progressive-ms
2022-07-07T10:25:25-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-new-data-show-cosentyx-improved-quality-life-over-5-years-two-thirds-patients-moderate-severe-plaque-psoriasis
2022-07-07T10:25:25-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-receives-fda-approval-cosentyx-label-update-include-moderate-severe-scalp-psoriasis
2022-07-07T10:25:28-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-new-data-reinforces-superiority-cosentyx-versus-stelara-achieving-skin-clearance-psoriasis-patients
2022-07-07T10:25:28-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-drug-promacta-receives-fda-breakthrough-therapy-designation-first-line-use-severe-aplastic-anemia-saa
2022-07-07T10:25:28-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-kisqali-received-fda-breakthrough-therapy-designation-initial-endocrine-based-treatment-premenopausal-women-hrher2-advanced-breast-cancer
2022-07-07T10:25:31-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-multiple-sclerosis-therapy-fingolimod-granted-fda-breakthrough-therapy-designation-pediatric-ms
2022-07-07T10:25:31-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-drug-crizanlizumab-shown-prolong-time-patients-first-sickle-cell-pain-crisis-subgroup-analysis-sustain-study
2022-07-07T10:25:31-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/primary-analysis-results-from-novartis-pivotal-juliet-trial-show-kymriahtm-tisagenlecleucel-sustained-complete-responses-six-months-adults-rr-dlbcl-difficult-treat-cancer
2022-07-07T10:25:34-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-initiates-study-evaluating-impact-higher-dosing-cosentyx-patients-ankylosing-spondylitis
2022-07-07T10:25:34-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-kisqali-first-and-only-cdk46-inhibitor-show-superior-median-pfs-compared-oral-endocrine-therapy-first-line-treatment-prospective-randomized-phase-iii-trial-dedicated-premenopausal-women-hrher2-advanced-breast-cancer
2022-07-07T10:25:34-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-presents-new-data-sabcs-across-broad-range-breast-cancer-patient-populations-combination-treatments-and-lines-therapy
2022-07-07T10:25:37-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-canakinumab-acz885-reduced-cardiovascular-risk-25-subgroup-cantos-phase-iii-trial-participants
2022-07-07T10:25:37-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-brolucizumab-rth258-demonstrates-superiority-versus-aflibercept-key-secondary-endpoint-measures-disease-activity-namd-leading-cause-blindness
2022-07-07T10:25:37-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-announces-study-data-demonstrating-cosentyx-reduced-signs-and-symptoms-psoriatic-arthritis-while-inhibiting-progression-joint-structural-damage
2022-07-07T10:25:40-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-presents-data-ash-patients-serious-blood-disorders-lymphoma-leukemia-and-sickle-cell-disease
2022-07-07T10:25:40-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-pivotal-data-show-children-and-adolescents-relapsing-ms-had-82-lower-relapse-rate-fingolimod-vs-interferon-beta-1a
2022-07-07T10:25:40-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-collaborates-pop-icon-cyndi-lauper-release-new-song-honor-world-psoriasis-day
2022-07-07T10:25:43-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-drug-promacta-shows-long-term-disease-control-chronicpersistent-immune-thrombocytopenia-itp
2022-07-07T10:25:43-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/alcon-dailies-teams-us-olympians-world-class-gymnast-laurie-hernandez-and-soccer-star-tobin-heath-launch-invisible-edge-campaign
2022-07-07T10:25:43-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-teams-actress-producer-and-activist-eva-longoria-launch-kiss-4-mbctm-generate-research-funding-and-support-metastatic-breast-cancer-community
2022-07-07T10:25:46-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-cosentyx-sets-new-benchmark-psoriasis-robust-5-year-sustained-efficacy-and-safety-phase-iii-data
2022-07-07T10:25:46-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/multimedia-assets-now-available-novartis-receives-first-ever-fda-approval-car-t-cell-therapy-kymriahtm-tisagenlecleucel-ctl019-children-and-young-adults-b-cell-all-refractory-or-has-relapsed-least-twice
2022-07-07T10:25:46-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-receives-first-ever-fda-approval-car-t-cell-therapy-kymriahtm-tisagenlecleucel-ctl019-children-and-young-adults-b-cell-all-refractory-or-has-relapsed-least-twice
2022-07-07T10:25:49-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-launches-first-large-scale-research-study-multiple-sclerosis-allows-participants-contribute-from-smartphones
2022-07-07T10:25:49-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/fda-accepts-biologics-license-application-amg-334-erenumab-important-regulatory-milestone-novartis
2022-07-07T10:25:49-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-confirms-5-year-data-first-and-only-fully-human-il-17a-inhibitor-cosentyx-reinforcing-sustained-efficacy-and-safety-profile-psoriasis
2022-07-07T10:25:52-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-pivotal-ctl019-6-month-follow-data-show-durable-remission-rates-children-young-adults-rr-b-cell-all
2022-07-07T10:25:52-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-interim-results-from-global-pivotal-ctl019-trial-show-durable-complete-responses-adults-rr-dlbcl
2022-07-07T10:25:52-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-receives-fda-approval-first-its-kind-kisqali-femara-co-pack-initial-treatment-hrher2-advanced-or-metastatic-breast-cancer
2022-07-07T10:25:55-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-expands-global-collaboration-amgen-commercialize-first-class-amg-334-erenumab-program-migraine-prevention-us-and-canada
2022-07-07T10:25:55-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-car-t-cell-therapy-ctl019-receives-fda-breakthrough-therapy-designation-treatment-adult-patients-rr-dlbcl
2022-07-07T10:25:55-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-announces-first-car-t-cell-therapy-bla-pediatric-and-young-adult-patients-rr-b-cell-all-granted-fda-priority-review
2022-07-07T10:25:58-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/new-analysis-shows-novartis-entresto-improves-glycemic-control-reduced-ejection-fraction-heart-failure-patients-diabetes
2022-07-07T10:25:58-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-cosentyx-shows-almost-all-psoriasis-patients-rapidly-regain-skin-clearance-following-treatment-pause
2022-07-07T10:25:58-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/alcon-receives-us-fda-approval-acrysof-iq-restor-30d-multifocal-toric-intraocular-lens-cataract-patients
2022-07-07T10:26:01-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-out-licenses-three-copd-products-us
2022-07-07T10:26:01-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-presents-results-from-first-global-registration-trial-ctl019-pediatric-and-young-adult-patients-rr-b-all
2022-07-07T10:26:01-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/new-analysis-novartis-entresto-data-shows-long-term-benefits-heart-failure-readmissions-and-total-cardiovascular-deaths
2022-07-07T10:26:04-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/alcon-introduces-new-air-optix-plus-hydraglyde-monthly-replacement-contact-lenses-american-academy-optometry-annual-meeting
2022-07-07T10:26:04-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-partners-prominent-us-health-advocacy-organizations-launch-first-social-networking-platform-heart-failure-patients-and-their-loved-ones
2022-07-07T10:26:04-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-late-breaking-data-show-cosentyx-continues-deliver-high-skin-clearance-majority-psoriasis-patients-four-years
2022-07-07T10:26:07-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-receives-three-new-fda-approvals-expanded-use-ilaris-patients-rare-periodic-fever-syndrome-conditions
2022-07-07T10:26:07-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/important-new-analysis-shows-novartis-entresto-associated-higher-relative-health-related-quality-life-scores-among-hfref-patients
2022-07-07T10:26:07-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-baf312-reduced-risk-disability-progression-pivotal-phase-iii-study-secondary-progressive-ms-patients
2022-07-07T10:26:10-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-data-finds-relapsing-ms-patients-gilenya-had-greater-treatment-retention-and-satisfaction-rates-vs-injectable-dmts
2022-07-07T10:26:10-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-announces-fda-approval-xolair-omalizumab-pediatric-allergic-asthma
2022-07-07T10:26:10-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/largest-global-psoriasis-survey-shows-85-us-respondents-faced-social-stigma-discrimination-and-humiliation-because-their-skin
2022-07-07T10:26:13-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/timely-use-novartis-entresto-could-prevent-or-postpone-over-28000-us-deaths-year-among-hfref-patients-according-expert-analysis-jama-cardiology
2022-07-07T10:26:13-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-data-show-gilenya-had-significantly-greater-patient-retention-compared-idmts-relapsing-remitting-ms
2022-07-07T10:26:13-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/media-statement-leading-us-cardiology-societies-strongly-recommend-entresto-new-standard-care-treatment-earlier-expected-joint-update-clinical-practice-guidelines-heart-failure
2022-07-07T10:26:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/media-statement-fortihfy-global-clinical-program-entresto
2022-07-07T10:26:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-receives-three-fda-breakthrough-therapy-designations-ilaris-treat-rare-types-periodic-fever-syndromes
2022-07-07T10:26:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/new-analyses-show-novartis-entrestotm-reduced-cardiovascular-death-or-hospitalization-heart-failure-consistently-benefitting-patients-reduced-ejection-fraction-hfref-regardless-prior-heart-failure-hospital-admissions-or-background
2022-07-07T10:26:19-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/new-novartis-data-show-cosentyx-demonstrated-sustained-superiority-skin-clearance-pasi-90-versus-stelara-week-52
2022-07-07T10:26:19-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/fda-approves-new-indication-novartis-drug-afinitor-progressive-nonfunctional-gi-and-lung-neuroendocrine-tumors-net
2022-07-07T10:26:19-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-receives-two-new-fda-approvals-cosentyx-secukinumab-treat-patients-ankylosing-spondylitis-and-psoriatic-arthritis
2022-07-07T10:26:22-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-announces-publication-two-landmark-studies-nejm-demonstrating-efficacy-cosentyx-patients-ankylosing-spondylitis
2022-07-07T10:26:22-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-highlights-new-ctl019-phase-ii-data-demonstrating-93-complete-remission-pediatric-patients-rr-all
2022-07-07T10:26:22-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-announces-new-ctl019-study-data-demonstrating-overall-response-adult-patients-certain-types-lymphoma
2022-07-07T10:26:25-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-pharmaceuticals-corporation-finalizes-settlement-agreement-resolving-civil-suit-filed-us-attorneys-office-southern-district-new-york
2022-07-07T10:26:25-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-heart-failure-medicine-entrestotm-substantially-cuts-30-day-hospital-readmissions-new-post-hoc-analysis-shows
2022-07-07T10:26:25-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/80-ankylosing-spondylitis-patients-treated-cosentyx-show-no-spinal-x-ray-progression-shown-novartis-new-two-year-observational-data
2022-07-07T10:26:28-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/approximately-80-psoriatic-arthritis-patients-treated-cosentyx-saw-no-progression-joint-damage-shown-novartis-new-two-year-observational-data
2022-07-07T10:26:28-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/fda-approves-new-novartis-dual-combination-bronchodilator-utibrontm-neohaler-patients-chronic-obstructive-pulmonary-disease
2022-07-07T10:26:28-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-clarification-specialty-pharmacy-settlement-principle-announcement
2022-07-07T10:26:31-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-announces-nejm-publication-secukinumab-phase-iii-data-confirming-significant-efficacy-patients-psoriatic-arthritis
2022-07-07T10:26:31-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/patients-aggressive-form-melanoma-lived-more-two-years-average-when-taking-novartis-therapies-tafinlar-mekinist
2022-07-07T10:26:31-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-launches-novartis-access-portfolio-affordable-medicines-treat-chronic-diseases-lower-income-countries
2022-07-07T10:26:34-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/fda-approves-novartis-drug-odomzo-sonidegib-locally-advanced-basal-cell-carcinoma-labcc-form-skin-cancer
2022-07-07T10:26:34-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-new-heart-failure-medicine-lcz696-approved-fda-reduce-risk-cardiovascular-death-and-heart-failure-hospitalization-now-called-entrestotm-sacubitrilvalsartan
2022-07-07T10:26:34-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-presents-new-data-wcd-shows-significant-efficacy-cosentyx-patients-psoriasis-palms-soles-feet-and-nails
2022-07-07T10:26:37-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-highlights-ctl019-data-showing-its-potential-treatment-specific-types-hard-treat-non-hodgkin-lymphoma
2022-07-07T10:26:37-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/combination-novartis-drugs-tafinlar-and-mekinist-shows-significant-survival-benefit-patients-metastatic-melanoma
2022-07-07T10:26:37-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-investigational-dual-bronchodilator-significantly-improved-lung-function-compared-single-bronchodilators-patients-moderate-severe-copd-phase-iii-studies
2022-07-07T10:26:40-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-pharmaceuticals-corporation-first-company-receive-number-one-ranking-two-years-row-diversityinc-top-50-companies-diversity-list
2022-07-07T10:26:40-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-announces-fda-approval-jadenutm-simplify-treatment-administration-patients-chronic-iron-overload
2022-07-07T10:26:40-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-presents-cosentyxtm-two-year-efficacy-and-safety-data-showing-sustainable-effect-psoriasis-patients
2022-07-07T10:26:43-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/new-novartis-data-show-more-cosentyxtm-treated-psoriasis-patients-achieved-clear-or-almost-clear-skin-pasi-90-compared-stelara
2022-07-07T10:26:43-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-heart-failure-medicine-lcz696-granted-fda-priority-review
2022-07-25T11:40:33-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-announces-fda-approval-first-il-17a-antagonist-cosentyxtm-secukinumab-moderate-severe-plaque-psoriasis-patients
2022-07-07T10:26:46-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-gains-fda-approval-signifor-lar-treat-patients-acromegaly-rare-and-life-threatening-hormonal-disorder
2022-07-07T10:26:46-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-highlights-new-ctl019-clinical-data-showing-complete-remissions-children-and-young-adults-relapsedrefractory-acute-lymphoblastic-leukemia
2022-07-07T10:26:49-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/nine-new-analyses-show-novartis-lcz696-could-change-course-heart-failure-patients
2022-07-07T10:26:49-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-first-il-17a-phase-iii-results-show-ain457-secukinumab-significantly-improves-psoriatic-arthritis-patients
2022-07-07T10:26:49-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-ain457-secukinumab-showed-significant-symptom-improvement-two-pivotal-phase-iii-ankylosing-spondylitis-studies
2022-07-07T10:26:52-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-present-first-il-17a-phase-iii-data-ain457-secukinumab-psoriatic-arthritis-and-ankylosing-spondylitis-acr-2014
2022-07-07T10:26:52-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-teams-multiple-sclerosis-advocate-and-musician-david-osmond-launch-ms-education-initiative-our-voice-songtm
2022-07-07T10:26:52-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-announces-fda-advisory-committee-unanimously-recommends-approval-ain457-secukinumab-patients-moderate-severe-plaque-psoriasis
2022-07-07T10:26:55-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-announces-ctl019-data-published-nejm-demonstrating-efficacy-certain-patients-acute-lymphoblastic-leukemia-all
2022-07-07T10:26:55-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-drug-afinitor-first-treatment-advanced-pancreatic-net-provide-overall-survival-more-35-years-phase-iii-trial
2022-07-07T10:26:55-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-new-heart-failure-medicine-lcz696-cut-cardiovascular-deaths-20-vs-ace-inhibitor-landmark-paradigm-hf-trial
2022-07-07T10:26:58-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-showcase-heart-failure-leadership-esc-congress-2014-results-new-first-its-type-medicine-lcz696
2022-07-07T10:26:58-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-announces-nejm-publication-two-pivotal-phase-iii-secukinumab-studies-demonstrating-statistically-significant-skin-clearance-psoriasis-patients
2022-07-07T10:26:58-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-personalized-cell-therapy-ctl019-receives-fda-breakthrough-therapy-designation
2022-07-07T10:27:01-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/pivotal-data-novartis-investigational-compound-lde225-show-marked-tumor-responses-advanced-basal-cell-carcinoma
2022-07-07T10:27:01-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-presents-key-advances-cancer-research-asco-and-eha-from-four-new-pivotal-studies-lung-blood-and-skin-cancers
2022-07-07T10:27:01-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-drug-signifor-lar-shows-superior-efficacy-acromegaly-patients-not-controlled-first-generation-somatostatin-analogues
2022-07-07T10:27:04-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-recognized-top-ranking-company-us-diversityinc-top-50-companies-diversity-list
2022-07-07T10:27:04-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-reports-new-phase-iii-data-showing-secukinumab-ain457-improved-moderate-severe-plaque-psoriasis-patients
2022-07-07T10:27:04-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-announces-fda-approval-xolair-omalizumab-chronic-idiopathic-urticaria-ciu-form-chronic-hives
2022-07-07T10:27:07-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-pharmaceuticals-corporation-stands-behind-medication-adherence-activities-and-reaffirms-commitment-patient-safety
2022-07-07T10:27:07-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-highlights-research-investigational-personalized-t-cell-therapy-ctl019-patients-forms-acute-and-chronic-leukemia
2022-07-07T10:27:07-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-hosts-competition-create-novel-mobile-solutions-heart-failure-caregivers
2022-07-07T10:27:10-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-announces-new-data-effects-investigational-rlx030-kidney-blood-flow-chronic-heart-failure-patients
2022-07-07T10:27:10-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-exelon-patch-now-fda-approved-treat-patients-across-all-stages-alzheimers-disease
2022-07-07T10:27:10-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/tv-host-phil-keoghan-and-novartis-team-inspire-people-ms-through-innovative-tandem-cycling-campaign
2022-07-07T10:27:13-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/relapsing-ms-patients-more-satisfied-novartis-oral-drug-gilenya-standard-injectable-therapies-according-new-study-results-cmsc
2022-07-07T10:27:13-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-highlights-new-findings-advancing-care-patients-170-abstracts-breast-lung-and-blood-cancers-asco-and-eha
2022-07-07T10:27:13-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-pharmaceuticals-corporation-disputes-allegations-two-us-government-lawsuits-and-looks-forward-fair-discussion-facts
2022-07-07T10:27:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/fda-approves-novartis-tobi-podhalertm-certain-cystic-fibrosis-patients-first-and-only-dry-powder-inhaled-antibacterial-us
2022-07-07T10:27:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/new-analysis-shows-novartis-drug-gilenya-significantly-reduced-rate-brain-volume-loss-across-three-large-phase-iii-studies
2022-07-07T10:27:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-reports-omalizumab-significantly-improved-chronic-idiopathic-urticaria-symptoms-patients-who-failed-standard-therapy
2022-07-07T10:27:19-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-drug-zortress-first-over-decade-approved-fda-prevent-organ-rejection-adult-liver-transplant-patients
2022-07-07T10:27:19-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-drug-exjade-first-treatment-approved-fda-chronic-iron-overload-patients-non-transfusion-dependent-thalassemia
2022-07-07T10:27:19-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/nejm-published-study-shows-novartis-compound-acz885-significantly-relieves-symptoms-patients-serious-form-childhood-arthritis
2022-07-07T10:27:22-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/multimedia-assets-novartis-drug-signifor-gains-fda-approval-first-medication-treat-cushings-disease-serious-endocrine-disorder
2022-07-07T10:27:22-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-drug-signifor-gains-fda-approval-first-medication-treat-cushings-disease-serious-endocrine-disorder
2022-07-07T10:27:22-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-phase-iii-study-shows-rlx030-improved-symptoms-and-reduced-deaths-one-third-patients-acute-heart-failure
2022-07-07T10:27:25-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/leeza-gibbons-joins-novartis-improve-caregiving-experience-millions-americans-through-real-world-peer-advice-alzheimersdiseasecom
2022-07-07T10:27:25-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-pharmaceuticals-corporation-emprende-una-campana-de-educacion-de-la-comunidad-hispana-de-ee-uu-sobre-la-enfermedad-de-alzheimer
2022-07-07T10:27:25-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-pharmaceuticals-corporation-embarks-alzheimers-disease-educational-effort-us-hispanic-community
2022-07-07T10:27:28-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/fda-advisory-committee-supports-use-tobramycin-inhalation-powder-from-novartis-patients-cystic-fibrosis
2022-07-07T10:27:28-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/higher-dose-novartis-drug-exelon-patch-approved-fda-patients-mild-moderate-alzheimers-disease
2022-07-07T10:27:28-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/npc-statement-comments-made-media-coverage-paycheck-fairness-act
2022-07-07T10:27:31-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/two-new-analyses-reinforce-consistent-efficacy-novartis-therapy-gilenya-across-wide-range-relapsing-ms-patients
2022-07-07T10:27:31-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/tv-host-phil-keoghan-and-professional-women-cyclists-join-novartis-raise-awareness-multiple-sclerosis
2022-07-07T10:27:31-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/higher-dose-novartis-drug-exelon-patch-showed-statistically-significantly-less-decline-function-alzheimers-vs-lower-dose
2022-07-07T10:27:35-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/new-extension-study-data-novartis-drug-gilenya-shows-patients-successfully-treated-7-years-relapsing-ms
2022-07-07T10:27:35-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-announces-update-united-states-prescribing-information-ms-therapy-gilenya-following-fda-review
2022-07-07T10:27:35-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-expands-transplant-portfolio-hecoria-first-generic-tacrolimus-can-be-prescribed-brand-name
2022-07-07T10:27:39-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-launches-arcaptatm-neohalertm-novel-once-daily-bronchodilator-chronic-obstructive-pulmonary-disease
2022-07-07T10:27:39-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/plaintiff-sales-representatives-and-novartis-pharmaceuticals-corporation-resolve-class-action-wage-and-hour-claims
2022-07-07T10:27:39-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-pivotal-study-exjade-shows-significant-reduction-iron-overload-patients-non-transfusion-dependent-thalassemia
2022-07-07T10:27:43-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/two-novartis-phase-iii-studies-show-twice-many-ph-cml-patients-achieve-deeper-levels-response-tasigna-compared-gleevec
2022-07-07T10:27:43-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-phase-iii-study-shows-acz885-helped-substantially-reduce-steroid-use-45-patients-serious-form-childhood-arthritis
2022-07-07T10:27:43-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-drug-afinitor-helps-women-advanced-breast-cancer-live-significantly-longer-without-their-disease-progressing
2022-07-07T10:27:46-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-study-shows-qti571-significantly-improved-walking-distance-patients-life-threatening-pulmonary-arterial-hypertension
2022-07-07T10:27:46-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-drug-afinitor-effective-patients-non-cancerous-kidney-tumors-associated-tsc-phase-iii-trial
2022-07-07T10:27:46-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-study-showed-acz885-provided-substantial-symptom-relief-84-patients-most-serious-form-childhood-arthritis
2022-07-07T10:27:49-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/fda-approves-supplemental-new-drug-application-novartis-therapy-gilenyatm-include-data-showing-reduction-t1-lesions-ms-marker-disease-activity
2022-07-07T10:27:49-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-receives-fda-approval-arcaptatm-neohalertm-novel-once-daily-bronchodilator-chronic-obstructive-pulmonary-disease
2022-07-07T10:27:49-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-data-shows-acz885-severe-gouty-arthritis-provided-better-pain-relief-and-reduced-risk-new-attacks-68-vs-steroid
2022-07-07T10:27:52-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-teams-phil-keoghan-host-amazing-race-raise-awareness-multiple-sclerosis-through-inspirational-national-bike-tour
2022-07-07T10:27:52-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-gains-fda-approval-afinitor-first-new-treatment-nearly-three-decades-patients-advanced-pancreatic-net
2022-07-07T10:27:52-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-therapy-gilenyatm-reduced-risk-ms-disability-progression-regardless-treatment-history-or-disease-severity-new-analysis-shows
2022-07-07T10:27:55-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/fda-advisory-committee-recommends-us-approval-novartis-once-daily-bronchodilator-qab149-copd
2022-07-07T10:27:55-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/important-information-extavia-interferon-beta-1-b-patients-regarding-triad-groups-alcohol-prep-products
2022-07-07T10:27:55-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-gains-fda-approval-amturnidetm-triple-combination-pill-treat-high-blood-pressure-patients-uncontrolled-two-medications
2022-07-07T10:27:58-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/longer-term-phase-iii-data-show-novartis-drug-tasigna-continues-surpass-gleevec-slowing-disease-progression-patients-newly-diagnosed-cml
2022-07-07T10:27:58-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-pharmaceuticals-corporation-restructuring-us-field-force-align-changing-product-portfolio-and-strategic-growth-priorities
2022-07-07T10:27:58-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/new-stand-together-ad-campaign-provides-strength-support-and-important-resources-11-million-alzheimers-caregivers
2022-07-07T10:28:01-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/analysis-shows-novartis-drug-tobi-associated-reduced-mortality-cystic-fibrosis-patients-common-lung-infection
2022-07-07T10:28:01-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-gains-fda-approval-gilenyatm-novel-first-line-multiple-sclerosis-treatment-shown-significantly-reduce-relapses-and-delay-disability-progression
2022-07-07T10:28:01-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-receives-fda-approval-tekamlotm-single-pill-combination-aliskiren-and-amlodipine-treat-high-blood-pressure
2022-07-07T10:28:04-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/us-affiliate-novartis-strongly-disputes-claims-past-discrimination-us
2022-07-07T10:28:04-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-pharmaceuticals-corporation-prevails-medicaid-pricing-case-alabama-supreme-court
2022-07-07T10:28:04-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/fda-approves-tekturna-hct-initial-treatment-patients-unlikely-achieve-their-blood-pressure-goals-single-agent
2022-07-07T10:28:07-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/video-new-biological-therapy-ilaris-approved-us-treat-children-and-adults-caps-serious-life-long-auto-inflammatory-disease
2022-07-07T10:28:07-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/video-fda-approves-exforge-hct-only-high-blood-pressure-treatment-combine-three-medications-single-pill
2022-07-07T10:28:07-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/video-gleevec-receives-us-approval-first-treatment-reduce-risk-cancer-returning-patients-gastrointestinal-stromal-tumors
2022-07-07T10:28:10-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/rad001-shows-potential-reverse-resistance-herceptin-metastatic-breast-cancer-patients-leading-phase-iii-trial
2022-07-07T10:28:10-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/video-novartis-vaccines-and-pta-battle-flu-public-health-vaccination-initiative-urges-families-lets-fight-flu-together
2022-07-07T10:28:10-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/early-data-show-potential-imatinib-mesylate-tablets-treat-life-threatening-form-pulmonary-artery-disease
2022-07-07T10:28:13-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/rad001-combined-sandostatin-lar-depot-and-monotherapy-controls-growth-rare-pancreatic-neuroendocrine-tumors
2022-07-07T10:28:13-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/rad001-granted-priority-review-us-based-potential-fill-unmet-medical-need-patients-advanced-kidney-cancer
2022-07-07T10:28:13-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-pharmaceuticals-corporation-appeal-judgment-alabama-pricing-case
2022-07-07T10:28:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/video-higher-initial-dose-gleevec-achieved-better-early-responses-standard-dose-patients-chronic-myeloid-leukemia
2022-07-07T10:28:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/early-data-presented-asco-show-potential-rad001-enhance-efficacy-and-overcome-resistance-breast-cancer-treatments
2022-07-20T16:05:08-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/video-major-independent-trial-demonstrates-significant-anticancer-benefit-zometa-women-early-stage-breast-cancer
2022-07-07T10:28:20-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/rad001-more-doubles-time-without-tumor-growth-after-failure-standard-treatment-patients-advanced-kidney-cancer
2022-07-07T10:28:20-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/strength-and-innovation-novartis-oncology-products-and-pipeline-potential-improve-patient-treatment-demonstrated-more-170-abstracts-asco-annual-meeting
2022-07-07T10:28:20-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/video-femara-helps-protect-against-return-breast-cancer-even-when-treatment-starts-several-years-after-completing-tamoxifen-therapy
2022-07-07T10:28:23-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/everolimus-rad001-significantly-extends-progression-free-survival-advanced-kidney-cancer-patients-after-failure-other-targeted-therapy
2022-07-07T10:28:23-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/video-and-photo-tekturna-hct-single-tablet-combination-tekturna-and-diuretic-receives-us-approval-treatment-high-blood-pressure
2022-07-07T10:28:23-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/photo-new-data-show-gleevec-halts-progression-advanced-stages-life-threatening-form-leukemia-sixth-year-treatment
2022-07-07T10:28:26-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/news-release-1-headline
2022-07-07T10:28:26-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/2005-release
2022-07-07T10:28:26-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/2004-release
2022-07-07T10:28:29-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-acquires-kedalion-therapeutics-and-its-innovative-ocular-delivery-platform-could-transform-patient-experience
2022-07-20T15:51:51-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-presents-new-four-year-data-efficacy-and-safety-kesimpta-ofatumumab
2022-10-11T20:23:10-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-tafinlar-mekinist-approved-fda-pediatric-patients-braf-v600e-low-grade-glioma-most-common-pediatric-brain-cancer
2023-03-17T12:24:49-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-ribociclib-kisqali-only-category-1-preferred-first-line-treatment-option-hrher2-mbc-combination-ai-updated-nccn-clinical-practice-guidelines-oncology-nccn-guidelines
2023-03-29T10:40:34-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/fda-approves-novartis-kymriah-car-t-cell-therapy-adult-patients-relapsed-or-refractory-follicular-lymphoma-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/fda-approves-novartis-vijoice-alpelisib-first-and-only-treatment-select-patients-pik3ca-related-overgrowth-spectrum-pros-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-pluvictotm-approved-fda-first-targeted-radioligand-therapy-treatment-progressive-psma-positive-metastatic-castration-resistant-prostate-cancer-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-cosentyx-receives-fda-approval-treatment-children-and-adolescents-enthesitis-related-arthritis-and-psoriatic-arthritis-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/fda-approves-novartis-leqvio-inclisiran-first-class-sirna-lower-cholesterol-and-keep-it-low-two-doses-year-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-announces-t-chargetm-next-generation-car-t-platform-first-human-data-ash-2021-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-kymriah-demonstrates-strong-responses-high-risk-patients-relapsed-or-refractory-follicular-lymphoma-extended-study-follow-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-data-highlight-efficacy-piqray-hrher2-metastatic-breast-cancer-pik3ca-driver-mutation-immediately-post-cdk46i-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/new-kisqali-data-shows-consistent-overall-survival-benefit-across-genomic-and-clinical-subtypes-interest-hrher2-metastatic-breast-cancer-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-iptacopan-meets-primary-endpoints-phase-ii-study-rare-kidney-disease-c3-glomerulopathy-c3g-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/fda-approves-novartis-scemblix-asciminib-novel-mechanism-action-treatment-chronic-myeloid-leukemia-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-presents-new-kisqali-data-showing-longest-median-overall-survival-ever-reported-hrher2-advanced-breast-cancer-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-announces-findings-from-real-world-study-alpelisib-demonstrating-clinical-benefit-people-pik3ca-related-overgrowth-spectrum-pros-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-launches-meet-pros-raise-awareness-and-support-education-pik3ca-related-overgrowth-spectrum-pros-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-pledges-10-year-commitment-morehouse-school-medicine-26-historically-black-colleges-universities-medical-schools-and-other-leading-organizations-co-create-effective-measurable-solutions-health-equity-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-investigational-checkpoint-inhibitor-tislelizumab-met-primary-endpoint-overall-survival-pivotal-phase-iii-trial-esophageal-cancer-after-systemic-therapy-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-announces-tabrecta-first-published-overall-survival-and-updated-overall-response-data-patients-metex14-metastatic-nsclc-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-177lu-psma-617-significantly-improves-overall-survival-and-radiographic-progression-free-survival-men-metastatic-castration-resistant-prostate-cancer-phase-iii-vision-study-1
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-kymriah-pivotal-trial-demonstrates-strong-response-rates-and-remarkable-safety-profile-relapsed-or-refractory-follicular-lymphoma-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-kisqali-reports-longest-median-overall-survival-postmenopausal-hrher2-metastatic-breast-cancer-patients-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-cosentyx-receives-fda-approval-treatment-children-and-adolescents-moderate-severe-plaque-psoriasis-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-reports-one-year-results-phase-iii-merlin-study-evaluating-beovu-every-four-week-dosing-and-provides-update-beovu-clinical-program-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-commits-addressing-racial-disparities-breast-cancer-screening-treatment-and-care-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-phase-iii-beovu-data-show-potential-fluid-resolution-more-diabetic-macular-edema-patients-fewer-injections-versus-aflibercept-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-receives-fda-approval-xolair-omalizumab-self-injection-prefilled-syringe-across-all-indications-appropriate-patients-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-entresto-granted-expanded-indication-chronic-heart-failure-fda-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-announces-positive-fda-advisory-committee-recommendation-use-entresto-treat-patients-hfpef-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-kisqali-demonstrates-nearly-five-years-median-overall-survival-metastatic-breast-cancer-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-investigational-stamp-inhibitor-asciminib-abl001-shows-superior-mmr-rate-bosulif-chronic-myeloid-leukemia-trial-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-and-amgen-partner-karamo-brown-support-and-empower-people-living-migraine-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-announces-fda-approval-xolair-omalizumab-adults-nasal-polyps-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/new-data-ash-reinforce-breadth-novartis-hematology-portfolio-across-multiple-blood-cancers-and-serious-hematologic-diseases-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/new-novartis-analyses-investigational-inclisiran-demonstrate-consistently-effective-and-sustained-ldl-c-reduction-month-17-regardless-age-and-gender-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-cosentyx-shows-early-synovitis-reduction-patients-psoriatic-arthritis-first-its-kind-study-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-announces-five-year-data-reinforce-safety-and-efficacy-profile-aimovig-erenumab-aooe-adult-patients-episodic-migraine-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-us-foundation-commits-25m-improve-health-equity-reducing-health-disparities-us-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-presents-data-actrims-ectrims-kesimpta-ofatumumab-newly-diagnosed-treatment-naive-adults-relapsing-multiple-sclerosis-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-new-analysis-shows-high-consistency-lowering-ldl-c-individual-response-investigational-inclisiran-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-launches-pso-know-podcast-series-hosted-music-icon-cyndi-lauper-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/fda-approves-novartis-kesimpta-ofatumumab-first-and-only-self-administered-targeted-b-cell-therapy-patients-relapsing-multiple-sclerosis-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-announces-fda-filing-acceptance-xolair-omalizumab-prefilled-syringe-self-administration-across-all-indications-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-announces-nejm-publication-phase-iii-asclepios-trials-demonstrating-superior-efficacy-ofatumumab-patients-relapsing-multiple-sclerosis-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-cosentyx-receives-fda-approval-new-indication-treat-active-non-radiographic-axial-spondyloarthritis-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-announces-long-term-relapse-free-survival-benefit-high-risk-stage-iii-melanoma-patients-treated-tafinlar-mekinist-following-surgery-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-announces-new-late-breaking-ofatumumab-data-ean-underscoring-commitment-advancing-treatment-relapsing-forms-multiple-sclerosis-rms-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-kisqali-shows-overall-survival-benefit-hrher2-advanced-breast-cancer-consistent-findings-patients-more-aggressive-disease-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-announces-fda-approval-met-inhibitor-tabrectatm-metastatic-non-small-cell-lung-cancer-metex14-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-us-foundation-supports-telehealth-programs-provide-access-care-new-jerseys-most-vulnerable-communities-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-new-analysis-further-showed-durable-and-potent-ldl-c-reduction-inclisiran-investigational-first-class-sirna-cholesterol-lowering-treatment-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-announces-met-inhibitor-capmatinib-inc280-first-potential-treatment-metex14-mutated-advanced-non-small-cell-lung-cancer-granted-priority-fda-review-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/public-private-collaboration-commits-accelerate-access-health-services-africa-reaching-17-million-people-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-announces-fda-filing-acceptance-xolair-omalizumab-treatment-nasal-polyps-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-kymriah-demonstrates-consistent-efficacy-and-safety-outcomes-us-patients-when-used-real-world-setting-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/new-novartis-medicine-adakveo-crizanlizumab-tmca-approved-fda-reduce-frequency-pain-crises-individuals-living-sickle-cell-disease-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-launches-pso-work-music-icon-cyndi-lauper-bring-life-impact-psoriasis-can-have-workplace-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-step-programtm-now-accepting-submissions-proposals-address-unmet-patient-needs-cancer-biomarker-testing-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-receives-fda-approval-beovu-offering-wet-amd-patients-vision-gains-and-greater-fluid-reductions-vs-aflibercept-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-positive-52-week-prevent-data-confirm-cosentyx-efficacy-addressing-entire-axspa-spectrum-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/avexis-presents-new-data-epns-continuing-show-significant-therapeutic-benefit-zolgensma-prolonging-event-free-survival-now-5-years-age-patients-spinal-muscular-atrophy-sma-type-1-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/entresto-improved-measures-heart-structure-and-function-hfref-patients-new-novartis-study-additional-data-complement-findings-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-teams-celebrity-interior-designer-nate-berkus-launch-my-home-sight-program-empowering-people-wet-amd-live-more-independently-home-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/fda-accepts-file-and-accelerates-review-novartis-sickle-cell-disease-medicine-crizanlizumab-seg101-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-offers-free-genetic-mutation-testing-program-advanced-melanoma-patients-results-can-help-doctors-and-patients-making-cancer-treatment-decisions-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/long-term-survival-benefit-shown-metastatic-melanoma-patients-treated-novartis-tafinlar-mekinist-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-shows-growing-strength-lung-cancer-innovation-new-capmatinib-investigational-data-and-novel-canakinumab-clinical-trials-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/avexis-announces-innovative-zolgensma-gene-therapy-access-programs-us-payers-and-families-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/avexis-receives-fda-approval-zolgensma-first-and-only-gene-therapy-pediatric-patients-spinal-muscular-atrophy-sma-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-data-asco-and-eha-demonstrate-novel-approaches-reimagining-medicine-cancer-and-serious-blood-disorders-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/five-nonprofit-organizations-receive-250000-through-novartis-step-programtm-support-sickle-cell-patient-initiatives-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-issues-voluntary-nationwide-recall-promacta-125-mg-oral-suspension-due-potential-peanut-contamination-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/new-avexis-data-aan-showed-long-term-durability-zolgensma-patients-spinal-muscular-atrophy-sma-type-1-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/avexis-presented-robust-data-aan-demonstrating-efficacy-zolgensma-broad-spectrum-spinal-muscular-atrophy-sma-patients-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-announces-fda-filing-acceptance-and-priority-review-brolucizumab-rth258-patients-wet-amd-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/avexis-expands-world-leading-gene-therapy-manufacturing-capacity-purchase-advanced-biologics-therapy-manufacturing-campus-longmont-colorado-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-receives-fda-approval-mayzent-siponimod-first-oral-drug-treat-secondary-progressive-ms-active-disease-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-late-breaking-data-further-support-initiation-entresto-hospital-and-first-choice-systolic-heart-failure-therapy-stabilized-patients-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-data-show-psoriasis-patients-treated-cosentyx-reported-improvements-quality-life-measures-early-week-4-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-investigational-therapy-crizanlizumab-seg101-receives-fda-breakthrough-therapy-designation-prevention-vaso-occlusive-crises-sickle-cell-disease-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-data-demonstrates-consistent-efficacy-and-tolerability-kisqali-combination-therapy-hrher2-advanced-breast-cancer-patients-difficult-treat-visceral-disease-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-investigational-byl719-alpelisib-plus-fulvestrant-consistently-improved-pfs-patients-pik3ca-mutated-hrher2-advanced-breast-cancer-new-solar-1-analyses-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/real-world-data-show-novartis-drug-promacta-improves-outcomes-itp-patients-compared-other-second-line-therapies-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-announces-longer-term-analyses-from-pivotal-kymriah-trials-showed-durable-responses-are-maintained-patients-advanced-blood-cancers-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-announces-new-crizanlizumab-seg101-data-analysis-sickle-cell-disease-and-investment-sentry-clinical-program-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/fda-approves-novartis-drug-promacta-first-line-saa-and-grants-breakthrough-therapy-designation-additional-new-indication-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-fund-five-innovative-ideas-support-patients-and-sickle-cell-community-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/new-novartis-study-supports-entresto-foundational-hfref-therapy-and-hospital-initiation-appropriate-stabilized-heart-failure-patients-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-data-ash-and-sabcs-show-strength-pipeline-and-portfolio-hematology-and-oncology-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-wins-esteemed-prix-galien-foundation-best-biotechnology-product-award-car-t-cell-therapy-kymriah-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/two-year-data-novartis-brolucizumab-reaffirm-superiority-versus-aflibercept-reducing-retinal-fluid-patients-namd-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-presents-new-cosentyx-data-demonstrating-long-term-response-and-safety-ankylosing-spondylitis-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-analysis-shows-crizanlizumab-seg101-increased-number-patients-free-sickle-cell-pain-crises-vs-placebo-during-sustain-study-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-announces-fda-filing-acceptance-siponimod-baf312-first-and-only-oral-drug-shown-delay-disability-progression-typical-spms-patients-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-teams-recording-artist-and-actress-jordin-sparks-and-scdaa-launch-generation-s-inspiring-new-sickle-cell-storytelling-project-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-announces-nejm-publication-landmark-paradigms-study-demonstrating-significant-benefit-gilenya-children-and-adolescents-relapsing-multiple-sclerosis-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-kisqali-now-first-and-only-cdk46-inhibitor-indicated-us-first-line-therapy-specifically-premenopausal-women-and-initial-therapy-fulvestrant-postmenopausal-women-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-launches-galaxies-hope-app-digital-experience-neuroendocrine-tumor-net-cancer-community-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/sandoz-inc-and-its-affiliate-novartis-pharmaceuticals-corporation-voluntarily-recall-select-blister-packages-products-us-due-packaging-requirements-child-resistance-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-and-amgen-highlight-findings-from-large-global-patient-survey-revealing-worldwide-approximately-60-employed-people-migraine-missed-average-week-work-month-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-announces-funding-patient-advocacy-initiatives-support-and-empower-metastatic-breast-cancer-community-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-receives-fda-approval-inclusion-new-evidence-cosentyx-inhibits-progression-joint-structural-damage-psoriatic-arthritis-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-juliet-trial-kymriah-demonstrates-more-one-year-durability-responses-adults-relapsed-or-refractory-dlbcl-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-survey-uncovers-real-world-impact-immune-thrombocytopenia-or-itp-rare-blood-disease-patients-quality-life-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/third-novartis-phase-iii-trial-shows-kisqali-combination-therapy-significantly-improves-pfs-hrher2-advanced-breast-cancer-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/fda-expedites-review-novartis-drug-promacta-first-line-severe-aplastic-anemia-saa-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/patient-reported-outcomes-tool-revealed-significant-improvement-symptom-frequency-and-quality-life-domains-entresto-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-and-amgen-announce-fda-approval-aimovigtm-erenumab-aooe-novel-treatment-developed-specifically-migraine-prevention-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-data-asco-and-eha-reinforce-companys-commitment-reimagining-cancer-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/alcon-teams-venus-williams-tennis-champion-and-dry-eye-sufferer-launch-systane-complete-eye-drops-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-announces-fda-approval-gilenya-first-disease-modifying-therapy-pediatric-relapsing-multiple-sclerosis-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/kymriah-tisagenlecleucel-first-class-car-t-therapy-from-novartis-receives-second-fda-approval-treat-appropriate-rr-patients-large-b-cell-lymphoma-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/alcon-introduces-air-optix-colors-contact-lenses-gemstone-collection-creating-new-ways-enhance-and-play-eye-color-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/new-novartis-phase-iii-data-brolucizumab-demonstrate-reliability-12-week-treatment-interval-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-launches-focalview-app-providing-opportunity-patients-participate-ophthalmology-clinical-trials-from-home-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/phase-iii-data-lancet-show-novartis-siponimod-significantly-improved-outcomes-patients-secondary-progressive-ms-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-new-data-show-cosentyx-improved-quality-life-over-5-years-two-thirds-patients-moderate-severe-plaque-psoriasis-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-receives-fda-approval-cosentyx-label-update-include-moderate-severe-scalp-psoriasis-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-new-data-reinforces-superiority-cosentyx-versus-stelara-achieving-skin-clearance-psoriasis-patients-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-drug-promacta-receives-fda-breakthrough-therapy-designation-first-line-use-severe-aplastic-anemia-saa-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-kisqali-received-fda-breakthrough-therapy-designation-initial-endocrine-based-treatment-premenopausal-women-hrher2-advanced-breast-cancer-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-multiple-sclerosis-therapy-fingolimod-granted-fda-breakthrough-therapy-designation-pediatric-ms-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-drug-crizanlizumab-shown-prolong-time-patients-first-sickle-cell-pain-crisis-subgroup-analysis-sustain-study-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/primary-analysis-results-from-novartis-pivotal-juliet-trial-show-kymriahtm-tisagenlecleucel-sustained-complete-responses-six-months-adults-rr-dlbcl-difficult-treat-cancer-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-initiates-study-evaluating-impact-higher-dosing-cosentyx-patients-ankylosing-spondylitis-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-kisqali-first-and-only-cdk46-inhibitor-show-superior-median-pfs-compared-oral-endocrine-therapy-first-line-treatment-prospective-randomized-phase-iii-trial-dedicated-premenopausal-women-hrher2-advanced-breast-cancer-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-presents-new-data-sabcs-across-broad-range-breast-cancer-patient-populations-combination-treatments-and-lines-therapy-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-canakinumab-acz885-reduced-cardiovascular-risk-25-subgroup-cantos-phase-iii-trial-participants-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-brolucizumab-rth258-demonstrates-superiority-versus-aflibercept-key-secondary-endpoint-measures-disease-activity-namd-leading-cause-blindness-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-announces-study-data-demonstrating-cosentyx-reduced-signs-and-symptoms-psoriatic-arthritis-while-inhibiting-progression-joint-structural-damage-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-presents-data-ash-patients-serious-blood-disorders-lymphoma-leukemia-and-sickle-cell-disease-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-pivotal-data-show-children-and-adolescents-relapsing-ms-had-82-lower-relapse-rate-fingolimod-vs-interferon-beta-1a-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-collaborates-pop-icon-cyndi-lauper-release-new-song-honor-world-psoriasis-day-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-drug-promacta-shows-long-term-disease-control-chronicpersistent-immune-thrombocytopenia-itp-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/alcon-dailies-teams-us-olympians-world-class-gymnast-laurie-hernandez-and-soccer-star-tobin-heath-launch-invisible-edge-campaign-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-teams-actress-producer-and-activist-eva-longoria-launch-kiss-4-mbctm-generate-research-funding-and-support-metastatic-breast-cancer-community-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-cosentyx-sets-new-benchmark-psoriasis-robust-5-year-sustained-efficacy-and-safety-phase-iii-data-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/multimedia-assets-now-available-novartis-receives-first-ever-fda-approval-car-t-cell-therapy-kymriahtm-tisagenlecleucel-ctl019-children-and-young-adults-b-cell-all-refractory-or-has-relapsed-least-twice-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-receives-first-ever-fda-approval-car-t-cell-therapy-kymriahtm-tisagenlecleucel-ctl019-children-and-young-adults-b-cell-all-refractory-or-has-relapsed-least-twice-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-launches-first-large-scale-research-study-multiple-sclerosis-allows-participants-contribute-from-smartphones-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/fda-accepts-biologics-license-application-amg-334-erenumab-important-regulatory-milestone-novartis-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-confirms-5-year-data-first-and-only-fully-human-il-17a-inhibitor-cosentyx-reinforcing-sustained-efficacy-and-safety-profile-psoriasis-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-pivotal-ctl019-6-month-follow-data-show-durable-remission-rates-children-young-adults-rr-b-cell-all-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-interim-results-from-global-pivotal-ctl019-trial-show-durable-complete-responses-adults-rr-dlbcl-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-receives-fda-approval-first-its-kind-kisqali-femara-co-pack-initial-treatment-hrher2-advanced-or-metastatic-breast-cancer-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-expands-global-collaboration-amgen-commercialize-first-class-amg-334-erenumab-program-migraine-prevention-us-and-canada-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-car-t-cell-therapy-ctl019-receives-fda-breakthrough-therapy-designation-treatment-adult-patients-rr-dlbcl-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-announces-first-car-t-cell-therapy-bla-pediatric-and-young-adult-patients-rr-b-cell-all-granted-fda-priority-review-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/new-analysis-shows-novartis-entresto-improves-glycemic-control-reduced-ejection-fraction-heart-failure-patients-diabetes-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-cosentyx-shows-almost-all-psoriasis-patients-rapidly-regain-skin-clearance-following-treatment-pause-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/alcon-receives-us-fda-approval-acrysof-iq-restor-30d-multifocal-toric-intraocular-lens-cataract-patients-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-out-licenses-three-copd-products-us-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-presents-results-from-first-global-registration-trial-ctl019-pediatric-and-young-adult-patients-rr-b-all-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/new-analysis-novartis-entresto-data-shows-long-term-benefits-heart-failure-readmissions-and-total-cardiovascular-deaths-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/alcon-introduces-new-air-optix-plus-hydraglyde-monthly-replacement-contact-lenses-american-academy-optometry-annual-meeting-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-partners-prominent-us-health-advocacy-organizations-launch-first-social-networking-platform-heart-failure-patients-and-their-loved-ones-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-late-breaking-data-show-cosentyx-continues-deliver-high-skin-clearance-majority-psoriasis-patients-four-years-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-receives-three-new-fda-approvals-expanded-use-ilaris-patients-rare-periodic-fever-syndrome-conditions-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/important-new-analysis-shows-novartis-entresto-associated-higher-relative-health-related-quality-life-scores-among-hfref-patients-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-baf312-reduced-risk-disability-progression-pivotal-phase-iii-study-secondary-progressive-ms-patients-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-data-finds-relapsing-ms-patients-gilenya-had-greater-treatment-retention-and-satisfaction-rates-vs-injectable-dmts-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-announces-fda-approval-xolair-omalizumab-pediatric-allergic-asthma-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/largest-global-psoriasis-survey-shows-85-us-respondents-faced-social-stigma-discrimination-and-humiliation-because-their-skin-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/timely-use-novartis-entresto-could-prevent-or-postpone-over-28000-us-deaths-year-among-hfref-patients-according-expert-analysis-jama-cardiology-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-data-show-gilenya-had-significantly-greater-patient-retention-compared-idmts-relapsing-remitting-ms-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/media-statement-leading-us-cardiology-societies-strongly-recommend-entresto-new-standard-care-treatment-earlier-expected-joint-update-clinical-practice-guidelines-heart-failure-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/media-statement-fortihfy-global-clinical-program-entresto-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-receives-three-fda-breakthrough-therapy-designations-ilaris-treat-rare-types-periodic-fever-syndromes-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/new-analyses-show-novartis-entrestotm-reduced-cardiovascular-death-or-hospitalization-heart-failure-consistently-benefitting-patients-reduced-ejection-fraction-hfref-regardless-prior-heart-failure-hospital-admissions-or-background-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/new-novartis-data-show-cosentyx-demonstrated-sustained-superiority-skin-clearance-pasi-90-versus-stelara-week-52-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/fda-approves-new-indication-novartis-drug-afinitor-progressive-nonfunctional-gi-and-lung-neuroendocrine-tumors-net-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-receives-two-new-fda-approvals-cosentyx-secukinumab-treat-patients-ankylosing-spondylitis-and-psoriatic-arthritis-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-announces-publication-two-landmark-studies-nejm-demonstrating-efficacy-cosentyx-patients-ankylosing-spondylitis-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-highlights-new-ctl019-phase-ii-data-demonstrating-93-complete-remission-pediatric-patients-rr-all-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-announces-new-ctl019-study-data-demonstrating-overall-response-adult-patients-certain-types-lymphoma-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-pharmaceuticals-corporation-finalizes-settlement-agreement-resolving-civil-suit-filed-us-attorneys-office-southern-district-new-york-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-heart-failure-medicine-entrestotm-substantially-cuts-30-day-hospital-readmissions-new-post-hoc-analysis-shows-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/80-ankylosing-spondylitis-patients-treated-cosentyx-show-no-spinal-x-ray-progression-shown-novartis-new-two-year-observational-data-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/approximately-80-psoriatic-arthritis-patients-treated-cosentyx-saw-no-progression-joint-damage-shown-novartis-new-two-year-observational-data-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/fda-approves-new-novartis-dual-combination-bronchodilator-utibrontm-neohaler-patients-chronic-obstructive-pulmonary-disease-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-clarification-specialty-pharmacy-settlement-principle-announcement-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-announces-nejm-publication-secukinumab-phase-iii-data-confirming-significant-efficacy-patients-psoriatic-arthritis-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/patients-aggressive-form-melanoma-lived-more-two-years-average-when-taking-novartis-therapies-tafinlar-mekinist-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-launches-novartis-access-portfolio-affordable-medicines-treat-chronic-diseases-lower-income-countries-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/fda-approves-novartis-drug-odomzo-sonidegib-locally-advanced-basal-cell-carcinoma-labcc-form-skin-cancer-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-new-heart-failure-medicine-lcz696-approved-fda-reduce-risk-cardiovascular-death-and-heart-failure-hospitalization-now-called-entrestotm-sacubitrilvalsartan-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-presents-new-data-wcd-shows-significant-efficacy-cosentyx-patients-psoriasis-palms-soles-feet-and-nails-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-highlights-ctl019-data-showing-its-potential-treatment-specific-types-hard-treat-non-hodgkin-lymphoma-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/combination-novartis-drugs-tafinlar-and-mekinist-shows-significant-survival-benefit-patients-metastatic-melanoma-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-investigational-dual-bronchodilator-significantly-improved-lung-function-compared-single-bronchodilators-patients-moderate-severe-copd-phase-iii-studies-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-pharmaceuticals-corporation-first-company-receive-number-one-ranking-two-years-row-diversityinc-top-50-companies-diversity-list-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-announces-fda-approval-jadenutm-simplify-treatment-administration-patients-chronic-iron-overload-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-presents-cosentyxtm-two-year-efficacy-and-safety-data-showing-sustainable-effect-psoriasis-patients-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/new-novartis-data-show-more-cosentyxtm-treated-psoriasis-patients-achieved-clear-or-almost-clear-skin-pasi-90-compared-stelara-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-heart-failure-medicine-lcz696-granted-fda-priority-review-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-announces-fda-approval-first-il-17a-antagonist-cosentyxtm-secukinumab-moderate-severe-plaque-psoriasis-patients-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-gains-fda-approval-signifor-lar-treat-patients-acromegaly-rare-and-life-threatening-hormonal-disorder-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-gains-fda-approval-signifor-lar-treat-patients-acromegaly-rare-and-life-threatening-hormonal-disorder-1
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-highlights-new-ctl019-clinical-data-showing-complete-remissions-children-and-young-adults-relapsedrefractory-acute-lymphoblastic-leukemia-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/nine-new-analyses-show-novartis-lcz696-could-change-course-heart-failure-patients-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-first-il-17a-phase-iii-results-show-ain457-secukinumab-significantly-improves-psoriatic-arthritis-patients-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-ain457-secukinumab-showed-significant-symptom-improvement-two-pivotal-phase-iii-ankylosing-spondylitis-studies-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-present-first-il-17a-phase-iii-data-ain457-secukinumab-psoriatic-arthritis-and-ankylosing-spondylitis-acr-2014-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-teams-multiple-sclerosis-advocate-and-musician-david-osmond-launch-ms-education-initiative-our-voice-songtm-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-announces-fda-advisory-committee-unanimously-recommends-approval-ain457-secukinumab-patients-moderate-severe-plaque-psoriasis-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-announces-ctl019-data-published-nejm-demonstrating-efficacy-certain-patients-acute-lymphoblastic-leukemia-all-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-drug-afinitor-first-treatment-advanced-pancreatic-net-provide-overall-survival-more-35-years-phase-iii-trial-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-new-heart-failure-medicine-lcz696-cut-cardiovascular-deaths-20-vs-ace-inhibitor-landmark-paradigm-hf-trial-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-showcase-heart-failure-leadership-esc-congress-2014-results-new-first-its-type-medicine-lcz696-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-announces-nejm-publication-two-pivotal-phase-iii-secukinumab-studies-demonstrating-statistically-significant-skin-clearance-psoriasis-patients-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-personalized-cell-therapy-ctl019-receives-fda-breakthrough-therapy-designation-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/pivotal-data-novartis-investigational-compound-lde225-show-marked-tumor-responses-advanced-basal-cell-carcinoma-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-presents-key-advances-cancer-research-asco-and-eha-from-four-new-pivotal-studies-lung-blood-and-skin-cancers-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-drug-signifor-lar-shows-superior-efficacy-acromegaly-patients-not-controlled-first-generation-somatostatin-analogues-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-recognized-top-ranking-company-us-diversityinc-top-50-companies-diversity-list-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-reports-new-phase-iii-data-showing-secukinumab-ain457-improved-moderate-severe-plaque-psoriasis-patients-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-announces-fda-approval-xolair-omalizumab-chronic-idiopathic-urticaria-ciu-form-chronic-hives-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-pharmaceuticals-corporation-stands-behind-medication-adherence-activities-and-reaffirms-commitment-patient-safety-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-highlights-research-investigational-personalized-t-cell-therapy-ctl019-patients-forms-acute-and-chronic-leukemia-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-hosts-competition-create-novel-mobile-solutions-heart-failure-caregivers-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-announces-new-data-effects-investigational-rlx030-kidney-blood-flow-chronic-heart-failure-patients-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-exelon-patch-now-fda-approved-treat-patients-across-all-stages-alzheimers-disease-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/tv-host-phil-keoghan-and-novartis-team-inspire-people-ms-through-innovative-tandem-cycling-campaign-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/relapsing-ms-patients-more-satisfied-novartis-oral-drug-gilenya-standard-injectable-therapies-according-new-study-results-cmsc-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-highlights-new-findings-advancing-care-patients-170-abstracts-breast-lung-and-blood-cancers-asco-and-eha-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-pharmaceuticals-corporation-disputes-allegations-two-us-government-lawsuits-and-looks-forward-fair-discussion-facts-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/fda-approves-novartis-tobi-podhalertm-certain-cystic-fibrosis-patients-first-and-only-dry-powder-inhaled-antibacterial-us-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/new-analysis-shows-novartis-drug-gilenya-significantly-reduced-rate-brain-volume-loss-across-three-large-phase-iii-studies-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-reports-omalizumab-significantly-improved-chronic-idiopathic-urticaria-symptoms-patients-who-failed-standard-therapy-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-drug-zortress-first-over-decade-approved-fda-prevent-organ-rejection-adult-liver-transplant-patients-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-drug-exjade-first-treatment-approved-fda-chronic-iron-overload-patients-non-transfusion-dependent-thalassemia-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/nejm-published-study-shows-novartis-compound-acz885-significantly-relieves-symptoms-patients-serious-form-childhood-arthritis-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/multimedia-assets-novartis-drug-signifor-gains-fda-approval-first-medication-treat-cushings-disease-serious-endocrine-disorder-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-drug-signifor-gains-fda-approval-first-medication-treat-cushings-disease-serious-endocrine-disorder-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-phase-iii-study-shows-rlx030-improved-symptoms-and-reduced-deaths-one-third-patients-acute-heart-failure-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/leeza-gibbons-joins-novartis-improve-caregiving-experience-millions-americans-through-real-world-peer-advice-alzheimersdiseasecom-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-pharmaceuticals-corporation-emprende-una-campana-de-educacion-de-la-comunidad-hispana-de-ee-uu-sobre-la-enfermedad-de-alzheimer-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-pharmaceuticals-corporation-embarks-alzheimers-disease-educational-effort-us-hispanic-community-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/fda-advisory-committee-supports-use-tobramycin-inhalation-powder-from-novartis-patients-cystic-fibrosis-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/higher-dose-novartis-drug-exelon-patch-approved-fda-patients-mild-moderate-alzheimers-disease-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/npc-statement-comments-made-media-coverage-paycheck-fairness-act-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/two-new-analyses-reinforce-consistent-efficacy-novartis-therapy-gilenya-across-wide-range-relapsing-ms-patients-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/tv-host-phil-keoghan-and-professional-women-cyclists-join-novartis-raise-awareness-multiple-sclerosis-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/higher-dose-novartis-drug-exelon-patch-showed-statistically-significantly-less-decline-function-alzheimers-vs-lower-dose-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/new-extension-study-data-novartis-drug-gilenya-shows-patients-successfully-treated-7-years-relapsing-ms-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-announces-update-united-states-prescribing-information-ms-therapy-gilenya-following-fda-review-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-expands-transplant-portfolio-hecoria-first-generic-tacrolimus-can-be-prescribed-brand-name-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-launches-arcaptatm-neohalertm-novel-once-daily-bronchodilator-chronic-obstructive-pulmonary-disease-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/plaintiff-sales-representatives-and-novartis-pharmaceuticals-corporation-resolve-class-action-wage-and-hour-claims-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-pivotal-study-exjade-shows-significant-reduction-iron-overload-patients-non-transfusion-dependent-thalassemia-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/two-novartis-phase-iii-studies-show-twice-many-ph-cml-patients-achieve-deeper-levels-response-tasigna-compared-gleevec-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-phase-iii-study-shows-acz885-helped-substantially-reduce-steroid-use-45-patients-serious-form-childhood-arthritis-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-drug-afinitor-helps-women-advanced-breast-cancer-live-significantly-longer-without-their-disease-progressing-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-study-shows-qti571-significantly-improved-walking-distance-patients-life-threatening-pulmonary-arterial-hypertension-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-drug-afinitor-effective-patients-non-cancerous-kidney-tumors-associated-tsc-phase-iii-trial-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-study-showed-acz885-provided-substantial-symptom-relief-84-patients-most-serious-form-childhood-arthritis-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/fda-approves-supplemental-new-drug-application-novartis-therapy-gilenyatm-include-data-showing-reduction-t1-lesions-ms-marker-disease-activity-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-receives-fda-approval-arcaptatm-neohalertm-novel-once-daily-bronchodilator-chronic-obstructive-pulmonary-disease-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-data-shows-acz885-severe-gouty-arthritis-provided-better-pain-relief-and-reduced-risk-new-attacks-68-vs-steroid-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-teams-phil-keoghan-host-amazing-race-raise-awareness-multiple-sclerosis-through-inspirational-national-bike-tour-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-gains-fda-approval-afinitor-first-new-treatment-nearly-three-decades-patients-advanced-pancreatic-net-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-therapy-gilenyatm-reduced-risk-ms-disability-progression-regardless-treatment-history-or-disease-severity-new-analysis-shows-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/fda-advisory-committee-recommends-us-approval-novartis-once-daily-bronchodilator-qab149-copd-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/important-information-extavia-interferon-beta-1-b-patients-regarding-triad-groups-alcohol-prep-products-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-gains-fda-approval-amturnidetm-triple-combination-pill-treat-high-blood-pressure-patients-uncontrolled-two-medications-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/longer-term-phase-iii-data-show-novartis-drug-tasigna-continues-surpass-gleevec-slowing-disease-progression-patients-newly-diagnosed-cml-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-pharmaceuticals-corporation-restructuring-us-field-force-align-changing-product-portfolio-and-strategic-growth-priorities-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/new-stand-together-ad-campaign-provides-strength-support-and-important-resources-11-million-alzheimers-caregivers-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/analysis-shows-novartis-drug-tobi-associated-reduced-mortality-cystic-fibrosis-patients-common-lung-infection-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-gains-fda-approval-gilenyatm-novel-first-line-multiple-sclerosis-treatment-shown-significantly-reduce-relapses-and-delay-disability-progression-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-receives-fda-approval-tekamlotm-single-pill-combination-aliskiren-and-amlodipine-treat-high-blood-pressure-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/us-affiliate-novartis-strongly-disputes-claims-past-discrimination-us-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-pharmaceuticals-corporation-prevails-medicaid-pricing-case-alabama-supreme-court-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/fda-approves-tekturna-hct-initial-treatment-patients-unlikely-achieve-their-blood-pressure-goals-single-agent-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/video-new-biological-therapy-ilaris-approved-us-treat-children-and-adults-caps-serious-life-long-auto-inflammatory-disease-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/video-fda-approves-exforge-hct-only-high-blood-pressure-treatment-combine-three-medications-single-pill-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/video-gleevec-receives-us-approval-first-treatment-reduce-risk-cancer-returning-patients-gastrointestinal-stromal-tumors-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/rad001-shows-potential-reverse-resistance-herceptin-metastatic-breast-cancer-patients-leading-phase-iii-trial-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/video-novartis-vaccines-and-pta-battle-flu-public-health-vaccination-initiative-urges-families-lets-fight-flu-together-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/early-data-show-potential-imatinib-mesylate-tablets-treat-life-threatening-form-pulmonary-artery-disease-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/rad001-combined-sandostatin-lar-depot-and-monotherapy-controls-growth-rare-pancreatic-neuroendocrine-tumors-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/rad001-granted-priority-review-us-based-potential-fill-unmet-medical-need-patients-advanced-kidney-cancer-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-pharmaceuticals-corporation-appeal-judgment-alabama-pricing-case-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/video-higher-initial-dose-gleevec-achieved-better-early-responses-standard-dose-patients-chronic-myeloid-leukemia-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/early-data-presented-asco-show-potential-rad001-enhance-efficacy-and-overcome-resistance-breast-cancer-treatments-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/video-major-independent-trial-demonstrates-significant-anticancer-benefit-zometa-women-early-stage-breast-cancer-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/rad001-more-doubles-time-without-tumor-growth-after-failure-standard-treatment-patients-advanced-kidney-cancer-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/strength-and-innovation-novartis-oncology-products-and-pipeline-potential-improve-patient-treatment-demonstrated-more-170-abstracts-asco-annual-meeting-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/video-femara-helps-protect-against-return-breast-cancer-even-when-treatment-starts-several-years-after-completing-tamoxifen-therapy-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/everolimus-rad001-significantly-extends-progression-free-survival-advanced-kidney-cancer-patients-after-failure-other-targeted-therapy-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/video-and-photo-tekturna-hct-single-tablet-combination-tekturna-and-diuretic-receives-us-approval-treatment-high-blood-pressure-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/photo-new-data-show-gleevec-halts-progression-advanced-stages-life-threatening-form-leukemia-sixth-year-treatment-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/news-release-1-headline-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/2005-release-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/2004-release-0
2023-06-03T05:49:16-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-kisqali-significantly-reduced-risk-recurrence-25-across-broad-population-patients-early-breast-cancer-clinically-meaningful-benefit-was-consistent-across-subgroups
2024-03-04T06:49:58-05:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-presents-new-five-year-data-disability-outcomes-and-safety-kesimpta-ofatumumab-people-living-relapsing-multiple-sclerosis
2023-12-28T13:50:04-05:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-kisqali-phase-iii-natalee-trial-meets-primary-endpoint-interim-analysis-demonstrating-clinically-meaningful-benefit-broad-population-patients-early-breast-cancer
2024-03-15T07:05:12-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-presents-pivotal-phase-iii-apply-pnh-data-ash-demonstrating-investigational-oral-monotherapy-iptacopan-superiority-over-anti-c5
2024-01-25T07:04:35-05:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-investigational-iptacopan-provides-clinically-meaningful-increases-hemoglobin-levels-complement-inhibitor-naive-patients-pnh
2024-02-11T06:49:41-05:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-kisqali-prolonged-pfs-benefit-pre-and-perimenopausal-patients-aggressive-hrher2-metastatic-breast-cancer-compared-chemotherapy
2023-12-28T13:50:04-05:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-highlights-scientific-advances-kisqali-iptacopan-scemblix-and-ytb323-data-sabcs-and-ash
2023-12-28T13:50:04-05:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-expands-beacon-hope-through-alliances-historically-black-medical-schools-address-systemic-health-disparities
2023-12-14T06:50:05-05:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-scemblix-novel-mechanism-action-shows-superior-long-term-efficacy-and-consistent-tolerability-96-week-follow-chronic-myeloid-leukemia-trial
2023-12-28T13:50:04-05:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-premieres-powerful-new-docuseries-tribeca-festival-shine-light-debilitating-skin-disease
2024-03-04T07:05:03-05:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/us-fda-approves-expanded-indication-novartis-leqvio-inclisiran-include-treatment-adults-high-ldl-c-and-who-are-increased-risk-heart-disease
2023-12-28T13:50:04-05:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-strengthens-commitment-beacon-hope-initiative-engages-new-collaborators-support-clinical-trial-diversity-break-down-economic-and-education-barriers
2023-12-28T13:50:04-05:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-presents-new-long-term-leqvio-inclisiran-data-demonstrating-consistent-efficacy-and-safety-beyond-six-years
2024-02-29T06:49:54-05:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-issues-voluntary-nationwide-recall-one-lot-sandimmune-oral-solution-cyclosporine-oral-solution-usp-100-mgml-due-crystallization
2023-12-28T13:35:07-05:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/fda-approves-novartis-cosentyx-first-intravenous-iv-formulation-interleukin-17a-antagonist-rheumatic-diseases
2023-12-28T13:50:04-05:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-pluvicto-shows-clinically-meaningful-and-highly-statistically-significant-rpfs-benefit-patients-psma-positive-metastatic-castration-resistant-prostate-cancer-pre-taxane-setting
2024-01-08T05:50:07-05:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-confirms-unconstrained-supply-pluvicto-and-continues-significantly-expand-number-treatment-centers
2023-10-26T17:47:07-04:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/fda-approves-novartis-cosentyx-first-new-biologic-treatment-option-hidradenitis-suppurativa-patients-nearly-decade
2023-12-28T13:50:04-05:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-issues-voluntary-us-nationwide-recall-two-lots-sandimmune-oral-solution-cyclosporine-oral-solution-usp-100-mgml-due-crystallization
2023-12-04T06:36:01-05:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-receives-fda-approval-fabhalta-iptacopan-offering-superior-hemoglobin-improvement-absence-transfusions-first-oral-monotherapy-adults-pnh
2023-12-06T00:35:53-05:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/latest-novartis-kisqali-natalee-analysis-reinforces-25-reduction-risk-recurrence-across-broad-population-patients-early-breast-cancer-supports-regulatory-submissions
2023-12-08T09:36:04-05:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-presents-new-48-week-results-from-phase-iii-apply-pnh-trial-showing-sustained-efficacy-and-long-term-safety-fabhalta-iptacopan-adults-paroxysmal-nocturnal-hemoglobinuria-pnh
2023-12-10T20:05:58-05:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-expands-production-pluvicto-addition-its-largest-and-most-advanced-radioligand-therapy-manufacturing-facility-indianapolis
2024-01-05T09:50:09-05:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/novartis-lutathera-significantly-reduced-risk-disease-progression-or-death-72-first-line-treatment-patients-advanced-gastroenteropancreatic-neuroendocrine-tumors
2024-01-19T10:19:32-05:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/fda-approves-xolair-omalizumab-first-and-only-medicine-children-and-adults-one-or-more-food-allergies
2024-02-16T11:34:40-05:00
daily
0.5
https://www.novartis.com/us-en/news/media-releases/new-england-journal-medicine-publishes-phase-iii-data-showing-xolair-omalizumab-significantly-reduced-allergic-reactions-across-multiple-foods-people-food-allergies
2024-02-25T14:04:54-05:00
daily
0.5
https://www.novartis.com/us-en/news/novartis-launches-new-preferred-firm-program-legal-services
2023-11-30T11:04:46-05:00
daily
1.0
https://www.novartis.com/us-en/news/novartis-pharmaceuticals-corporation-novartis-statement-recall-outside-united-states-sandoz-generic-valsartan-and-sandoz-valsartan-and-hydrochlorothiazide-film-coated-tablets
2023-11-30T11:06:40-05:00
daily
1.0
https://www.novartis.com/us-en/news/form-483-posting-us-food-and-drug-administration-fda-novartis-statement
2023-11-30T11:05:56-05:00
daily
1.0
https://www.novartis.com/us-en/news/novartis-provides-update-use-and-safety-beovu-patients-wet-amd
2023-12-01T19:32:25-05:00
daily
1.0
https://www.novartis.com/us-en/news/life-science-companies-and-bill-melinda-gates-foundation-joint-communique
2023-11-30T10:59:30-05:00
daily
1.0
https://www.novartis.com/us-en/news/beacon-hope-addressing-health-disparities-through-holistic-community-based-collective-action
2023-11-30T10:57:12-05:00
daily
1.0
https://www.novartis.com/us-en/news/updated-packaging-now-available-sandimmune-100-mg-blister-packages
2023-11-30T10:55:26-05:00
daily
1.0
https://www.novartis.com/us-en/news/new-policy-related-340b-program
2023-11-30T10:58:49-05:00
daily
1.0
https://www.novartis.com/us-en/news/notice-healthcare-providers-and-entities
2023-11-30T11:00:05-05:00
daily
1.0
https://www.novartis.com/us-en/news/standing-racial-equity-and-justice-one-novartis
2023-11-30T11:00:45-05:00
daily
1.0
https://www.novartis.com/us-en/news/novartis-joins-accelerating-covid-19-therapeutic-interventions-and-vaccines-activ-initiative
2023-11-30T11:01:33-05:00
daily
1.0
https://www.novartis.com/us-en/news/novartis-us-response-covid-19
2023-11-30T10:58:03-05:00
daily
1.0
https://www.novartis.com/us-en/news/corrective-action-certain-100-mg-sandimmune-and-neoral-blister-packages-us
2023-11-30T11:04:09-05:00
daily
1.0
https://www.novartis.com/us-en/news/radioligand-therapy-supply-information
2024-01-05T12:51:40-05:00
daily
1.0
https://www.novartis.com/us-en/news/highlighting-unmet-needs-hidradenitis-suppurativa-hs
2023-11-30T10:54:28-05:00
daily
1.0
https://www.novartis.com/us-en/news/collaborating-address-disparities-cancer-screening
2023-11-30T10:53:41-05:00
daily
1.0
https://www.novartis.com/us-en/stories/mccourty-twins-friends-shine-spotlight-sickle-cell-disease
2022-03-29T09:28:04-04:00
daily
1.0
https://www.novartis.com/us-en/stories/sourcing-innovation-strategically
2023-04-11T13:47:12-04:00
daily
1.0
https://www.novartis.com/us-en/stories/word-street-what-cell-and-gene-therapy
2022-03-29T04:11:13-04:00
daily
1.0
https://www.novartis.com/us-en/stories/day-reflection-novartis
2023-04-11T13:45:43-04:00
daily
1.0
https://www.novartis.com/us-en/stories/shaping-future-sickle-cell-disease
2022-07-21T09:54:08-04:00
daily
1.0
https://www.novartis.com/us-en/stories/novartis-looks-brightest-academic-minds-reimagine-metastatic-breast-cancer-treatment
2023-04-11T13:53:19-04:00
daily
1.0
https://www.novartis.com/us-en/stories/working-together-novartis-fight-covid-19-and-help-people-need
2023-04-11T13:54:40-04:00
daily
1.0
https://www.novartis.com/us-en/stories/reimagining-healthcare-challenging-times-novartis-society-us-report-2020
2023-04-11T13:50:28-04:00
daily
1.0
https://www.novartis.com/us-en/stories/telemedicine-helping-patients-underserved-communities-access-quality-healthcare
2022-03-29T09:16:34-04:00
daily
1.0
https://www.novartis.com/us-en/stories/understanding-heart-health-inequities-during-black-history-month
2023-04-11T13:49:02-04:00
daily
1.0
https://www.novartis.com/us-en/stories/building-clinical-trial-diversity-long-term-equity
2023-04-11T14:02:04-04:00
daily
1.0
https://www.novartis.com/us-en/stories/home-app-helps-patients-stay-engaged-and-adherent-vision-monitoring-remotely
2023-04-11T14:03:46-04:00
daily
1.0
https://www.novartis.com/us-en/stories/addressing-health-inequities-starts-looking-within
2023-04-11T14:00:47-04:00
daily
1.0
https://www.novartis.com/us-en/stories/learning-connecting-and-moving-forward-together
2022-03-29T09:36:09-04:00
daily
1.0
https://www.novartis.com/us-en/stories/our-collective-commitment-dei-movement
2022-07-20T12:28:53-04:00
daily
1.0
https://www.novartis.com/us-en/stories/know-facts-and-be-advocate-prostate-cancer-awareness-month
2023-09-15T10:46:41-04:00
daily
1.0
https://www.novartis.com/us-en/stories/remembering-mens-health-national-veterans-and-military-families-month
2023-11-14T02:29:35-05:00
daily
1.0